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SUMMARY AND EXPLANATION OF DISSERTATION FORMAT 
This dissertation is divided into an introduction, a 
literature review, two sections of results and discussion, 
and a progress and prospectus section. The introduction 
presents my personal philosophies and outlooks on the essen­
tiality of an integrated animal and crop production system 
for agriculture to be a sustainable food producing 
enterprise. 
The literature review outlines the magnitude and 
importance of gluconeogenesis in ruminants with particular 
emphasis on milk production. The metabolism of various 
tracers of glucose metabolism is discussed in detail and 
several other tracers are proposed for use. The differences 
of various tracers are emphasized and a theory is developed 
as to how these differences in tracers can be utilized to 
define the kinetics of glucose metabolism. 
The first section of results and discussion is entitled, 
"A method for determination of carbon dioxide specific radio­
activity and concentration in blood, rumen fluid, and 
expired air". The method was developed for use in studying 
propionate metabolism, but its application in this disserta­
tion has allowed quantitation of carbon recycling between 
plasma glucose and blood carbon dioxide. 
The second section of results and discussion is 
entitled, "Recycling of carbon in ruminant gluconeogenesis". 
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and is an application of part of the theory developed in 
the literature review to define total glucose recycling, 
total physical recycling, total chemical recycling, and 
recycling of carbon from plasma glucose to carbon dioxide 
and to lactate. 
The progress and prospectus summarizes my research and 
development at Iowa State and briefly outlines desirable 
future research involvement. 
The original objective of my dissertation research was 
to quantitate the metabolism of ruminally produced pro­
pionate. Although many technical and analytical problems 
have been overcome enroute to achieving the original objec­
tive, several still remain. The results presented herein 
are an assembly of some intermediate projects that seemed 
important in progressing toward my initial objective. 
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INTRODUCTION 
In introducing this dissertation, I will take the 
liberty to go beyond the usual introductory material and 
include some of my philosophies. Inasmuch as this disserta­
tion is being submitted in partial fulfillment for the 
degree, Doctor of Philosophy, such an expansion seems 
reasonable. I will include discussion of a) my rationale 
for choosing the research described in this dissertation; 
b) the role of ruminants in producing food as well as con­
serving soil, our most valuable resource; and c) the mutli-
faceted role of land-grant university teachers, the ranks 
of whom I hope to join. In general, these few introductory 
pages will be devoted to an exposition of my commitment to 
research in ruminant nutrition and metabolism. 
Ruminants are a genetically diverse group of animals 
populating all continents except Anartica. Ruminants popu­
late areas ranging from humid tropics (baraboo sheep, water 
buffalo) to artic tundra (caribou), and from Himalayan 
Mountains (yak) to lowland deserts (dromedary) (see Fig. 1). 
Most other climatic and terrain conditions in between are 
included also. This illustrates the diversity of ruminants 
that makes them adaptable to most environmental situations. 
The most striking common characteristic is an enlarged 
forestomach adapted to a pregastric fermentation of 
Figure 1. Subordinate taxonomy of the Suborder Ruminantia, 
with selected species to illustrate genetic 
diversity 
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feedstuffs. It is this fermentative capability that pro­
vides ruminants with a unique niche in our ecology. It 
allows them to efficiently utilize cellulose, which is the 
most abundant organic compound on earth and one that cannot 
be digested by vertebrates without microbial assistance. 
The genetic diversity of ruminants is not being utilized 
effectively to increase world animal production. The humid, 
cool-temperate areas of the world maintain 30 percent of 
the world's ruminant animals which produce 70 percent of 
the world's milk and 60 percent of the beef and veal. I 
suspect the intensity of production in the humid, cool-
temperate region is due, in large measure, to its being the 
region where modern agriculture research originated. Also, 
many current researchers and most research stations defining 
biological mechanisms are located in the humid, cool-
temperate region. Yet other regions possess great potential 
if technology designed for a specific region is developed. 
The humid tropics, for example, have tremendous water and 
solar energy resources for forage production. Tropical 
plants are generally of low nutritive value or are poor 
seed producers. Tropical ruminants have not been selected 
for specific production purposes under intensified condi­
tions. A similar situation was present at one time in the 
humid, cool-temperate region of the world. Tremendous 
challenges are before us. I am convinced that anyone 
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choosing a career in agricultural research will not run 
out of challenges. 
The well-intentioned argument that grain production 
should be intensified for direct human consumption, elimi­
nating animal agriculture, is often heard. This argument 
is so wide-spread that it is presented explicitly in a 
Time-Life book series directed to children. A quantitative 
counter-argument is difficult to construct, but qualitative 
points should be adequate to dispell this misconception 
from the thinking of most reasonable people. 
First, if grain production were intensified greatly, 
the soil necessary to raise crops would erode rapidly. 
Iowa, in the heart of the world's richest grain-producing 
area, has already lost over half of its soil resource. 
This soil loss has not yet caused great reductions in pro­
ductivity because of the abundance of topsoil present when 
tillage began. Much less productive subsoil is beginning 
to appear on knolls, however, indicating that further soil 
erosion losses will be accompanied by reduced yields. Cur­
rently, Iowa soil is lost at an estimated average yearly 
rate of 17 tons per acre while soil genesis is about 5 tons 
per acre. Intense row cropping magnifies soil erosion by 
making soil structure more friable and hence more suscep-r 
tible to erosion. If we take the same attitude toward our 
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soil resource that seems prevalent for petroleum, i.e., 
"use it till it's gone", the result will be catastrophic. 
Second, control of soil loss by mechanical means, such 
as terraces, require large investments of capital and 
mechanical energy for establishment and maintenance. 
Third, row-crop production maximizes soil exposure for 
erosion at the same time erosive forces of wind and rain 
are most intense. The tremendous impacting force of rain 
on soil (1000 foot-pounds acre ^ hour"^ for rainfall of 1 
inch hour fragments surface soil into fine particles 
that occlude soil pores. Impaction slows infiltration to 
the subsoil and increases water runoff. This has the 
effect of increasing soil erosion but also decreases effi­
ciency of water utilization. 
Fourth, forage crops for animal production promote 
soil conservation in several ways. The vegetative canopy 
is very effective in reducing soil erosion caused by wind. 
Forage crops directly impede water runoff, and runoff is 
reduced indirectly by partial interception of rainfall by 
the forage canopy. Forage results in less water striking 
the soil and greatly reduces the impact force of rain. 
The root system of forages improves infiltration of water 
into the soil. Forage crops improve soil tilth by promoting 
aggregation of soil particles into large, stable granules. 
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The four examples just discussed are not meant to be 
the overexaggerations of a doomsday sayer. I have tried to 
point out that ruminants as forage utilizers have an impor­
tant role in providing food, now and in the future. I sug­
gest that agriculture production should be away from large 
specialized enterprises, and into smaller and integrated 
production units for maximum return on our resources. 
Estimation of the optimum balance of crop and animal pro­
duction for any given area must be determined by combined 
efforts of agronomists, animal scientists, economists, 
geologists, climatologists, political scientists, and 
nutritionists. 
There are two points concerning economics I would like 
to make. First, marketing and financing procedures for 
agricultural commodities need to be reviewed critically. 
This past spring (1980), in the face of depressed grain 
prices, acreage planted to row-crop grains increased at the 
expense of pasture, oats (used primarily as a cover crop in 
establishing new stands of forage crops), and timber acre­
age. This obvious paradox is rationalized by expecting 
more product to sell for a lower unit price and still yield 
more total income to meet the financial obligations of Iowa 
farmers. Such economic reasoning can only be successful for 
short-term situations. The current increase in grain prices 
is not likely to discourage grain production. In simple 
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terms, we lose two bushels of soil for each bushel of corn 
produced. My concern is that in the year-to-year situation, 
our economy dictates increased grain production and 
decreased livestock production. As pointed out earlier, 
long-term continuation of such policy has very severe limi­
tations. Our current marketing system ignores depletion of 
our soil resource as a liability. Is it wise to export 
domestic grains to support livestock industry on foreign 
soil? Approximately 20% of our grain export will ultimately 
be manure to fertilize someone else's soil. Limiting 
exports is not meant in a selfish manner, but we are in 
effect, selling our future production ability and depositing 
the resources in areas climatically less favorable to pro­
duction. Can we and should we manipulate markets to 
reflect more accurately total production costs including 
soil loss? What are the possibilities of exporting animal 
products, perishable commodities, instead of grain in an 
effort to recycle resources at the point of production and 
thus maintain productive ability? 
A second point of economics is that of animal agri­
culture's contribution to our total economy. At the farm 
level, animal products contribute over 4% of our gross 
national product. Animal agriculture has been criticized 
for inefficiency, but ruminants may produce more edible 
product than the amount of feed they consume that could be 
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consumed by man. The full production potential of ruminants 
is far from being realized because available technology is 
not being applied. It has been estimated that in the humid, 
cool-temperate portion of the United States, liveweight beef 
production could be increased to 42 million metric tons or 
milk production to 567 million metric tons by optimum 
management of our forage crops. Current total United States 
production is 18 million metric tons liveweight beef gains 
and 52 million metric tons of milk. This increase in pro­
duction of beef or milk would not require alteration of 
current land use pattern. 
In summary of these two points of economics, I would 
like to emphasize my optimism on the ability of farmers to 
meet the increasing food demand of the enlarging world popu­
lation of people. Production in animal agriculture is far 
below the potential production that could be realized with 
current technology; whereas row-crop production is very near 
its production potential and major technological break­
throughs are necessary for further increases in row-crop 
production. What is lacking is a marketing and distribu­
tion system that makes it profitable for farmers to produce 
animal products in addition to cash row-crops. A balance 
of animal and crop production on each farm maintains farming 
as a sustainable enterprise. The mono-culture system that 
is encouraged by the current economic situation is 
unsustainable. 
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It is not expected that readers of this dissertation 
need an explanation of the importance of ruminant agri­
culture. I think it is important, however, for everyone to 
reflect on his career to justify that his efforts make 
some positive contribution to society. I am convinced that 
research on ruminant nutrition is a worthwhile pursuit that 
will provide benefit to many. 
The area of ruminant nutrition I have chosen for 
research is gluconeogenesis. An adequate energy supply is 
now recognized as essential for survival of a society. The 
importance of an adequate energy supply for survival of an 
organism has long been recognized. Glucose is the hub of 
energy metabolism. Thus ruminant gluconeogenesis is an 
exciting research area, an understanding of which holds much 
promise for improving ruminant production efficiency. In an 
effort to limit this introduction, I have deferred further 
discussion of gluconeogenesis for the literature review. 
Teachers, particularly at land-grant universities, hold 
a position that I esteem. They have the opportunity to do 
basic and applied research, and they also have the oppor­
tunity for direct interaction with many who will be farmers, 
workers, or managers in agriculture-related industries. An 
indirect influence on current farmers can be achieved 
through the extension service. The most important influence 
will come from the direct contact with students. The 
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trade-school approach to undergraduate education must be 
avoided, although often desired by students. I am optimis­
tic that farms of the future will consist of a diversity of 
small enterprises, interrelated by one enterprise utilizing 
by-products of another to make the overall production unit 
resource efficient. This is not to be construed to be a 
farm of the 1940s. The successful manager of such a farm 
will have a background in a diversity of agricultural and 
business principles and an understanding of how these dif­
ferent principles can be integrated into a single produc­
tion unit. If one approaches the classroom with the 
philosophy of emphasizing what a student with an education 
can do for the world community rather than what an educa­
tion can do for the student, the student's best interests 
will be served. 
The information presented in this introduction purpose­
fully has been kept general. The following citations Cfull 
information listed in the References) may be used as bibli­
ographic material supporting the philosophies that were 
developed: Anonymous, ca. 1979; Baldwin, 1980; Byerly et 
al., 1978; National Academy of Sciences, 1978; Hughes et 
al., 1962; Wedin et al., 1975; Wilkinson, 1979; Timmons, 
1980; Pimentel et al., 1976; Johnson et al., 1977; Brink et 
al., 1977; Walker and Timmons, 1980; Iowa Crop and Livestock 
Reporting Service, 1980a,b; and The Holy Bible, 1962). 
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LITERATURE REVIEW 
This literature review will elaborate upon the diges­
tive physiology of ruminants to demonstrate the importance 
of gluconeogenesis as the major source of blood glucose. 
The vital role of glucose in milk synthesis is discussed to 
instill in readers the essentiality of an understanding of 
gluconeogenesis in ruminants to maximize milk production 
efficiency. A brief discussion of methods used to measure 
kinetics of glucose metabolism is presented as a forum to 
establish terminology of kinetics. The kinetic methods 
portion of the literature review also provides an introduc­
tion to the phenomenon recycling, that component of glucose 
kinetics to which this dissertation is addressed. Because 
of the reliance on isotopically labeled glucoses for making 
glucose kinetic measurements, the isotopic fate of variously 
labeled glucoses are traced. Metabolism of other compounds 
are discussed with regard to their use as possible tracers 
to delineate physical as opposed to chemical components of 
recycling. From the literature review, the rationale is 
developed for conducting the experiments reported in this 
dissertation. 
Importance of Gluconeogenesis 
Although I consider fermentation in ruminants to be an 
asset, it is not without liabilities. The fermentation of 
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cellulose in the reticulorumen is indeed advantageous. 
However, dietary starches and free sugars also are fermented 
rapidly. In fact, most dietary carbohydrates can be 
accounted for by the amounts of volatile fatty acids, 
methane, and carbon dioxide produced through fermentation 
(Lindsay, 1978) . It can be determined by inspection of 
metabolic pathways that it would be energetically more 
efficient for ruminants to utilize a-linked polysaccharides 
and free sugars directly, omitting microbial intervention. 
There have been research efforts to increase production 
efficiency by increasing by-pass of dietary starch past the 
rumen (0rskov et al., 1968). Such research efforts largely 
have been abandoned because of recent findings indicating 
post-ruminal utilization of starch has some restrictions. 
Factors indicating that starch by-passing rumen fer­
mentation is not well-utilized include the following, a) 
Maltase activity within the small intestine is inadequate 
for appreciable hydrolysis of starch to glucose CCoombe and 
Siddons, 1973). b) Intestinal pH is below the optimum pH 
for amylase activity (Mayes and 0rskov, 1974; Russell, 1979). 
The reduced intestinal pH appears to be due to an increase 
in intestinal microbial activity associated with increased 
starch by-pass. Dietary buffers are effective in increasing 
intestinal pH to a more desired value for amylase activity, 
but are ineffective in increasing starch digestibility 
16 
(Russell, 1979). c) The small intestines of adult, but not 
suckling, sheep lack an active transport system for glucose 
absorption (Scharrer, 1976). It is unlikely that free 
glucose in the intestinal lumen would ever reach a concen­
tration where net mucosal to serosal diffusion of glucose 
would be possible. 
Some researchers (Lindsay, 1978; Young, 1977) have con­
cluded that approximately 90% of the glucose utilized by 
ruminants is provided by gluconeogenesis. In contrast, 
Armstrong and Smithard (1979) estimate that up to 77% of 
the glucose utilized can be provided by glucose absorption 
from a corn-based diet having a 65:35 concentrate to forage 
ratio. The 77% estimate was based on disappearance of 
starch from the intestine and the assumption that it was 
absorbed as glucose. The high negative correlation between 
starch content and pH of digesta suggests that part of 
intestinal starch disappearance is a result of microbial 
activity (Mayes and 0rskov, 1974). Recently, Huntington et 
al. (1980) combined portal vein-arterial concentration dif­
ferences with blood flow measurements and isotopic glucose 
tracers to calculate glucose production rate, net portal 
glucose absorption, glucose utilization by gut tissue, and 
total glucose absorption. Total glucose absorption, as a 
percentage of glucose production, increased from -3% on a 
pelleted hay diet to 25% on an 85% concentrate corn-based 
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pelleted diet. The net glucose absorption and glucose 
utilization by gut tissue, expressed as percentage of 
glucose production, increased from -10 to 15% and 6 to 10%, 
respectively, for the hay and 85% concentrate diets. Thus, 
25% of the glucose utilized was supplied by glucose absorp­
tion. It is curious that changing to an 85% concentrate 
caused a disproportionate increase in glucose utilization 
by gut tissue. There was approximately a three-fold 
increase in gut glucose utilization whereas overall glucose 
utilization (production) was increased less than two-fold. 
An additional factor for consideration is the associa­
tive effects of feeds on digestibility (Blaxter and Wainman, 
1964) . Excessive cereal grain concentrate depresses diges­
tibility of cellulose in mixed rations (Raymond, 1969; 
Blaxter and Wainman, 1964). Mertens and Loften (1980) sug­
gest that the reduced digestibility of fiber is an indirect 
result of rapid fermentation of starch causing an increased 
acidity of rumen contents which inhibits cellulose activity 
(Stewart, 1977). Entry of fermentable carbohydrate into 
the intestines is associated with reduced synthesis of 
microbial biomass and hence reduces microbial amino acid 
supply to the host (Armstrong and Smithard, 1979). Cellu­
lose that by-passes the rumen is at least partly fermented 
in the terminal ileum, cecum, and colon providing energy to 
the host in the form of volatile fatty acids. Microbial 
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protein synthesis associated with fermentation in the lower 
gut, however, is quantitatively excreted in the feces, and 
thus is of no benefit to the host (Elliott and Little, 1977). 
From the preceding paragraphs it is evident that there 
is controversy over the amount of glucose that is provided 
by direct glucose absorption. Although my ideas are not 
neutral, I hope that I have been fair in presenting both 
sides. I conclude that 75 to 100% of the glucose utilized 
must be met by gluconeogenesis. The energetic inefficiency 
of microbial fermentation of dietary carbohydrate to vola­
tile fatty acids that are partly reconverted to glucose by 
the host is, in my opinion, the best alternative. It 
requires a smaller input than the energy loss associated 
with trying to overcome the inefficiency of fermentation by 
overloading with dietary starch. 
Thus far, I have tried to convince readers of the 
importance of gluconeogenesis as a source of blood glucose. 
This by itself is incomplete without a discussion of the 
vital role of the dynamics of glucose metabolism in main­
taining production. For such a discussion I have chosen 
the role of glucose in maintaining lactation, the area of 
ruminant production that interests me most. 
The importance of blood glucose in maintaining lacta­
tion has been implicated by many research approaches. The 
lactating mammary gland of fed goats obtains 30 to 50% of 
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its energy from oxidation of glucose and 20 to 30% from . 
blood acetate, while in the whole animal only about 7 to 
11% of the carbon dioxide is derived from glucose (Schultz, 
1974). In addition to being the preferred energy source 
for mammary gland, glucose provides at least 85% of the 
carbon in lactose, 70% in glycerol, and 5% in protein 
(Kleiber et al., 1955) and provides 34% of NADPH, 
required for fatty acid synthesis (Chaiyabutr et al., 1980). 
Bickerstaffe et al. (1974) estimate that mammary gland 
glucose utilization in relation to whole body glucose 
metabolism of the lactating cow is 66%. I have applied 
these numbers to a cow producing 89 kg milk daily, as 
referenced by Young (1977), to obtain an estimate of 
maximum glucose utilization during lactation (Table 1). 
The 2.528 kg glucose carbon per day supplied by gluconeo-
genesis probably is an overestimate because mammary glucose 
utilization in relation to whole body glucose utilization is 
likely to increase at this high production. For more 
average high-producing cows at peak lactation, gluconeo-
genesis may supply 1.3 to 1.6 kg glucose carbon daily. The 
amount of glucose carbon being oxidized to carbon dioxide 
has been omitted because Chaiyabutr et al. (1980) have 
shown that carbon dioxide production from glucose matches 
NADPH,production from glucose. 
Table 1. Estimation of daily glucose need provided by gluconeogenesis in a cow producing 89 kg milk 
per day with special emphasis on mammary gland glucose need 
Amount of glucose carbon used in milk lactose synthesis: 
89 kg milk x 4.9% lactose = 4.361 kg lactose 
4.361 kg lactose x 42% carbon = 1.832 kg carbon 
1.832 kg carbon x 85% from glucose = 1.557 kg 
1.577 kg 
Amount of glucose carbon used in milk protein synthesis: 
89 kg milk x 3.2% protein = 2.848 kg protein 
2.848 kg protein x 54% carbon^ = 1.538 kg carbon 
1.538 kg carbon x 5% from glucose = 0.077 kg 
.077 kg 
Amount of glucose carbon used in milk fat synthesis : .220 kg 
Glycerol glucose need: .109 kg 
89 kg milk x 3.5% fat = 3.115 kg fat 
3.115 kg fat X 1 mol triglyceride/.722 kg fat^ = 4.314 mol triglyceride 
4.314 mol triglyceride x .036 kg glycerol carbon/mol triglyceride = .155 kg carbon 
•155 kg carbon x 70% from glucose = .109 kg carbon 
NADPHjIT^ glucose need; .111 kg 
4.312 mol triglyceride x 3 = 12.942 mol fatty acid 
12.942 mol fatty acid x 14 mol carbon/fatty acid^ = 181.188 mol fatty acid carbon 
181.188 mol fatty acid x 30% from acetate^ = 54.356 mol fatty acid carbon 
54.356 mol fatty acid carbon v 2 = 27.178 mol acetate incorporated into fatty acid 
27.178 mol acetate incorporated x 2 mol NADPH,H"^ / mol acetate incorporated = 54.356 mol NADPH,H^ 
54.356 mol NADPHjff*" x 34% from glucose = 18.481 mol NADPH,Hr*" 
18.481 mol NADPH^ 2 mol NADPH,H^ / mol glucose carbon = 9.241 mol glucose carbon 
9.241 mol carbon x 0.012 kg/mo1 = .111 kg 
Amount of glucose carbon used by mammary gland: 1.854 kg 
Amount of glucose carbon used by whole animal: 
1.854 kg V .66 = 2.809 kg 
2.809 kg 
Amount of glucose carbon produced by gluconeogenesis : 2.528 kg 
2.809 kg X 90% = 2.528 kg 
^Taken from percent carbon in casein (Stecher, 1968). 
^Calculated from average fatty acid composition of bovine milk fat (Jenness, 1974). 
^Barry, 1964. 
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The estimates just discussed, within precision of the 
data, are in agreement with those calculated from Kronfeld's 
data (Kronfeld et al., 1968; Kronfeld, 1976). When milk 
production was regressed on mammary gland glucose uptake, 
the relation of 1 kg milk produced per 72 g of glucose 
uptake was observed with 85% of total glucose utilization 
occurring in the mammary gland. 
Having demonstrated the importance of glucose as a 
precursor of milk constituents and a provider of energy and 
reducing equivalents required for milk synthesis, the dis­
cussion will be directed to the role of glucose in regu­
lating milk production. Linzell and Peaker (1971) state, 
"It is now generally assumed that [milk] lactose concentra­
tions cannot vary under physiological conditions in cows 
and must play a decisive role in controlling the volume of 
secretion". The major contribution of glucose carbon to 
lactose carbon implies that glucose supply to the mammary 
gland is a limiting factor in milk production. Depressing 
plasma glucose concentration by insulin infusion markedly 
reduces milk yield (Linzell, 1967). Omission of glucose 
from the perfusing medium of perfused mammary glands 
inhibits both lactose synthesis and milk secretion (Hardwick 
et al., 1961). Omission of acetate or amino acids depress 
fat and protein secretion, respectively, with little effect 
on milk volume. Upon reintroduction of glucose into the 
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perfusate, the milk secreted initially has increased fat and 
protein concentration. Thus fat and protein synthesis may 
continue without glucose, but lactose synthesis from glucose 
is essential for secretion of milk. 
Attempts to increase milk production by exogenous glu­
cose infusions are likely to be ineffective. Although an 
approximately linear relationship exists between 100 to 300 
mg glucose per liter of plasma, 500 mg/1 appears sufficient 
to sustain maximal production (Kronfeld et al., 1963). 
Therefore, it would be of no advantage to increase plasma 
glucose concentration above physiological concentrations, 
which may result in ruminai atony (Svendsen, 1974). An 
exogenous source of glucose suppresses gluconeogenesis 
(Hartley and Black, 1966) and the resulting increased plasma 
glucose concentration may elicit an insulin response, 
directing energy to adipose instead of the mammary gland 
and causing low-fat milk syndrome (Davis and Brown, 1970) . 
Thus, the need for a balanced supply of nutrients to 
the mammary gland is evident and has been discussed by 
Kronfeld (1976). Rook (1979) suggested that acetate supply 
and not glucose, was the limiting factor in persistence of 
lactation beyond peak production. After peak production, 
the cow returns to a positive energy balance. The shift of 
energy distribution may cause energy to become the limiting 
factor in milk synthesis. Glucose is used very efficiently 
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in milk synthesis because of a low activity of pyruvate 
dehydrogenase (Read et al., 1977), but is a poor energy 
source via the tricarboxylic acid cycle for the same reason. 
Although it is essential to provide a balance of fat for 
energy and glucose for synthesis and secretion throughout 
lactation for maximum productivity, the existence of ketosis 
in high-producing cows suggests that the greatest economic 
gains are likely to come from an ability to increase glucose 
supply. 
Ketosis develops because the glucose supply is inade­
quate to provide catalytic oxaloacetic acid for oxidation 
of fat the cow has mobilized in an effort to meet her 
energy demands. A cow on the brink of developing ketosis 
with a given dietary regime, theoretically should be at her 
peak for production efficiency and genetic potential. Once 
dairy nutritionists develop a technique that will create 
ketosis in all cows on any dietary regime, I suggest that 
animal breeders use the production efficiency at ketosis as 
a selection trait to develop lines of cattle adapted to 
specific production systems. 
A major challenge is to develop a process that will 
force all cows to increase milk production until they 
become ketotic. Hardwick et al. C1961) demonstrated that 
lactose synthesis regulates milk volume. By somehow 
artificially inducing lactose synthesis, milk production 
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could be increased concomitantly and create a glucose drain 
that eventually will cause ketosis. Factors regulating 
lactose synthesis were reviewed by Kuhn et al. (1980) and 
Jones (1977; 1978). A research proposal concerning induc­
tion of lactose synthesis will not be presented, but such 
induction would have great impact on the dairy industry. 
Cows with induced lactose synthesis will always be limited 
by glucose availability, reemphasizing the importance of 
gluconeogenesis research. 
It is doubtful there will ever be a large market for 
aqueous lactose solutions. It seems more reasonable to 
increase nutrient output by increasing volume and maintain­
ing constant composition than to keep volume constant and 
increase solids content. Thus, lactose synthesis induced 
cows may show additional research need for limiting factors 
for synthesis of other milk constituents. 
One application of lactose synthetase induced cows 
could be in combination with protected fat diets now in 
vogue. Palmquist and Jenkins (1980) recently reviewed this 
area. The rationale for using protected fat in diets is to 
increase digestible energy intake, clearly an important con­
sideration in maintaining production in an animal that is 
in negative energy balance. Improvements in performance 
have been marginal. There is usually an associated increase 
in milk fat percentage and a change in milk fatty acid 
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composition. The alterations in fatty acid composition 
indicate that more dietary fat is secreted directly in the 
milk. The results suggest that any improvement in produc­
tion efficiency would be derived from reduced maintenance 
energy costs because it would not be necessary to put fat 
or "condition" on cows in later lactation. Such fat is now 
used as an energy source in the initial stage of the next 
lactation. However, if "conditioned" cows fed a high-fat 
diet were challenged by artificially inducing lactose 
synthesis a much improved yield of milk of near normal 
composition is likely because of the increased available 
energy. 
This section of the literature review has included 
both literature and speculation. If I have provided 
readers with an appreciation for the magnitude and neces­
sity of gluconeogenesis in cattle, I have achieved my goal. 
Also, I hope I have transmitted some understanding of my 
enthusiasm for research in ruminant nutrition. 
Methods of Measuring Kinetics of Glucose Metabolism 
The isotope-dilution methods used to measure kinetics 
of glucose metabolism (glucose kinetics) have been reviewed 
by White et al. (1969) and more recently by Young (1977) . 
There are three methods of isotope administration into the 
blood plasma: a) continuous infusion, b) primed-dose con­
tinuous infusion, and c) single injection; all three being 
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related mathematically (Hetenyi and Norwich, 1974). The 
names given each method are reasonably self-descriptive. 
During continuous infusion or primed-dose continuous 
infusion of radioactive glucose, the plasma glucose spe­
cific radioactivity asymptotically approaches a plateau. 
The plateau specific radioactivity is approximated, from 
which the rate the infused labeled glucose is being diluted 
by non-labeled glucose is calculated by Eq. 1. 
P = r/SAp (1) 
where P = glucose production rate; r = labeled glucose 
infusion rate; and SA^ = plateau specific radioactivity of 
plasma glucose. The production rate of glucose has also 
been termed entry rate, disposal rate, irreversible loss, 
utilization rate, turnover, glucose need, and glucose 
requirement. 
Glucose production rate is the only kinetic parameter 
that can be calculated directly from continuous infusion 
data. In addition, glucose pool size can be calculated 
from primed-dose continuous infusion data if priming dose 
and sampling intervals are appropriate to reliably estimate 
the y-intercept of the plot of glucose specific radioac­
tivity versus time. Glucose pool size can be calculated by 
Eq. 2. 
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Q = dose/SA^^Q (2) 
where Q = glucose pool size; dose = radioactivity in priming 
dose; and SA^_q = estimated glucose specific radioactivity 
at time zero. See Shipley and Clark (1972) for a discussion 
of appropriate priming dose. 
After single injections of labeled glucose, the glucose 
specific radioactivity decreases in a multi-exponential 
manner toward zero. Although single injection data are the 
most difficult to analyze mathematically, they yield the 
most kinetic information. Glucose production rate and 
glucose pool size are calculated by Eqs. 3 and 4, 
respectively. 
n 
P = dose / I  { h . / g . )  (3) 
i=l ^ ^ 
n 
Q = dose / I A. (4) 
i=l 1 
where n = number of exponentials required to describe the 
glucose specific radioactivity curve; A^ = the y-intercept 
of the i-th exponential; and g^= -the slope of the i-th 
exponential. Other symbols have been described previously. 
The existence of a multi-exponential glucose specific 
radioactivity curve following a single injection of labeled 
glucose demonstrates that labeled glucose leaves plasma and 
returns at a later time. This phenomenon can be explained 
29 
either by different anatomic pools of glucose that exchange 
with each other, or by metabolism of glucose to other com­
pounds that subsequently are converted back to glucose with 
retention of the isotopic tracer. A combination of the two 
previous possibilities is likely. A measure of the total 
amount of glucose that enters plasma, independent of source, 
can be calculated from Eg. 5. 
n 
TER = Q ( I H. . g. ) (5) 
i=l ^ 1 
where TER = total entry rate of glucose; and = the 
y-intercept of the i-th exponential expressed as a fraction 
of the sum of y-intercepts of all exponentials (see Eg. 6). 
n 
H. = A. / I A (6) 
1 1 i=l 1 
Other symbols have been defined previously. 
Thus the term, total entry rate, includes glucose pro­
duction rate plus glucose that leaves plasma and later 
returns. The difference between glucose total entry rate 
and production rate is defined to be recycling (Eg. 7). 
Recycling = TER - P (7) 
Kronfeld (1977) has differentiated recycling into two parts. 
The part of recycling attributable to physical distribution 
of glucose within the body is termed reentry. The part of 
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recycling that is attributable to metabolism of glucose to 
other compounds that are subsequently converted back to 
glucose is left defined as recycling. Recycling also has 
been defined as the difference between glucose production 
rate measured by [U-^^C]-D-glucose and I^H]-D-glucose 
(Katz et al., 1974a; 1974b). 
Fate of Tritium Tracers Used in Measuring Kinetics 
of Glucose Metabolism 
In this section, glucoses labeled with tritium at each 
carbon are individually traced through pathways of glucose 
metabolism. The purpose is to determine if various compo­
nents of glucose recycling can be identified by combination 
of data obtained by separate injections of variously labeled 
glucoses. For [^^C]-glucose, this information can be 
obtained by inspection of a chart of metabolic pathways. 
The two complicating factors in tracing carbons are carbon 
rearrangement in the hexose-monophosphate-pentose (HMP) 
pathway and state of equilibrium at branch points. The 
fate of variously ^^C-labeled glucoses in metabolism have 
been reviewed (Segal et al., 1961; Wood et al., 1963; Katz, 
1961; and Katz and Wood, 1960). Carbon skeletons of com­
pounds in Figs. 2 through 7 were derived from metabolic 
pathways described by Mahler and Cordes (1971) and Lehninger 
(1970). 
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Information is not so easily obtained for tritium, 
because reaction mechanisms and stereochemistry must be con­
sidered also. Isotope effects are more likely to occur for 
tritium, but are largely ignored for lack of quantitative 
information. Tritium transferred from glucose to water or 
to nucleotides is considered an irreversible loss. There 
are data to support tritium transfer to water being irre­
versible (Judson and Leng, 1972), but loss to nucleotides 
has not been verified to be irreversible in vivo. The irre­
versibility of tritium loss to nucleotides will be influ­
enced equally for all isotope positions by the kinetics of 
the reduced nucleotide pool. The irreversibility is 
influenced individually by the equilibrium constant and by 
reactant and product concentrations where tritium is trans­
ferred to nucleotides. These individual differences are 
likely to be small among isotope positions as is the rein­
corporation of tritium from nucleotide to glucose metabolite. 
Most of the data presented in this section were 
obtained from nonruminants and it is assumed that reaction 
mechanisms do not differ among species. It has been demon­
strated, however, that relative amounts of enzymes do differ 
between ruminant and nonruminant species (Ballard et al., 
1969). The differences in the relative amounts of enzymes 
among species may cause differences in the degree of 
equilibrium attained by metabolic intermediates to differ 
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among species also. Differences in the degree of equilib­
rium attained by a reactant at a branch point in a metabolic 
pathway is critical to the interpretation of isotope loss 
(Katz and Wood, 1960). It will be pointed out, as appro­
priate, where these points occur. 
From this introduction, it is readily apparent that 
much work will be necessary to verify the theory that is 
developed in this section of literature review for applica­
tion to ruminants. 
3 [1- H]-D-glucose 
The fate of tritium from the 1-position of glucose is 
traced in Fig. 2. (In all discussion of tritium distribu­
tion, the number after the word tritium will indicate the 
glucose carbon where the tritium originated, i.e., tritium 
from the 1-position of glucose is tritium"^, etc.) Glucose 
entering the HMP pathway loses tritium""^ to NADP"*" at the 
glucose 6-phosphate dehydrogenase reaction where glucose 
6-phosphate is oxidized to 6-phosphoglucono-ô-lactone 
(Pontremoli and Grazi, 1969). Assuming this loss is irre­
versible (equilibrium strongly in direction of NADPH, 
3 formation, Lehninger, 1970), recycling measured with [1- H]-
D-glucose as the tracer will not include HMP the pathway. 
At the triose level in the glycolytic pathway, dihy-
droxyacetone phosphate can be interconverted with glycerol 
Figure 2. Metabolic fate of tritium from [1-^H]-D-glucose 
legend: 1 = hexokinase; 2 = glucose 6-phosphatase; 3 = 
phosphoglucoisomerase; 4 = phosphofructokinase; 
5 = diphosphofructose phosphatase; 6 = aldolase; 
7 = triose phosphate isomerase; 16 = glycerol 
phosphate dehydrogenase; 17 = glycerol 3-phospha-
tase; 18 = glyceraldehyde 3-phosphate dehydrogenase; 
19 = phosphoglycerate kinase; 20 = phosphogly-
ceromutase; 21 = enolase; 22 = pyruvate kinase; 
23 = pyruvate carboxylase; 24 = malate dehydro­
genase; 25 = fumarase; 26 = phosphoenolpyruvate 
carboxykinase; 27 = glucose 6-phosphate dehydro­
genase; 28 = 6-phosphoglucono-6-lactone; 29 = 
lactonase; 30 = 6-phosphogluconate dehydrogenase; 
31 = phosphopentose isomerase; 32 = phosphopentose 
epimerase; 33 = transketolase; 34 = transaldolase 
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-1 
without loss of tritium . Thus recycling measured with 
3 [1- H]-D-glucose will include recycling via glycerol. 
Interconversion of dihyrodxyacetone phosphate and 
glyceraldehyde 3-phosphate labels the 3-position of 
glyceraldehyde 3-phosphate (same as from [6- H]-D-glucose) 
without loss of tritium ^ or tritium"^. There is no loss 
of tritium ^ or tritium ^ in formation of lactate, but the 
fate of tritium ^ or tritium ^ in recycling of lactate to 
glucose is less certain. Dunn et al. (1967) measured the 
tritium/^^C ratio of carbons 1 through 3 of glucose fol­
lowing intravenous injection of [6-^H,-D-glucose into 
rats. The ratio was less than 0.1, thus suggesting essen­
tially all tritium ^ or tritium"^ is lost in recycling 
from lactate. The presence of a small amount of tritium 
through 6 on carbons 1 through 3 may result from some 
glyceraldehyde 3-phosphate conversion to dihydroxyacetone 
phosphate prior to its passage through glycolysis to 
lactate in the liver. 
The mechanism by which tritium ^ or tritium ® is lost 
involves carboxylation of pyruvate to oxaloacetate. 
Ignoring isotope effects, there is a 33% chance of loss of 
tritium during carboxylation (25% chance of loss of 
3 tritium from 16- H]-D-glucose). There is additional oppor­
tunity for tritium loss by equilibration of oxaloacetate 
with fumarate via malate. If oxaloacetate is interconverted 
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to fumarate via malate at least twice, it is possible to 
have complete loss of tritium originating from either 
[1-^H]- or [6-^H]-D-glucose. 
The tritium/^^C ratio of carbon 1 of glucose has not 
been measured in ruminants. The seemingly more intense 
gluconeogenesis in ruminants may not allow ample time for 
two-fold equilibration of oxaloacetate and fumarate if the 
relative demand for oxaloacetate as a glucose precursor is 
—  1  —6  increased. Further doubt that all tritium or tritium 
is lost from carbon 3 of lactate before conversion to glu­
cose is caused by the differences in cellular distribution 
of pyruvate carboxylase. Ruminants have a greater percent­
age of the total pyruvate carboxylase activity in cytosol 
(Ballard et al., 1969). This confounds the scheme by 
forcing oxaloacetate formed in the cytosol to pass through 
the mitochondrial membrane and equilibrate with fumarate in 
the mitochondria before tritium loss can occur. Thus, 
although uncertain, it is probable that recycling measured 
3 3 
with either II- H]-D-glucose or [6- H]-D-glucose eliminates 
recyIcing via lactate. 
[2-^H]-D-glucose 
The fate of tritium from the 2-position of glucose is 
traced in Fig. 3. Katz and Dunn (1967) injected [2-^H]-D-
glucose intravenously into rats and found that tritium"^ 
was promptly and nearly quantitatively transferred to body 
2 
Figure 3. Metabolic fate of tritium from [2- H]-D-glucose 
legend: 1 = hexokinase; 2 = glucose 6-phosphatase; 3 = 
phosphoglucoisomerase; 4 = phosphofructokinase; 
5 = diphosphofructose phosphatase; 6 = aldolase; 
7 = triose phosphate isomerase; 16 = glycerol 
phosphate dehydrogenase; 17 = glycerol 3-phospha-
tase; 18 = glyceraldehyde 3-phosphate dehydrogenase; 
19 = phosphoglycerate kinase; 20 = phosphogly-
ceromutase; 21 = enolase; 22 = pyruvate kinase; 
23 = pyruvate carboxylase; 24 = malate dehydro­
genase; 25 = fumarase; 26 = phosphoenolpyruvate 
carboxykinase; 27 = glucose 6-phosphate dehydro­
genase; 28 = 6-phosphoglucono-ô-lactone; 29 = 
lactonase; 30 = 6-phosphogluconate dehydrogenase; 
31 = phosphopentose isomerase; 32 = phosphopentose 
epimerase; 33 = transketolase; 34 = transaldolase 
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water. Similar results were obtained in vitro from rat 
adipose tissue under conditions of lipolysis and hence low 
HMP pathway activity; but there was up to 30% tritium"^ 
retention in fatty acids, glycerol, and lactate under con­
ditions of lipogenesis and hence high activity of the HMP 
pathway (Katz and Rognstad, 1969) . Thus, the activity of 
phosphoglucoisomerase relative to glucose 6-phosphate dehy­
drogenase is critical to the amount of tritium ^ lost to 
body water by isomerization of glucose 6-phosphate to 
fructose 6-phosphate. 
Examination of the phosphoglucoisomerase reaction mech­
anism reveals several factors that magnify the sensitivity 
of rate of isomerization relative to HMP activity and phos-
phofructokinase activity with regard to tritium ^ loss. 
First, to a varying degree (0 to 80%), the tritium from the 
2-position of glucose 6-phosphate remains enzyme bound and 
is transferred to the 1-position of fructose 6-phosphate 
(Rose, 1970). This transfer is probably about 50% in vivo 
(Rose and Rose, 1969). Second, there is a significant 
isotope effect at the phosphoglucoisomerase reaction (Rose 
and O'Connell, 1961). Tritiated substrates react only 
about one third the rate of unlabeled substrates. This 
reduced rate not only has the effect of concentrating 
tritiated glucose 6-phosphate for glucose 6-phosphate dehy­
drogenase, but also when tritium is transferred from the 
40 
2-position of glucose 6-phosphate to fructose 6-phosphate, 
the tritiated fructose 6-phosphate becomes concentrated 
for phosphofructokinase. 
Black et al. (1957) estimated that 50 to 70% of glu­
cose utilization in lactating cows occurred via the HMP 
pathway. This is two- to three-fold the percentage HMP 
activity observed in rat adipose by Katz and Rognstad (1969) 
with 30% tritium retention in products of glucose metabo­
lism. Assuming an increase in relative flux through the 
HMP pathway indicates an increase in glucose 6-phosphate 
dehydrogenase activity relative to phosphoglucoisomerase 
activity, ruminants should retain more tritium than 
observed by Katz and Rognstad (1969). 
Metabolism of I2-^H]-glucose 6-phosphate by the HMP 
pathway results in labeling fructose 6-phosphate with 
tritium""^ at positions 1 and 3 or in position 1 only. 
3 
Decarboxylation of 12- H]-6-phosphogluconate by 6-phospho-
3 gluconate dehydrogenase yields II- H]-ribulose 5-phosphate. 
3 
If [1- Hj-ribulose 5-phosphate is metabolized to fructose 
6-phosphate via sedoheptulose 7-phosphate, positions 1 and 
3 will be tritiated, whereas metabolism via xylulose 
5-phosphate and erythrose 4-phosphate labels only position 
1 of fructose 6-phosphate. 
Tritium"^ transferred to the 1-position of fructose 
3 6-phosphate from 12- H]-D-glucose via HMP pathway is 
41 
stereochemically identical to tritium in [1-^H]-fructose 
3 6-phosphate derived from [1- H]-D-glucose (Pontremoli and 
3 Grazi, 1969). The fate of [1- H]-D-glucose has already 
been described. Tritium ^ transferred to position 3 of 
fructose 6-phosphate is identical to that from metabolism 
3 
of [3- H]-D-glucose which will be described later. 
The tritium ^  on the 1-position of fructose 6-phosphate 
3 derived from [2- H]-D-glucose via isomerization is 
3 
stereochemically distinct from that derived from [1- H]-D-
glucose (Dorrer et al., 1966). This is important only from 
the standpoint that tritium of fructose 6-phosphate derived 
3 from [ 2 -  H]-D-glucose will be transferred back to its 
original position if the isomerization is reversed, there­
fore preventing loss by glucose 6-phosphate dehydrogenase 
activity. Otherwise, metabolism of the tritiated fructose 
3 6-phosphate derived from [ 2 -  H]-D-glucose procédés as 
3 described for [1- H]-D-glucose. 
Loss of tritium ^ in conversion of glucose to glycogen 
is variable among different tissues even within the same 
animal (Katz and Dunn, 1967) . Amounts of tritium ^ lost 
will depend on relative rates of phosphoglucoisomerase, 
phosphoglucomutase, glucose 6-phosphate dehydrogenase, and 
glucose 6-phosphatase. 
42 
[3-^H]-D-glucose 
The fate of tritium from the 3-position of glucose is 
traced in Fig. 4. In the HMP pathway, tritium"^ is lost to 
NADP^ at the conversion of 6-phosphogluconate to ribulose 
5-phosphate by 6-phosphogluconate dehydrogenase (Pontremoli 
and Grazi, 1969). The equilibrium constant has not been 
determined but by nature of the oxidative decarboxylation, 
the equilibrium should strongly favor NADPH,H^ formation. 
Assuming this tritium ^ loss to be irreversible, recycling 
3 
measured with [3- H]-D-glucose would not include HMP path­
way activity. 
3 
Metabolism of 13- H]-D-glucose via glycolysis is more 
complicated. Cleavage of fructose 1,6-diphosphate by 
aldolase into glyceraldehyde 3-phosphate and dihydroxyace-
tone phosphate yields dihydroxyacetone stereochemically 
labeled as shown in Fig. 4 (Rose and Rose, 1969; Axelrod, 
1967). Isomerization of the labeled dihydroxyacetone phos­
phate to glyceraldehyde 3-phosphate by triose isomerase 
transfers tritium ^ to position 2 of glyceraldehyde 3-phos-
phase (Rose and Rose, 1969), If the glyceraldehyde 3-phos­
phate thus formed proceeds on through glycolysis, tritium ^ 
will be lost to body water in the dehydration of 2-phospho-
glyceric acid to phosphoenolpyruvate by action of enolase 
(Rose and Rose, 1969). Thus, recycling measured with 
Figure 4. Metabolic fate of tritium from [3-^H]-D-glucose 
legend; 1 = hexokinase; 2 = glucose 6-phosphatase; 3 = 
phosphoglucoisomerase; 4 = phosphofructokinase; 
5 = diphosphofructose phosphatase; 6 = aldolase; 
7 = triose phosphate isomerase; 16 = glycerol 
phosphate dehydrogenase; 17 = glycerol 3-phospha-
tase; 18 = glyceraldehyde 3-phosphate dehydrogenase; 
19 = phosphoglycerate kinase; 20 = phosphogly-
ceromutase; 21 = enolase; 22 = pyruvate kinase; 
23 = pyruvate carboxylase; 24 = malate dehydro­
genase; 25 = fumarase; 26 = phosphoenolpyruvate 
carboxykinase; 27 = glucose 6-phosphate dehydro­
genase; 28 = 6-phosphoglucono-ô-lactone; 29 = 
lactonase; 30 = 6-phosphogluconate dehydrogenase; 
31 = phosphopentose isomerase; 32 = phosphopentose 
epimerase; 33 = transketolase; 34 = transaldolase 
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[3-^H]-D-glucose does not include recycling from pyruvate 
or lactate. 
3 
The amount of [3- H]-D-glucose included in recycling 
via glycerol is defined less sharply. Dihydroxyacetone 
phosphate directly reduced to glycerol will retain 
tritium" . As already described, isomerization to glycer­
aldehyde 3-phosphate transfers tritium ^ to the 2-position. 
3 
However, during isomeration of the [ 2 -  H]-glyceraldehyde 
3-phosphate back to dihydroxyacetone phosphate tritium ^ is 
exchanged with hydrogen of body water (Rose and Rose, 1969). 
This seems to be a most peculiar reaction mechanism, and 
more mention of it will be made in the next paragraph. In 
summary, previously isomerized dihydroxyacetone phosphate 
converted to glycerol will not be labeled from tritium ^. 
Thus, the degree of recycling through glycerol measured by 
[3- Hj-D-glucose is dependent on the relative activities of 
triose isomerase and glycerol phosphate dehydrogenase. 
The reaction mechanism for triose isomerase as 
described by Rose and Rose C1969) is odd. I do not under­
stand why the enzyme would transfer hydrogen for the reac­
tion going in one direction while exchanging hydrogen with 
the medium going in the opposite direction. The answer, 
in part, may be due to unclear communication. Rose (1970) 
in another publication briefly states that little proton 
transfer occurs at the triose isomerase reaction. Noltmann 
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(1972) presents a persuasive argument, however, that the 
kinetics of complete exchange of tritium with medium may 
not be possible. This apparent contradiction has little 
impact on interpretation of results from kinetic measure-
3 
ments made with [3- H]-D-glucose. One exception could be 
some transfer of tritium ^ to the 5-position of hexose 
phosphates if tritium ^ were transferred to glyceraldehyde 
3-phosphate, which subsequently condensed with another 
dihydroxyacetone phosphate forming fructose 1,6-diphosphate. 
No tritium ^ is lost by interconversion of glucose 
with glycogen. 
I4-^H]-D-glucose 
The fate of tritium from the 4-position of glucose is 
traced in Fig. 5. There is a partial loss of tritium"^ to 
body water in the HMP pathway. This results from epimeriza-
tion of position 3 of ribulose 5-phosphate (derived from 
4-position of glucose) to xylulose 5-phosphate by action 
of phosphopentose epimerase (Maxwell, 1961; Glaser, 1972). 
By nature of the HMP pathway, ribulose 5-phosphate also 
must be isomerized to ribose 5-phosphate by phosphopentose 
isomerase in order to maintain flux through the pathway. 
It is necessary for ribose 5-phosphate and xylulose 
5-phosphate to be at equilibrium for complete tritium ^ 
loss. It is not known if this equilibrium is achieved in 
vivo, but it is unlikely. Thus, the amount of HMP activity 
3 
Figure 5. Metabolic fate of tritium from [4- H]-D-glucose 
legend: 1 = hexokinase; 2 = glucose 6-phosphatase; 3 = 
phosphoglucoisomerase; 4 = phosphofructokinase; 
5 = diphosphofructose phosphatase; 6 = aldolase; 
7 = triose phosphate isomerase; 16 = glycerol 
phosphate dehydrogenase; 17 = glycerol 3-phospha-
tase; 18 = glyceraldehyde 3-phosphate dehydrogenase; 
19 = phosphoglycerate kinase; 20 = phosphogly-
ceromutase; 21 = enolase; 22 = pyruvate kinase; 
23 = pyruvate carboxylase; 24 = malate dehydro­
genase; 25 = fumarase; 26 = phosphoenolpyruvate 
carboxykinase; 27 = glucose 6-phosphate dehydro­
genase; 28 = 6-phosphoglucono-5-lactone; 29 = 
lactonase; 30 = 6-phosphogluconate dehydrogenase; 
31 = phosphopentose isomerase; 32 = phosphopentose 
epimerase; 33 = transketolase; 34 = transaldolase 
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included in recycling measured by [4-^H]-D-glucose is 
uncertain. 
In glycolysis there is complete loss to body water of 
3 tritium derived from [4- H]-D-glucose. The loss occurs at 
the phosphorylation of glyceraldehyde 3-phosphate to 
1,3-diphosphoglycerate by action of glyceraldehyde dehydro­
genase (Rose and Rose, 1969). Thus, recycling measured with 
3 [4- H]-D-glucose does not include recycling from pyruvate 
or lactate. 
Careful attention to stereochemistry is important in 
tracing the fate of tritium derived from position 4 of glu­
cose in the triose isomerase reaction. The stereochemical 
structure of dihydroxyacetone phosphate formed by isomeriza-
tion of glyceraldehyde 3-phosphate is shown in Fig. 5 (Rose 
and Rose, 1969). Complexing of dihydroxyacetone phosphate 
with aldolase will release tritium"^ to body water (Rose 
and Rieder, 1955). The rate of complexing with aldolase 
and the rate of glycerol phosphate dehydrogenase activity 
varies under different metabolic conditions (Katz and 
3 
Rognstad, 1966). Recycling of tritium from 14- H]-D-
glucose via glycerol would require conversion of glycer­
aldehyde 3-phosphate to glycerol and the reverse conversion 
without the intermediate dihydroxyacetone phosphate com­
plexing with aldolase. Intuition may suggest the odds of 
this occurring are remote, but the data of Katz and 
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Rognstad (1966) indicate tritium ^ retention is not 
negligible. 
Katz and Rognstad (1976) further suggest that posi­
tions 4, 5, and 6 of glucose may be detritiated by action 
of transaldolase (Ljungdal et al., 1961). This action 
involves an exchange of glyceraldehyde 3-phosphate without 
cleavage of carbon-tritium bonds. This reaction is readily 
reversible and thus no tritium ^ is lost from the system. 
No tritium ^ is lost by interconversion of glucose 
with glycogen. 
[5-^H]-D-glucose 
The fate of tritium from the 5-position of glucose is 
traced in Fig. 6. Ignoring possible isotope effects, 
3 
tracing metabolism of IS- H]-D-glucose is relatively simple. 
-5 
There is no loss of tritium in the HMP pathway, thus HMP 
intermediates are included in recycling measured with 15-
3 —5 15- H]-D-glucose. Complete loss of tritium occurs when 
glyceraldehyde 3-phosphate is isomerized to dihydroxyacetone 
phosphate, thus eliminating glycerol recycling. Loss of 
-5 tritium at the enolase reaction as described in metabolism 
3 
of 13- HJ-D-glucose prevents inclusion of recycling via 
-5 lactate. No loss of tritium occurs by interconversion of 
glucose with glycogen. 
3 
Figure 6. Metabolic fate of tritium from [5- H]-D-glucose 
legend: 1 = hexokinase; 2 = glucose 6-phosphatase; 3 = 
phosphoglucoisomerase; 4 = phosphofructokinase; 
5 = diphosphofructose phosphatase; 6 = aldolase; 
7 = triose phosphate isomerase; 16 = glycerol 
phosphate dehydrogenase; 17 = glycerol 3-phospha-
tase; 18 = glyceraldehyde 3-phosphate dehydrogenase; 
19 = phosphoglycerate kinase; 20 = phosphogly-
ceromutase; 21 = enolase; 22 = pyruvate kinase; 
23 = pyruvate carboxylase; 24 = raalate dehydro­
genase; 25 = fumarase; 26 = phosphoenolpyruvate 
carboxykinase; 27 = glucose 6-phosphate dehydro­
genase; 28 = 6-phosphoglucono-6-lactone; 29 = 
lactonase; 30 = 6-phosphogluconate dehydrogenase; 
31 = phosphopentose isomerase; 32 = phosphopentose 
epimerase; 33 = transketolase; 34 = transaldolase 
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Figure 7. Metabolic fate of tritium from [6- H]-D-glucose 
legend; 1 = hexokinase; 2 = glucose 6-phosphatase; 3 = 
phosphoglucoisomerase; 4 = phosphofructokinase; 
5 = diphosphofructose phosphatase; 6 = aldolase; 
7 = triose phosphate isomerase; 16 = glycerol 
phosphate dehydrogenase; 17 = glycerol 3-phospha-
tase; 18 = glyceraldehyde 3-phosphate dehydrogenase; 
19 = phosphoglycerate kinase; 20 = phosphogly-
ceromutase; 21 = enolase; 22 = pyruvate kinase; 
23 = pyruvate carboxylase; 24 = malate dehydro­
genase; 25 = fumarase; 26 = phosphoenolpyruvate 
carboxykinase; 27 = glucose 6-phosphate dehydro­
genase; 28 = 6-phosphoglucono-6-lactone; 29 = 
lactonase; 30 = 6-phosphogluconate dehydrogenase; 
31 = phosphopentose isomerase; 32 = phosphopentose 
epimerase; 33 = transketolase; 34 = transaldolase 
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[6-^H]-D-glucose 
The fate of tritium from the 6-position of glucose is 
traced in Fig. 7. There is no loss of tritium ^ by inter-
conversion of glucose with glycogen or glycerol, nor with 
passage through the HMP pathway. Thus, recycling measured 
3 
with [6- H]-D-glucose will include all these components. 
The fate of tritium ^ in conversion of pyruvate back to 
phosphoenolpyruvate is less certain. The metabolism of 
3 [6- H]-D-glucose beyond glyceraldehyde 3-phosphate is 
3 identical to tritium derived from [1- H]-D-glucose. A dis­
cussion of this metabolism has been presented (see [1-^H]-
D-glucose). 
Summary of Metabolism of Tritiated Glucoses and Development 
of Rationale for Experimental Approach 
There are marked differences in fates of isotopes from 
various isotopically labeled glucoses. These differences 
are schematically diagramed in Figs. 8 through 14 and sum­
marized in Table 2. All components of recycling are 
included in kinetic measurements made with -D-glucose 
as the tracer. Obviously, none of the tritium labeled 
glucoses will include recycling from carbon dioxide. How­
ever, none of the tritium labeled glucoses exclude only 
carbon dioxide recyling. This necessitates that the carbon 
dioxide contribution to recycling be measured directly and 
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CO 
Figure 8. Schematic diagram of glucose metabolism measured 
with lU-l^Cj-D-glucose tracer 
I 
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Figure 9. Schematic diagram of glucose metabolism measured 
with Il-^H]-D-glucose tracer 
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LACTATE GLYCOGEN 
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Figure 10. Schematic diagram of glucose metabolism measured 
with 12-3hJ-D-glucose tracer 
59 
LACTATE GLYCOGEN 
GLYCEROL 
GLUCOSE 
HMP 
CO, 
Figure 11. Schematic diagram of glucose metabolism measured 
with [3-^Hj-D-glucose tracer 
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Figure 12. Schematic diagram of glucose metabolism measured 
with [4-^Hj-D-glucose tracer 
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Figure 13. Schematic diagram of glucose metabolism measured 
with i5-^H]-D-glucose tracer 
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Figure 14. Schematic diagram of glucose metabolism measured 
with I6-^H]-D-glucose tracer 
Table 2. Summary of glucose carbon recycling measured with variously labeled 
glucoses 
Does label recycle from compound below to glucose? 
Glucose label COg Glycerol Lactate BMP Glycogen 
U-^^C 
1-^H 
3 
2- H 
3-^H 
4-^H 
5-\ 
6-^H 
yes 
no 
no 
no 
no 
no 
no 
yes 
yes 
uncertain 
uncertain 
uncertain 
no 
yes 
yes 
monogastric - no 
ruminants - uncertain 
uncertain 
no 
no 
no 
monogastric - no 
ruminants - unertain 
yes 
no 
yes 
yes 
uncertain uncertain 
no 
uncertain 
yes 
yes 
yes 
yes 
yes 
yes 
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this has been done. Techniques and results are presented 
in Section I and Section II of this dissertation. 
3 [6- H]-D-glucose may exclude recycling from lactate. 
The completeness of exclusion could be ascertained by 
simultaneous injection of [6-^H, 6-^^C]-D-glucose and 
measuring the tritium/^^C ratio of the 1-position of glu­
cose. Let us assume this ratio is negligible. The contri­
bution of lactate to recycling could then be assessed by 
difference between recycling measured with [U-^'^C]-D-glucose 
and with [6-^H]-D-glucose after correction for carbon 
dioxide recycling that had been measured directly. 
The contribution of glycerol to recycling could then 
be assessed by difference between recycling measured with 
3 3 [6- Hl-D-glucose and with [5- H]-D-glucose. A small dif­
ference would be tentative support that tritium recycling 
3 from [6- H]-D-glucose does not include lactate because 
glycerol contribution to recycling would be expected to be 
small. 
Contributions of the HMP pathway to recycling could 
3 then be calculated by difference using either II- H]- or 
3 3 [3- H]-D-glucose as tracer. Ignoring cost, 13- H]-D-glucose 
would be the preferred tracer because its metabolism to 
lactate is more sharply defined. Lactate is expected to be 
a larger contributor to recycling than glycerol. 
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3 3 
Metabolism of [2- H]- and [4- H]-D-glucose is too com­
plex to be of value in routine application. These tracers 
require detailed knowledge of intracellular reaction rates 
and metabolite concentrations for evaluation of data. 
Tracers used for the present study include [U-^^C]-, 
[2-^H]-, [5-^H]-, and [6-^H]-D-glucose and NaH^^CO^. The 
inclusion of [2-^H]-D-glucose in the list of selected 
tracers warrants some clarification. I emphasize that the 
work reported herein was not a major goal of our research 
group nor of my assigned duties. Research funds were 
limited and the I2-^H]-D-glucose used was residual from a 
previous project. Major gaps in our knowledge preventing 
the research presented in Section II of this dissertation 
from being a neatly packaged work are: a) measuring 
tritium/^^C ratios of position 1 of glucose following injec­
tion of 6-^^C]-D-glucose and b) data from I3-^H]-D-
glucose as the tracer. 
The major advantage of defining components of glucose 
recycling by difference after using variously labeled glu­
coses is that only one analytical technique, determination 
of glucose specific radioactivity, is required. Our labora­
tory has developed a very reliable and rapid technique for 
determination of glucose specific radioactivity (Mills et 
al., 1980). Thus, a large number of samples can be proc­
essed easily, allowing establishment of a large data base 
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for various nutritional conditions in a relatively short 
time. 
Alternatively, direct measurements of components of 
recycling involve much more tedious analytical techniques 
and more complex mathematical analyses. Each compound 
involved in recycling must be isolated for determination of 
specific radioactivity after -D-glucose injection. 
In addition, data from a [U-^^C] injection of each compound 
is necessary to calculate recycling. This markedly 
increases laboratory work. 
The methods described in the previous paragraphs are 
not applicable for reasonable in vivo measurements of 
recycling via the HMP pathway. Recycling via HMP pathway 
can be assessed in vivo by use of [2-^^C]-D-glucose as a 
tracer (Landau and Bartsch, 1966) . The method requires a 
carbon-by-carbon degradation of glucose to determine the 
distribution of specific radioactivity of each carbon of 
glucose. This degradation is a very long and tedious pro­
cedure. For reliable results of the degradation procedure, 
millicurie amounts of expensive (relative to tritium labeled 
glucoses) tracer must be used for each experiment. Ratios 
of yield from fl-^^C]- and I6-^^CJ-D-glucose have been 
misused to estimate HMP pathway activity. The knowledge of 
intermediary metabolism conditions needed to calculate HMP 
14 pathway activity by these COg yields restricts the method 
to in vitro applications (Katz et al., 1966). 
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By taking advantage of the differential loss of tritium 
from variously labeled glucoses, much tedious laboratory 
work can be eliminated. It would be relatively easy to 
establish a data base from which realistic statistical 
extrapolations could be made for describing the utilization 
of glucose in populations of animals. It is desirable to do 
limited direct measurements to validate the fate of 
tritium from variously labeled glucoses. 
An Alternate HMP Pathway 
After completing the previous portion of this litera­
ture review, I learned of a variant HMP pathway (Williams 
and Clark, 1971; and Williams et al., 1978a,b) which is 
different from the classical HMP pathway (Horecker et al., 
1954; and Gibbs and Horecker, 1954) shown in Figs. 2 through 
7. According to Williams et al. (1974), the classical HMP 
pathway (F-type) is solely operative in adipose, whereas 
the variant (L-type) HMP pathway is the exclusive form in 
liver (Longenecker and Williams, 1980b). The carbon rear­
rangements of the L-type HMP pathway are proposed (Long­
enecker and Williams, 1980a) and are presented in Fig. 15. 
Reaction mechanisms have not been elucidated for enzymes 
involved in the L-type extension of the pathway so there 
can be no unequivocal determination of the fate of tritium 
labels from variously labeled glucoses. Because the HMP 
pathway in liver is most critical to possible recycling of 
Figure 15. Proposed alternate HMP pathway occurring in liver 
legend; 1 = hexokinase; 2 = glucose-6-phosphatase; 3 = 
phosphoglucoisomerase; 4 = glucose 6-phosphate 
dehydrogenase; 5 = phosphofructokinase; 6 = 
lactonase; 7 = 6-phosphogluconate dehydrogenase; 
8 = phosphopentose isomerase; 9 = ribulose-5-
phosphate epimerase; 10 = arabinose 5-phosphate 
epiitierase; 11 = transketolase; 12 = triose phosphate 
isomerase; 13 = aldolase; 14 = D-glycero D-ido-
octulose 1,3-diphosphate:D-altro-heptulose 
7-phosphotransferase 
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glucose via HMP, attention must be given to possible rami­
fications of the newly elucidated L-type HMP pathway. 
The oxidative portions (glucose 6-phosphate to ribulose 
5-phosphate) of F- and L-type HMP pathways are identical. 
Thus, there is no difference in the fate of tritium from 
positions 1 and 3 of glucose. The direct involvement of 
dihydroxyacetone phosphate will cause variable loss of 
tritium derived from the 5-position of glucose in the L-type 
HMP pathway. There are no alterations of carbon-carbon or 
carbon-hydrogen bonds of position 6 derived from glucose in 
either pathway. Loss of tritium from position 6 would be 
unexpected. There also is a condensation reaction involving 
dihydroxyacetone phosphate. The reactive free-alcohol 
carbon of dihydroxyacetone phosphate may be derived from 
either carbon 2 or 4 of glucose. Thus, dependent on the 
stereochemistry of the reaction mechanism, tritium loss 
would be expected at this reaction. However, for reasons 
described earlier, glucoses tritiated at position 2 or 4 
already have been dismissed as useful tracers for estimating 
recycling. Therefore, additional complications of their 
metabolism have little impact on the previously developed 
theory. 
The L-type HMP pathway invalidates the assumption of 
no tritium loss from position 5 of glucose by HMP pathway 
activity. Components of chemical recycling can still be 
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estimated by difference using [1-^H]-, [5-^H]-, and [6-^H]-
D-glucose if complete loss of tritium occurs from the 
3-position of pyruvate in recycling back to phosphoenol-
3 3 pyruvate. The difference between [1- H]- and [6- H]-D-
glucose recycling is the amount due to HMP pathway. 
Approximately one-third of the tritium will be lost from 
the 5-position of glucose per cycle through the L-type HMP 
pathway. This fraction times the amount of recycling via 
3 
HMP pathway determined by difference between [1- H]- and 
[6-^H]-D-glucose can be used to correct for the amount of 
3 tritium lost from [5- H]-D-glucose via HMP pathway. Results 
3 from the HMP-corrected [5- H]-D-glucose data can be used to 
calculate recycling via glycerol by difference between 
3 3 [5- H]- and [6- H]-D-glucose recycling. Although no loss 
of tritium from either position occurs by F-type HMP path­
way, it is not necessary to know the relative proportion of 
F-type and L-type metabolism because of the anatomical 
location of the two types of cycles. The occurrence of 
F-type HMP pathway in adipose requires that any glucose 
entering this pathway be metabolized to glycerol, pyruvate, 
or lactate, or a nonphosphorylated derivative thereof for 
exit from the adipocyte and subsequent reincorporation back 
into glucose. Such metabolism would cause complete detrita-
tion of position 5 of glucose and hence exludes extrahepatic 
HMP pathway activity from measured HMP recycling. 
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Other Tracers for Defining Glucose Recycling 
To this point, the literature review has been directed 
toward recycling of glucose carbon through metabolic deriv­
atives of glucose (i.e., chemical recycling). Another pos­
sible component of recycling is the physical distribution 
of tracer glucose throughout the body glucose pools and 
return of some of these glucose molecules to the blood. It 
is conceivable that labeled glucose injected into blood 
plasma begins equilibration with interstitial glucose before 
mixing within the plasma is complete. Allsop et al. (1979) 
observed multiexponential disappearance of labeled glucose 
from the circulation of anesthetized, hepatectomized, 
bilateral nephrectomized dogs after a 36 hour fast. Blood 
glucose concentration was maintained by continuous infusion 
of a constant amount of glucose; the proper infusion rate 
of glucose had been determined in a preliminary period 
prior to label injection. In this preparation, no chemical 
recycling of glucose should occur by conventional metabolic 
pathways because organs containing glucose 6-phosphatase 
activity had been removed (Raggi et al., 1960). Complete 
data were presented only for the most dramatic case. From 
these data glucose production rate was 2.3 mg min ^ kg ^ 
(glucose infusion raté was 1.89 mg ^ kg ^) and recycling 
—1 —1 
was 95 mg min kg . This amount of recycling is an 
exceedingly high value even for intact dogs. Estimating 
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from the data of Altszuler et al. (1975), using the method 
of Katz et al. {1974a), a reasonable estimate is 3 mg min ^ 
kg ^ for intact dogs with a glucose production rate of 
-1 -1 3 mg min kg . Even though Allsop's results appear 
unrealistic, the possibility remains that recycling may be 
due, in part, to physical mixing of tracer in the plasma 
and extracellular fluid. The remainder of this literature 
review is a discussion of possible intravascular and extra­
cellular tracers. 
Extracellular tracers 
D-xylose D-xylose, a five carbon aldose sugar, is 
used clinically as a test substance for intestinal malab­
sorption (Davidson and Wells, 1963), and generally is pre­
sumed to be metabolically inert (Blatherwick et al., 1936). 
The similarity in size, structure, and chemistry between 
xylose and glucose prompted the conclusion that xylose 
would be a good extracellular tracer for physical recycling 
of glucose. My experiments using D-xylose as a tracer 
yielded most peculiar results. After conducting the xylose 
experiments, I discovered a review of xylose metabolism 
that presented very convincing evidence that D-xylose is 
metabolized (Demetrakopoulos and Amos, 1978) . It is con­
cluded, therefore, that D-xylose is unsuitable as an 
extracellular tracer. 
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2-Deoxy-D-glucose Metabolism of 2-deoxy-glucose 
has been reviewed by Brown (1962) and by Webb (1966). 
Although pharmacological doses of this glucose analog 
inhibit glucose metabolism, tracer doses should mimic glu­
cose metabolism up to the glucose 6-phosphate step. 
2-Deoxy-D-glucose enters cells via the glucose transport 
system at a rate approximating glucose entry and with 
similar responses to insulin. Once inside the cell, 
2-deoxy-D-glucose is phosphorylated by hexokinase, with 
phosphorylating capacity exceeding cell entry. Thus, no 
free 2-deoxy-D-glucose accumulates intracellularly but is 
trapped as the phosphorylated derivative because 2-deoxy-D-
glucose 6-phosphate is not a substrate for phosphoglucoiso-
merase or glucose 6-phosphate dehydrogenase. Because non-
gluconeogenic tissues lack glucose 6-phosphatase activity, 
cellular uptake is an irreversible loss for 2-deoxy-D-
glucose. No has been detected following ^^C-2-
deoxy-D-glucose administration. A more recent study 
(Renner et al., 1972), in general, confirms that phosphory­
lation exceeds facilitated diffusion at 2-deoxy-D-glucose 
concentrations less than 0.5 mM. But at 4.2 mM, 2-deoxy-D-
glucose entered cells rapidly by diffusion and free 2-deoxy-
D-glucose accumulated intracellularly. Small amounts of 
2-deoxy-D-6-phosphogluconate were observed also. 
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Recycling measured with 2-deoxy-D-glucose will include 
physical recycling plus recycling of hepatic glucose 6-
phosphate. A model to illustrate how radioactive tracer 
doses of 2-deoxy-D-glucose might be used to measure physical 
recycling of glucose will now be presented and discussed. 
First, the numbers necessary for constructing a model 
are presented and the calculations summarized in Table 3. 
Assume a 200 kg steer is producing 12 mmol glucose carbon 
min has a plasma glucose concentration of 0.027 mmol of 
glucose carbon ml ^ CO.8 mg glucose ml ^), and has a glucose 
pool size of 525 mmol of glucose carbon (17.5 g). These 
are rounded numbers from a lU-^^C]-D-glucose tracer experi­
ment reported in Section II of this dissertation. Further, 
liver weight is 1% of body weight (Ziegler, 1966), liver 
glucose 6-phosphate concentration is 0.07 mmol per kg wet 
liver weight (Clark et al., 1974), and liver glucose con­
centration is equal to plasma glucose concentration 
(Newsholme and Start, 1973). An estimate of hepatic pool 
sizes of glucose and glucose 6-phosphate are 54 and 0.84 
mmol carbon, respectively. Hooper and Short (1977) 
measured the hepatic glucose extraction coefficient to be 
80% for conscious sheep. Using an 80% extraction coeffi­
cient and cardiac output of 155 ml blood min ^ kg body 
weight ^ (Waldern et al., 1963) and assuming 30% of cardiac 
output goes to the liver (Tiran et al., 1975), the 
Table 3. Calculations for modeling hepatic glucose 6-phosphate, hepatic glucose, and blood plasma 
glucose exchange of a 200 kg steer having a gluconeogenic rate of 12 mmol carbon min~^, 
plasma glucose concentration of 0.027 mmol glucose carbon ml~^ and glucose pool size of 
525 mmol glucose carbon 
Calculation of hepatic pool sizes 
Liver weight = 1% body weight = 2 kg liver 
Liver glucose 6-phosphate concentration = 0.07 mmol per kg liver 
Liver glucose 6-phosphate pool size = concentration x liver mass^ = 0.84 mmol carbon 
Liver glucose concentration = plasma glucose concentration = 0.027 mmol carbon ml~^ 
Liver glucose pool size = concentration x liver mass& = 54 mmol carbon 
Calculation of glucose flux from plasma to hepatocytes 
Hepatic extraction coefficient for glucose =0.80 
Cardiac output = 155 ml blood • min~^ • kg body wt~ = 31000 ml min~^ 
Hepatic blood flow = 30% cardiac output = 9300 ml min~^ 
Hepatic plasma flow = hepatic blood flow x (1 - Hct) = 31000 ml min"^ x .75 = 6975 ml min~^ 
Plasma glucose flow to the liver = hepatic plasma flow x plasma glucose concentration = 
188 mmol carbon min~^ 
Glucose flux from plasma to hepatocytes = plasma glucose flow to liver x extraction coefficient 
= 150 mmol carbon min~^ 
Calculation of carbon flux from hepatic glucose to hepatic glucose 6-phosphate 
Hexokinase activity =0.7 ymol • min~^ • g wet liver weight"! 
Glucokinase activity = 0.0 
Carbon flux from glucose to glucose 6-phosphate = hexokinase activity x liver mass = 
8.4 mmol carbon rain"! 
^Assuming a density of 1.0. 
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hepatocellular-plasma exchange should be 150 mmol glucose 
carbon min ^. Maximum hexokinase activity is expected to 
be 0.7 ramol min ^ g wet liver weight ^ (Scrutton and Utter, 
1968). Thus, maximum glucose conversion to glucose 6-
phosphate is 8.4 mmol carbon min ^. 
Landau et al. (1958) observed that 30% of a 2-deoxy-
D-glucose dose was excreted in the urine by 16 hour and the 
excretion was exponential as would be expected. The calcu­
lated excretion rate is approximately 0.04% min~^. Urinary 
excretion of 2-deoxy-D-glucose results from poor renal 
tubular reabsorption (Knight et al., 1977). Loss of 2-
deoxy-D-glucose into the intestine is unlikely. Entry into 
chick intestinal epithelial cells from the mucosal side is 
by diffusion and phosphorylation is rapid and irreversible 
(Kimmich and Randies, 1976). The lack of significant glu­
cose 6-phosphatase activity in ruminant intestinal mucosa 
CRaggi et al., 1960) should prevent diffusion of 2-deoxy-
D-glucose into the intestinal lumen. 
Presentation of this mass of numbers may have clouded 
the vision of the objective of modeling 2-deoxy-D-glucose 
metabolism in cattle to gain an understanding of physical 
chemical recycling of glucose. Let us summarize these 
numbers by incorporating them into two models; first, the 
portion of glucose metabolism that is labeled by 2-deoxy-
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Figure 16. An abbreviated model of glucose metabolism 
restricted to the portion labeled by a tracer 
dose of 2-deoxy-D-glucose 
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D-glucose and second, a model of 2-deoxy-D-glucose super­
imposed on the partial glucose model. 
An abbreviated model of glucose metabolism restricted 
to the portion labeled by a trace dose of 2-deoxy-D-glucose 
is presented in Fig. 16. The model has been simplified by 
the assumption that all glucose entering the system does 
so by hepatic gluconeogenesis. Thus, there is 12 mmol 
carbon min ^ entering the glucose 6-phosphate pool from 
gluconeogenesis and a 8.4 mmol carbon min ^ by phosphoryla­
tion of intracellular hepatic glucose. The dephosphoryla-
tion of hepatic glucose 6-phosphate must therefore be 20.4 
mmol carbon min ^. The hepatic glucose formation of 20.4 
mmol carbon min by action of glucose 6-phosphatase plus 
entry of 150 mmol carbon min ^ from extracellular glucose 
requires exit of 162 mmol carbon min from hepatic cells 
to extracellular space. Because exit of 2-deoxy-D-glucose 
from the extracellular space is irreversible, only the 
measured irreversible loss of glucose (12 mmol carbon min 
can be included in the model. Obviously, if physical 
recycling is to exist, the extracellular glucose pool must 
be subdivided. However, the existence of "pure" physical 
recycling has not yet been verified. The hepatic glucose 
and hepatic glucose 6-phosphate pools turnover 6.5 and 24 
times each minute, respectively, indicating their contribu­
tion to recycling is negligible. 
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Figure 17. A model of 2-deoxy-D-glucose metabolism super­
imposed on a partial model of glucose metabolism 
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The model of 2-deoxy-D-glucose metabolism superimposed 
on the abbreviated glucose model (Fig. 17) is identical to 
Fig. 16 except there is a urinary loss of 2-deoxy-D-glucose 
and the measured irreversible loss of 2-deoxy-D-glucose 
corrected for urine excretion will equal net tissue uptake 
of glucose. Note that tissue is not restricted to extra-
hepatic. Thus, the difference in net tissue uptake and 
irreversible loss of glucose measured with [U-^^C]-D-glucose 
is equal to chemical recycling. The difference in total 
recycling measured with [U-^^C]-D-glucose and chemical 
recycling measured by combination of [U-^^C]-D-glucose and 
2-deoxy-D-glucose is physical recycling. Any available 
radioactive labeled 2-deoxy-D-glucose would be a suitable 
tracer. 
L-glucose An important requirement of a tracer is 
that it behave in a manner indistinguishable from tracee in 
the system being modeled. Although L-glucose differs only 
in stereochemistry from D-glucose tracee, this difference 
makes L-glucose metabolically inert to the point that it 
enters cells only very slowly by diffusion (Bowen-Pope and 
Rubin, 1977; Baur and Heldt, 1977; Hooper and Short, 1977; 
and Goresky, 1967). Thus, L-glucose should be a very good 
extracellular marker for physical recycling of glucose. 
Physical recycling could be measured directly from single-
injection experiments of radioactively labeled L-glucose. 
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Disposal of L-glucose from the body is expected to be via 
urine because of a lack of renal tubular reabsorption 
(Knight et al., 1977). Rate of cellular uptake could 
easily be estimated from accumulation in red blood cells. 
Other extracellular tracers Inulin was used in 
some preliminary studies in our laboratory. Doses of 
sufficient size for reliable chemical measurement of inulin 
caused aberrant glucose kinetic measurements. Use of 
inulin as an extracellular marker has been discontinued. 
A radioactive inulin tracer might be acceptable because the 
quantity of inulin would be much less. 
Sucrose behaves similarly to glucose in the extracel­
lular space within the liver (Goresky and Bach, 1970). 
Assuming capillary endothelium to be as permeable as liver 
sinusoids to sucrose, it may be an acceptable tracer of 
extracellular physical recycling of glucose. 
Krebs and Lund (1966) indicate the sugar alcohols D-
arabitol, mannitol, and dulcitol are not metabolized by 
liver and kidney tissue slices. These also are possible 
extracellular tracers. 
Intravascular tracers 
p-aminohippuric acid (PAH) The use of PAH as a 
blood-flow marker (Katz and Bergman, 1969) implies that it 
remains within the vascular bed. Initially one would expect 
PAH to be a good intravascular tracer. The divergence from 
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monoexponential form of PAH disappearance following a 
single-injection of PAH (Van Stekelenburg et al., 1976; 
Oldendorf and Kitano, 1972; and Mandel et al., 1955) was 
initially thought to be due to physical mixing within the 
vascular bed. Experiments to refine the PAH blood flow 
method (Meerdink et al., 1981b) have revealed considerable 
interconversion of PAH to its acetylated derivative. This 
interconversion probably does not take place in blood and 
places doubt on the prospect of PAH remaining within the 
vascular bed. Further investigations of PAH as a blood flow 
marker should indicate its degree of suitability as an 
intravascular tracer. 
Polyethylene glycol (PEG) Near quantitative excretion 
of PEG in urine was observed after an intravenous injection 
of PEG into human subjects (Shaffer and Critchfield, 1947). 
PEG is a polymer available in several ranges of specified 
molecular weights. It should be possible to select a range 
of molecular weights that remain intravascular but still 
have considerable leakage into the glomerular filtrate. An 
initial screen for proper molecular weight range can be done 
by chemical assay of PEG CRussell et al., 1981). Subsequent 
use would involve radioactively labeled PEG of the selected 
size. The selected PEG may be useful as a blood-flow marker. 
Albumin Albumin labeled with T-1824 or radioactive 
iodine also may be applied as an intravascular marker. 
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There are some complicating factors involved with using 
labeled albumin. There is a noticeable delay in transit 
time across the liver relative to ^^Cr-labeled red blood 
cells indicating extravascularization of albumin (Goresky 
and Bach, 1970). A similar occurrence might be expected in 
the kidney. The presence of albumin in lymph (Guyton, 
1971) demonstrates that extravascularization probably occurs 
in all capillary beds but to a much lesser degree than in 
the liver. Labeled albumin remains in the vascular system 
for a relatively long time, lengthening the time required 
between successive experiments with an animal. 
Labeled red blood cells Red blood cells also can 
be labeled with ^^Cr (Albert, 1973), ^^Fe or ^^Fe (Underwood 
and Rowland, 1964) for use as an intravascular tracer. 
Procedures required to label red blood cells restrict use 
of this marker to a reference method. Possible complica­
tions may be incurred by sequestration of red blood cells 
by the spleen. The labeled red cells would be cleared 
from the vascular system only very slowly. 
Relevance of physical recycling in modeling glucose 
metabolism 
A model of glucose metabolism is a compartmental-
metabolic model superimposed on a circulatory-diffusion 
model and linked by membrane transport. In order to gain 
an understanding of the whole system for glucose metabolism 
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in an animal, we must be able to define and guantitate the 
parts. Such understanding must be available for proper 
interpretation of control mechanisms. An understanding of 
control mechanisms is what we must strive to attain, for it 
holds the key to improving efficiency of animal production. 
I get a feeling that little communication has been achieved 
when ideas are presented only in abstract form. Hence, 
examples will follow. 
L-glucose is restricted to the circulatory-diffusion 
model. Analysis of L-glucose kinetics by mathematical 
theory outlined by Perl C1963), Zierler (1963), and Water-
house and Keilson (1972) should enable definition and 
quantitation of this subsystem. It is unlikely that recy­
cling measured with L-glucose will be the same as physical 
recycling measured with 2-deoxy-D-glucose. Physical recy­
cling measured with 2-deoxy-D-glucose includes, in addition 
to the circulation-diffusion subsystem, membrane interac­
tions at the interface of the metabolic subsystem and the 
circulation-diffusion subsystem. Resolution of these sub­
system components will allow examination of factors influ­
encing cellular uptake of glucose, clearly an important 
consideration for increasing milk production. 
There is experimental evidence that the mechanism 
whereby insulin stimulates glucose transport is by a 
translocation of glucose transport protein from golgi 
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membranes to the plasma membrane (Cushman and Wardzala, 
1980; and Suzuki and Kono, 1980). Transport proteins in 
each location have a similar Km for glucose. Insulin 
increases plasma membrane transport activity 200%, but the 
decrease in transport activity by the golgi membranes is 
350% more than the accompanying increase in transport 
activity by the plasma membrane. These data suggest that 
the number of glucose transport proteins of the plasma 
membrane is variable but with a constant Km and that trans­
port rate per transport protein also is variable. Thus, 
under influence of insulin, more glucose binding sites are 
exposed on the plasma membrane with a reduced extracellular-
intracellular inversion rate. The result is an increased 
glucose pool size at the extracellular-interacellular 
interface. Can this effect be selectively localized? 
Ideally we would like to direct localization to intra-
mammary golgi membranes, the site of lactose synthesis. 
Modification of cell membranes should have no effect on 
L-glucose kinetics, but would markedly affect 2-deoxy-D-
glucose kinetics. 
The metabolism of variously labeled glucoses and data 
interpretations have been discussed already. By combining 
data obtained from the variously labeled glucoses with 
data from 2-deoxy-D-glucose and L-glucose, the whole 
system of glucose metabolism can be defined. Once the 
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system is defined, it then will be possible to identify 
control factors by perturbing the system and to ultimately 
adjust the system to achieve maximum production efficiency. 
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SECTION I. A METHOD FOR DETERMINATION OF CARBON DIOXIDE 
SPECIFIC RADIOACTIVITY AND CONCENTRATION IN 
BLOOD, RUMEN FLUID, AND EXPIRED AIR 
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ABSTRACT 
A method is described for determining carbon dioxide 
specific radioactivity and carbon dioxide concentration in 
blood, rumen fluid, and expired air. The carbon dioxide of 
blood and rumen fluid samples is selectively liberated by 
1 M phosphate buffer (pH 5.8) containing 1 mM NaN^ and 
5 mM NaF. Liberated carbon dioxide is quantitatively 
trapped in BafOHjg and amounts of carbon dioxide determined 
by titration of unconsumed hydroxide ion. The trapped 
BaCOg is solubilized with 10% EDTA in 1 M THAM (pH 9) and 
radioactivity determined by liquid scintillation. For quan­
titative determination of expired carbon dioxide, a measured 
fraction of expired air is bubbled through BaCOHjg. The 
amount of carbon dioxide trapped is determined by titrating 
an aliquot of the trapping solution after centrifugation to 
precipitate the BaCO^. The carbon dioxide is regenerated 
by addition of acid and quantitatively retrapped in 
ethanolamine. Radioactivity is determined by liquid 
scintillation of ethanolamine carbamate. 
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INTRODUCTION 
A reliable method for carbon dioxide specific radio­
activity is essential in isotopic tracer studies of energy-
yielding metabolites. The importance of short-chain mono-
carboxylic acids in energy metabolism of ruminants causes 
frequent use of these acids as the injected tracer. 
Published methods for determining carbon dioxide specific 
radioactivity use strong acid to liberate carbonate from 
blood CRose, 1976; and Hinks et al., 1966). These methods 
are not valid for carbon dioxide specific radioactivity 
determination under conditions of high specific radio­
activity of short-chain monocarboxylic acids because these 
acids will volatilize into the alkali trap. Anderson and 
Snyder (1969) demonstrated that carbon dioxide could be 
liberated selectively from bicarbonate in the presence of 
formate, acetate, and propionate at pH 6. 
Our method is an improvement and refinement of the 
aforementioned papers. Data are presented to demonstrate 
inhibition of metabolic generation of carbon dioxide during 
carbon dioxide trapping. We have also extended our study 
to quantitatively define the resolution of the assay. The 
method is further adapted to determine carbon dioxide 
specific radioactivity and concentration in expired air. 
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MATERIALS AND METHODS 
Apparatus for Blood and Rumen Fluid Carbon Dioxide 
Reaction vessels (Fig. 1.1) consist of 6-ounce wide-
mouth glass jars capped with No. 10 rubber stoppers. A 
suspension hook is made by passing nickel-chromium alloy 
wire through the center of the stopper and bending the wire. 
A suspension bucket is made by cutting the top off a 60 ml 
Nalgene^ bottle and attaching wire for a bail. The trapping 
vial is a 20 ml scintillation vial. Before use, the reac­
tion vessels and trapping vials are flushed separately with 
Ng. One ml of 0.3N BafOHlg containing thymolphthalein is 
added to the trapping vial and 20 ml of 1 M phosphate buf­
fer (pH 5.8) containing 1 mM NaNg, an oxidative phosphoryla­
tion inhibitor, and 5 mM NaF, a glycolysis inhibitor, is 
added to the reaction vessel. The apparatus is assembled. 
A 3 ml sample of blood or a 2 ml sample of rumen fluid con­
taining added HgClg to stop microbial carbon dioxide produc­
tion is added to the reaction vessel, the vessel restoppered 
and shaken at 100 to 110 strokes per minute with an 
Eberbach shaker. Shaking provides agitation to prevent a 
^Fisher Scientific Company, Pittsburgh, Pennsylvania. 
2 
Model 5850. Eberbach Corporation, Ann Arbor, Michigan. 
Figure 1.1. Apparatus for trapping carbon dioxide from 
samples of blood and rumen fluid 
legend: A = rubber stopper; B = reaction vessel; C = trap­
ping vial; D = suspension bucket; E = Ba(0H)2; 
F = phosphate buffer plus sample 
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surface film of BaCO^ from forming and causes BaCO^ to 
precipitate. 
Experiment 1 
To determine the diffusion rate of carbon dioxide from 
reaction vessel contents into the BafOHjg trap, two series 
of reaction vessels were assembled. To each of one series, 
126 ymols of NaCOg were added; the other series served as 
blanks. The trapping vial was removed from one vessel of 
each series after 0, 15, 30, 60, 90, 120, and 180 minutes 
of incubation. The trapping vial contents were titrated to 
disappearance of blue color of thymolphthalein after 
addition of 2 ml of COg-free distilled water. A Hach^ 
titrator was used to deliver 0.586N HCl, and contents of 
the trapping vial were stirred with Ng. 
Experiment 2 
This experiment was to ascertain if the phosphate buf­
fer mixture selectively liberates carbon dioxide while con­
comitantly inhibiting metabolic generation of carbon dioxide 
from other substrates. Two series of reaction vessels were 
prepared. Three ml of blood were added to each vessel of 
one series and 2 ml of rumen fluid were added to the other 
series of vessels from a 50 ml sample, to which 1 ml of 
^Hach Chemical Company, Ames, Iowa. 
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saturated HgClg had been added. Each series was subdivided 
into four groups of four. One group was spiked with 11968 
dpm of [U-^^C]-D-glucose, another group with 27803 dpm of 
Na-[1~^^C]-D-acetate, and another group with 7864 dpm 
NaH^^COg. The remaining group was for background control. 
After a three-hour incubation, trapping vials were removed 
and titrated as before. BaCO^ was solubilized by adding 1 
ml of 10% EDTA in 1 M THAM (pH 9), rinsing the tip of the 
titrator with the edta/THAM while it is added. Radioac­
tivity was determined by liquid scintillation after adding 
18 ml of Beckman ready-solv EP^. Experiment 2 was repeated 
using incubation times of 3, 6, and 9 hours. 
Experiment 3 
A series of 33 reaction vessels were prepared and sub­
divided into equal groups of three. Vessels were spiked by 
group with increments of 12.64 ymol NaCO^ and titrated after 
a three-hour incubation. A standard curve, ranging from 0 
to 26.4 ymol carbon dioxide with triplicates at each point, 
was constructed. Resolution along the curve was determined 
by linear calibration using equation (6.14.2) of Snedecor 
and Cochran (196 7). 
^Beckman Instruments, Inc., Fullerton, California. 
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Apparatus for Trapping Expired Carbon Dioxide 
The apparatus used to trap and quantitate carbon 
dioxide from expired air is illustrated in Fig. 1.2. The 
trapping vessel is a 250 ml wide-mouth centrifuge bottle 
capped with a No. 7 rubber stopper and containing 50 ml of 
0.3N BafOHjg containing thymolphthalein. The gas scrubber 
is constructed by attaching the apex of a plastic centrifuge 
1 2 
cone to glass-tubing with Tygon tubing. The base of the 
scrubber is immersed in the BafOHjg. A gas outlet is pro­
vided by inserting a short piece of glass tubing through 
the stopper. An injection port, capped with a tubing 
septum, is made similarly by passing a second piece of glass 
tubing through the stopper. During carbon dioxide collec­
tion, the scrubber inlet tubing is connected to an aliquoting 
gas meter^ through which the expired air is passed, and the 
outlet tubing is attached to a second gas meter^. 
After carbon dioxide collection, trapping vessels with 
openings plugged with glass rods are swirled vigorously to 
^Amicon Corporation, Lexington, Massachusetts. 
2 Norton, Plastics and Synthetics Division, Akron, Ohio. 
3 • 
Zentralwerkstatt Gottingen G.m.b.H., Gottingen, West 
Germany. 
'^Wet test meter. Precision Scientific Company, Chicago, 
Illinois. 
Figure 1.2. Apparatus for trapping carbon dioxide from 
expired air 
legend: A = trapping vessel; B = outlet; C = inlet; 
D = injection port; E = gas scrubber. 
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disperse any BaCO^ film, and centrifuged to hasten precipi­
tation of BaCOg. Aliguots of supernatant are removed and 
titrated as previously described. Amount of carbon dioxide 
trapped is calculated using the equation: 
;mol COj trapped = (E - S)(normality of acid) 
where B = y l  acid to titrate blank; and S = yl acid to 
titrate sample. 
Radioactivity of trapped carbonate is determined by 
regeneration of carbon dioxide and subsequent retrapping. 
This is accomplished by adding 100 ml H^O to the trapping 
vessel, attaching the scrubber to a stream on Ng, and 
attaching to the outlet, glass tubing immersed in 9 ml 
ethanolamine/methanol (20/80, v/v) contained in a scintil­
lation vial (Fig. 1.2). Twelve ml of IN HCl is injected 
via the injection port and the regenerated carbon dioxide 
is trapped as ethanolamine carbamate. After 1 hour of bub­
bling Ng, the apparatus is disassembled and the tubing that 
had been submersed in ethanolamine/methanol is rinsed with 
8 ml toluene containing 4 g PPO and 0.05 g POPOP per liter 
(Fox, 1976), and mixing the rinse with the ethanolamine/ 
methanol. Evaporation of methanol during trapping may 
necessitate adding varying amounts of methanol to make the 
ethanolamine/ethanolamine carbamate miscible in the toluene. 
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The radioactivity is determined by liquid 
scintillation. 
Experiment 4 
Efficiency of expired carbon dioxide trapping was 
determined by connecting two vessels in series and col­
lecting a 0.6% aliquot of expired carbon dioxide from a 
215 kg steer for 30 minutes. Quadriplicate 1 ml aliquots 
were taken from each trapping vessel for titration. 
Experiment 5 
The purpose of this experiment was threefold; 1) to 
determine the rate of transfer of regenerated carbon dioxide 
from the expired-carbon dioxide trapping vessel into the 
ethanolamine trap; 2) to determined efficiency of the 
ethanolamine trap; and 3) to determine the possible presence 
of carbonate in the 1 ml titration aliquot removed from the 
supernatant of the expired carbon dioxide trap. Although 
the equilibrium for BaCO^ formation and its solubility both 
favor complete separation of radioactivity into the precipi­
tate, we still chose to verify this. 
The rate of regenerated carbon dioxide transfer was 
measured by spiking a prepared expired carbon dioxide 
trapping vessel with 34663 ± 605 dpm of NaH^^CO^ and regen­
erating the carbon dioxide as just described, with one 
exception. Instead of continuous trapping for one hour. 
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the ethanolamine trap was replaced with a fresh ethanolamine 
trap at 10 minute intervals. The six traps subsequently 
were prepared for counting as described earlier. The small 
amount of radioactive carbonate was all that was present, 
but transfer is a first-order process, and the rate con­
stant will be unaffected by amount. Although the design 
effectively measures transfer rate, the results may over 
estimate recovery because of replacement with fresh 
ethanolamine. 
These shortcomings were overcome by testing the method 
under experimental conditions. Expired carbon dioxide was 
trapped from a 205 kg steer over timed intervals after 
injecting NaH^^COg into the rumen. Expired carbon dioxide 
was trapped as described in the description of apparatus. 
Regenerated carbon dioxide was trapped, however, using two 
ethanolamine traps in series. For this experiment, the 1 
ml titration aliquots also were prepared for liquid scintil­
lation counting after titration by adding 1 ml of 10% EDTA 
in 1 M THAM and scintillation fluid as described for traps 
for blood and rumen fluid carbon dioxide to determine loss 
of radioactivity in the titration aliquot. 
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RESULTS AND DISCUSSION 
Experiment 1 
The rate of diffusion of carbon dioxide from reaction 
vessels into the BAfOHlg trap is presented in Fig. 1.3. 
Trapping of carbon dioxide is virtually complete by 90 
minutes, however, 120 to 180 minutes have been used rou­
tinely in application of the method. The diffusion rate 
is described by the equation; 
where t = minutes of reaction; = cumulative trapping of 
carbon dioxide at time = t; and A^ = amount of carbon 
dioxide to be liberated at t = 0. 
Experiment 2 
Results of experiment 2 (Table 1.1) indicate that 1 M 
phosphate buffer (pH 5.8) containing 1 mM NaN^ and 5 mM NaF 
completely liberates carbon dioxide while volatilization of 
acetic acid is not measurable. Also, there is no generation 
of carbon dioxide by oxidation of D-glucose or Na acetate 
during incubation. The data presented are after a 3 hour 
incubation, but comparable results were obtained after up 
to 9 hours incubation. 
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Figure 1.3. Rate of diffusion of CO. from reaction vessel 
into Ba (OH)2 traps 
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Table 1.1. Effectiveness of 1 M phosphate buffer (pH 5.8) containing 
1 mM NaNg and 5 tnM NaF in selectively liberating CO2 while 
concomitantly inhibiting generation of CO2 from other 
substrates^ 
Radioactive spike added Radioactivity recovered in Ba(0H)2 trap 
to biological fluid suspended above biological fluid 
Substrate Radioactivity^ Blood^ Rumen fluid^ 
(dpm) 
D-glucose 11968 + 11 98 ± 19 cpm 70 + 4 cpm 
Na Acetate 27803 ± 311 82 ± 3 cpm 70 + 4 cpm 
NaHCOg 7864 ± 154 7830 ± 727 dpm 7695 + 489 dpm 
^dpm data corrected for background; cpm data not corrected for 
background of 90 ± 11 cpm. 
^Four observations. 
Experiment 3 
A standard curve was drawn by regressing ymol carbon 
dioxide (x) against yEg acid (y) used to titrate residual 
Ba(0H)2 (Fig. 1.4). This regression had an 
R-sguare of 0.9992, a slope of -2.010, and a y-intercept of 
296.2. The intercept value corresponds to a mean of 295.7 
for triplicate values of reaction vessels containing no 
added NaCO^. The slope of -2 agrees with the theoretical 
consumption of two equivalents of hydroxide ion per mol of 
carbon dioxide trapped. 
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Figure 1 . 4 .  standard curve for carbon dioxide assay. 
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The results of linear calibration to determine resolu­
tion of the assay are presented in Fig. 1.5. The 95% con­
fidence limits on a predicted x-value (ymol COg) from a 
given y-value (viEq acid) range from 5.6 to 6.6 ymol of 
carbon dioxide over the domain of the standard curve. 
Experiment 4 
No measurable carbon dioxide escaped trapping by the 
first trapping vessel. The first expired carbon dioxide 
trapping vessel in sequentially connected series required 
120 ± 2.40 yEq acid. Titration blanks of 1 ml samples of 
the BatOHjg solution used in trapping required 296 ± 2.83 
yEq acid, whereas the second vessel of the series required 
295 ± 2.42 yEq acid. 
The figures translate into 87.9 ymol of carbon dioxide 
being trapped from a 0.409% aliquot of expired air from a 
215 kg steer over a 30 minute period. The aliquoting gas 
meter was set to take a 0.6% aliquot. The 0.409% aliquot 
size was determined from the total gas flow through the 
aliquoting meter and a second gas meter measuring effluent 
from the trapping vessels after correcting for the gas 
volume of the trapped carbon dioxide. The deviation of the 
actual aliquot from the setting on the aliquoting meter is 
due to resistance to gas flow caused by the trapping 
apparatus. Although, this resistance is insignificant with 
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regard to animal expiration, it does cause aliquot size to 
be different than the meter setting. Therefore, it is 
necessary to measure aliquot size using two gas meters 
previously calibrated against one another if total expired 
carbon dioxide is to be measured. 
Experiment 5 
The cumulative recovery in the ethanolamine trap of 
regenerated carbon dioxide is shown in Fig. 1.6. The 
transfer rate of carbon dioxide from the trapping vessel to 
the ethanolamine trap is described by the equation: 
\ " agcl - e"°'°g46t) 
where t = time in minutes after addition of acid to regen­
erate carbon dioxide from carbonate; = cumulative amount 
of carbon dioxide transferred to the ethanolamine trap from 
t = 0 to t = t; and = amount of carbonate in the expired 
carbon dioxide trapping vessel at t = 0. 
The efficiency of the ethanolamine traps is demon­
strated in Table 1.2. The carryover of carbon dioxide into 
the second ethanolamine trap in series was only 0.89 ± 0.63% 
of the amount trapped in the first trap. The loss of 
carbonate in the 1 ml titration aliquot removed from the 
expired carbon dioxide trapping vessel is shown also in 
Table 1.2. The loss was 0.037 ± 0.072% of the amount of 
carbon dioxide trapped in the first ethanolamine trap. 
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Table 1.2. Efficiency of ethanolamine in retrapping regenerated CO2 
from expired CO2 traps and effectiveness of in 
precipitating determined during an in vivo isotopic 
tracer experiment 
Time* Trap 1 Trap 2 
Titration 
aliquot Trap 2/Trap 1 
Titration 
aliquot/ 
Trap 1 
(min) (dpm) (dpm) (dpm) 
0- 9 37814 254 12 .0067 .0003 
9- 19 84874 423 26 .0050 .0003 
19- 29 16542 74 0 .0045 .0000 
29- 39 62765 539 6 .0086 .0001 
39- 49 65435 349 76 .0053 .0012 
49- 59 66343 1363 68 .0205 .0010 
59- 69 58671 283 10 .0048 .0002 
69- 79 51636 1178 3 .0228 .0001 
79- 89 42681 380 2 .0089 .0001 
89- 99 36060 490 3 .0136 .0001 
99-109 36885 488 - 1 .0132 .0000 
109-119 29939 166 3 .0055 .0001 
134-149 30555 138 - 2 .0045 -.0001 
149-164 26230 5 2 .0002 .0001 
164-179 18627 38 2 .0020 .0001 
179-194 19820 112 2 .0057 .0001 
194-209 14818 249 3 .0168 .0002 
209-224 13245 69 40 .0052 .0030 
224-239 11660 173 1 .0148 .0001 
^Time interval of expired CO2 collection relative to time a dose 
of NaH^^COg was injected into the rumen of a steer. 
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The losses are negligible. In the cases of carbonate loss 
in the titration aliquot, it is indistinguishable from zero. 
In no case did the cpm exceed twice background, whereas 
total dpm in the system ranged from approximately 12000 to 
85000 dpm. 
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GENERAL DISCUSSION 
We have demonstrated the reliability of our method by 
the selective liberation of carbon dioxide and the absence 
of metabolic generation of carbon dioxide and by defining 
the resolution of the assay. The method is simple and 
rapid, thus amenable to metabolic studies requiring other 
simultaneous laboratory activities. The expired carbon 
dioxide method requires more manipulation but readily fits 
into a "mass production" scheme. We have processed in 
excess of 100 samples of rumen fluid, blood, and expired air 
combined, in addition to the activities associated with an 
8-hour in vivo isotopic tracer study in one day's time for 
two people. 
112 
REFERENCES 
Anderson, R. E., and F. Snyder. 1969. Quantitative collec­
tion of CO2 in the presence of labelled short-chain 
acids. Anal. Biochem. 27:311-314. 
Fox, B. W. 1976. Techniques of sample preparation of liquid 
scintillation counting. Page 276 T. S. Work and 
E. Work, eds. Laboratory techniques in biochemistry and 
molecular biology. Volume 5, part I. American Elsevier 
Publishing Co., Inc., New York, NY. 
Hinks, N. T., S. C. Mills, and B. P. Setchell. 1966. A 
simple method for the determination of the specific 
activity of carbon dioxide in blood. Anal. Biochem. 
17:551-553. 
Rose, J. G. 1976. The determination of total blood CO2 and 
its specific radioactivity in 0.2 ml blood samples. 
Anal. Biochem. 76:358-360. 
Snedecor, G. W., and W. G. Cochran. 1967. Statistical 
methods. 6th ed. The Iowa State University Press, Ames, 
lA. 
113 
SECTION II: RECYCLING OF CARBON IN RUMINANT GLUCONEOGENESIS 
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ABSTRACT 
Various components of recycling of glucose carbon were 
measured in three Holstein steers weighing from 200 to 276 
kg and fed 385 g of a 70:30 roughage ; concentrate diet 
every two hours. Total recycling of glucose carbon ranged 
from 50 to 64 mmol carbon min . Recycling via carbon 
dioxide, measured directly, was 0.4 mmol carbon min"^ and 
was 1 mmol carbon min ^ via pyruvate-lactate, measured by 
combination of [6-^H]- and [U-^^C]-glucose tracers. Total 
chemical recycling, assessed by combination of 2-deoxy-
glucose and lU-^^C]-glucose, was 17 to 22 mmol carbon min"^ 
and physical recycling was 40 to 47 mmol carbon min ^. 
Components of chemical recycling other than carbon dioxide 
and lactate and components of physical recycling could not 
be defined. Limited data from steers on other dietary 
regimes are presented. 
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introduction 
After an intravenous single-injection of isotopically 
labeled glucose, plasma glucose specific radioactivity does 
not decrease in a mono-exponential manner (Young et al., 
1974). Therefore, glucose must be leaving plasma and sub­
sequently returning after some time delay. The delay may 
be caused by cellular metabolism of glucose to compounds 
that are released by the cells and then reincorporated into 
plasma glucose by gluconeogenesis; or the delay may be due 
to slow equilibration of tracer glucose into anatomically 
separated pools of glucose. 
A detailed review of metabolism of tritium labeled 
glucoses and of 2-deoxy-glucose has been presented in the 
literature review of this dissertation. Essentially all 
3 tritium is lost from 16- HJ-glucose during metabolism of 
pyruvate to phosphoenolpyruvate in rats (Dunn et al., 1967). 
Metabolism beyond pyruvate, therefore, is included in glu­
cose irreversible loss and excluded from glucose recycling 
when I6-^Hj-glucose is used as the tracer. Irreversible 
loss measured with -glucose does not include recy­
cling via pyruvate-lactate. Thus, the difference in glucose 
irreversible loss measured with I6-^H]-glucose and lU-^^CJ-
glucose is an estimate of pyruvate-lactate recycling CKatz 
et al., 1974a, 1974b). 
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The glucose analog, 2-deoxy-glucose, mimics glucose 
metabolism up to glucose 6-phosphate (Brown, 1962; Webb, 
1966; and Renner et al., 1972) but is not metabolized 
further. However, 2-deoxy-glucose is excreted in the urine 
at about 0.04% min ^ (Landau et al., 1958). Expressing 
both 2-deoxy-glucose and glucose tracer data as percent of 
administered dose, then subtraction of urinary loss of 
2-deoxy-glucose from irreversible loss of 2-deoxy-glucose 
should equal tissue uptake of glucose. Then subtraction of 
irreversible loss of [U-^^C]-glucose from 2-deoxy-glucose 
irreversible loss corrected for urinary loss should equal 
total chemical recycling of glucose. Total recycling of 
-glucose (White et al., 1969) minus total chemical 
recycling determined by difference between 2-deoxy-glucose 
and -glucose irreversible losses should equal 
physical recycling. 
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MATERIALS AND METHODS 
Recycling of Glucose Carbon via Carbon Dioxide 
A 200 kg Holstein steer fitted with a rumen cannula 
(Hecker, 1969; Jarrett, 1948) was fed according to regime A 
listed in Table 2.1. Blood samples were taken from an 
indwelling aorta catheter established by the procedure of 
Olsen et al. (1967). A dose of 263.31 yCi [U-^'^C]-glucose 
was administered intravenously over a 20-second interval. 
Serial blood samples were taken at timed intervals over the 
subsequent four-hour period (see Appendix, Tables 2.5a and 
2.5b) and specific radioactivity of plasma glucose (Mills et 
al., 1980) and blood carbon dioxide (Section I of this dis­
sertation) were determined. 
Table 2.1. Summary of feeding regimes 
Feeding Regime 
Ingredient A B C D 
(grams every 2 hr) 
Chopped alfalfa hay 262 64 292 
Dehydrated alfalfa 
pellets (17% C.P.) 100 
Protein supplement 
(Felco dairy 50) 51 80 
Cracked corn 113 206 233 
Steamed, flaked corn 320 
nahgpo^ 6 
Trace mineral salt 
(Morton) 4 
TOTAL 385 321 500 525 
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Similarly, plasma glucose and blood carbon dioxide 
specific radioactivities were determined following an intra­
venous dose of 489.28 yCi NaH^^CO^ given on a separate occa­
sion. The data were fitted to first-order multi-exponential 
curves (Barr et al., 1979) and areas under the curves were 
calculated. Recycling of glucose carbon through the blood 
carbon dioxide pool was calculated from the calculated 
areas as shown in Table 2.2 (Mann and Gurpide, 1966; and 
Depocas and DeFreitas, 1970). 
Recycling of Glucose Carbon via Pyruvate-Lactate 
Two pairs of Holstein steers were used. Pair A weighed 
276 and 258 kg and was fed according to regime A (Table 2.1). 
Pair B weighed 301 and 320 kg and was fed according to 
regime B (Table 2.1) . All steers had indwelling bilateral 
external jugular vein catheters and pair A had rumen 
cannulae (Hecker, 1969; Jarrett, 1948). Isotope was admin­
istered as single injections through the left catheter and 
blood samples were withdrawn from the right catheter. 
Blood sampling times relative to dose administration are 
presented in the Appendix (Tables 2.6a through 2.30). 
Steers of pair A were given simultaneous doses of 
[6-^H]- and [U-^^C]-glucose. Blood and plasma glucose 
specific radioactivities were determined (Mills et al., 
1980). Hematocrits were measured to allow calculation of 
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red blood cell (RBC) glucose specific radioactivity. Steers 
3 
of pair B were dosed on separate occasions with [2- H]-, 
[5-^H]-, [6-^H]-, and [U-^'^C]-glucose. Blood glucose 
specific radioactivities were determined (Schmidt et al., 
1975). 
Data were fitted to three-component, first-order expo­
nential curves (Barr et al., 1979). Glucose irreversible 
losses were calculated from areas under the fitted curves. 
Recycling via pyruvate-lactate was estimated as the dif-
3 ference in glucose irreversible loss measured with 16- H]-
and [U-^^C]-glucose (Katz et al., 1974a). Difference 
between irreversible losses calculated after [5-^H]- and 
3 [6- H]-glucose injections estimates glycerol recycling plus 
one-third of the hepatic HMP recycling (Longenecker and 
Williams, 1980a, 1980b). 
Differentiation of Physical and Chemical Recycling 
Four Holstein steers with bilateral indwelling external 
jugular vein catheters were used. The left catheter was 
used for isotope administration and the right catheter for 
blood sampling. Two of the steers, weighing 258 and 276 kg 
were fed according to regime A (Table 2.1); one 292 kg steer 
was fed according to regime C; and one 439 kg steer was fed 
according to regime D. Steers of regime A were given 
simultaneous doses of -glucose and Il-^HJ-d-deoxy-
glucose. Steers of regime C and D were dosed on separate 
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occasions with [6- H]-glucose and [1- H]-2-deoxy-glucose. 
Blood sampling relative to times after dose administration 
are given in the Appendix (Tables 2.31 through 2.39). 
Experiments were replicated three- and two-times for glucose 
and 2-deoxy-glucose, respectively, for the steer of regime 
D. One experiment with each tracer was conducted for each 
of the other steers. 
Blood glucose specific radioactivities were determined 
by the method of Mills et al. (1980) for steers of regime A 
and by the method of Schmidt et al. (1975) for steers of 
regimes C and D. Radioactivity of 2-deoxy-glucose was 
expressed as dpm per ml of blood. Data were fitted to 
three-component, first-order exponential curves (Barr et al., 
1979) . Irreversible loss and glucose total recycling were 
calculated using formulas of White et al. (1969). Urinary 
loss of 2-deoxy-glucose was assumed to be 0.04% min ^ 
(Landau et al., 1950). Tissue uptake of glucose was calcu­
lated by subtracting estimated urinary loss of 2-deoxy-
glucose from 2-deoxy-glucose irreversible loss. Chemical 
recycling was calculated by subtracting glucose irreversible 
loss from tissue uptake of glucose. Physical recycling was 
calculated by subtracting chemical recycling from total 
recycling. 
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RESULTS AND DISCUSSION 
Recycling of Glucose Carbon via Carbon Dioxide 
The plasma glucose to blood carbon dioxide interrela­
tionship portion of glucose metabolism is represented in 
Fig. 2.1. The interrelationship is shown as a direct 
interconversion from one metabolite pool to another for 
simplicity of illustration, realizing other intermediate 
pools are present. Direct interconversion, however, is not 
a constraint imposed by the system of equations used in 
solving this portion of the model of glucose metabolism. 
The essential calculations are shown in Table 2.2. Plasma 
glucose and blood carbon dioxide production rates were 11.5 
and 79.7 mmol carbon min , respectively. Total glucose 
production (11.5 mmol carbon min minus glucose production 
from precursors other than blood carbon dioxide (8.8 mmol 
carbon min equals the amount of blood carbon dioxide 
derived from precursors other than glucose that is converted 
to glucose (2.7 mmol carbon min ^). Total flux of carbon 
from blood carbon dioxide to plasma glucose (3.0 mmol 
carbon min minus the amount of blood carbon dioxide 
derived from precursors other than glucose that is converted 
to glucose equals the amount of carbon that is recycled 
from glucose to blood carbon dioxide and back to plasma 
glucose (0.4 mmol carbon min ). Total recycling of glucose 
carbon, estimated from the formula of White et al. (1969), 
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BLOOD CO 
PLASMA 
GLUCOSE 
RQ2 — 2.3 RO2 78.1 
Figure 2.1. Model of carbon exchange between plasma glucose 
and blood carbon dioxide by direct and indirect 
paths. Units are mmol carbon min"^ 
Table 2.2. Calculation of values for Figure 2.1 and recycling of carbon from plasma glucose to blood 
carbon dioxide and back to plasma glucose 
14 a 
a = dose of [U- C]-glucose injected intravenously = 100 
3 = dose of NaH^^CO^ injected intravenously = 100^ 
A = area under the plasma glucose specific radioactivity curve after a injection = 8.687^ 
B = area under the blood carbon dioxide specific radioactivity curve after a injection = 1.009^ 
C = area under the plasma glucose specific radioactivity curve after g injection = 0.321^ 
D = area under the blood carbon dioxide specific radioactivity curve after g injection = 1.255^ 
H = (D X A) - (B X C) = 10.578® 
GP(Total glucose production) = a/A = 11.511^ 
CP(Total blood carbon dioxide production) = g/D = 79.681^ 
= a(D - C)/H = 8.829^ 
Rgg = 6(A - B)/H = 71.637^ 
Rg^ = (S X B)/H = 9.538^ 
Rj^2 = (ct X C)/H = 3.035^ 
RQ^ = I(a X D) - (g X B)]/H = 2.326^ 
Rq2 = [(B X A) - (a X C)]/[(D x A) - (B x C)] = 78.140^ 
GC(amount of blood carbon dioxide not derived from glucose that is converted to plasma glucose) = 
GP - R^q = 2.682^ 
CR[amount of carbon recycled from plasma glucose to blood carbon dioxide and back to plasma glucose 
(carbon dioxide recycling)] = R^^ - GC = 0.353^ 
^Data were calculated as dpm per mmol carbon expressed as percentage of the dose, thus doses are 
represented as 100% and area units are min x mmol carbon"^ x 100%. 
b -1 
mmol carbon min 
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was 50 iranol carbon min ^. Thus, glucose carbon recycling via 
blood carbon dioxide is a very minor component of total 
recycling. 
Recycling of Glucose Carbon via Pyruvate-Lactate 
Results of experiments to determine glucose carbon 
recycling via pyruvate-lactate for dietary regimes A and B 
are presented in Tables 2.3a and 2.3b, respectively. The 
overall mean for recycling through pyruvate-lactate was 
0.95 ± 15 mmol carbon min ^ for regime A and 2.39 ± 0.35 
mmol carbon min ^ for regime B. Although differences in 
pyruvate-lactate recycling were not statistically significant 
(P < 0.07), the over two-fold difference observed was unex­
pected. Dietary regimes A and B are isoenergetic (Herbein 
et al., 1978). Also, the small differences in body size 
should not be an influence on glucose irreversible loss 
(Moss, 1980). The conclusions of Herbein et al. (1978) and 
of Moss (1980) are strengthened by the good agreement of 
values of 11.05 ± 0.35 and 11.25 ± 0.95 mmol carbon min ^ 
for glucose irreversible loss measured with [U-^^C]-glucose 
for regimes A and B, respectively. 
Although total metabolizable energy of the dietary 
regimes was equivalent, the physical composition of the 
diets was greatly different. Thus, the profile of metabo­
lites absorbed from the gut are likely to be different. 
Previous studies with dietary regimes A and B have shown 
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Table 2.3a. Amount of glucose carbon recycling from 
pyruvate-lactate for steers on dietary regime A 
Glucose 
irreversible loss 
Glucose tracer 
1 . g Recycling via 
Animal Expt. [U- C] [6- H] lactate-pyruvate 
(mmol carbon rain 
181 A 9.6 10.7 1.1 
B 11.6 12.5 0.9 
C 11.0 11.4 0.4 
Average 10.7 ±0.6 11.5 ±0.5 0.8+0.21 
8046 F 9.3 10.4 1.1 
G 11.6 12.6 1.0 
H 13.3 14.5 1.2 
Average 11.4 ± 1.2 12.5 ± 1.2 1.1 ± 0.06 
Table 2.3b. Amount of glucose carbon recycling from pyruvate-lactate for steers on dietary regime 
Tracer used to measure glucose irreversible loss 
3^4 3 3 3 Recycling via 
Animal [U- Cj-glucose [6- Hj-glucose [5- H]-glucose [2- H]-glucose pyruvate-lactate 
— 
(mmol carbon min ) 
114 12.20 ± 0.13 (2) 14.24 + 0.02 (2) 13.29 (1) 15.35 (1) 2.04 
7424 10.30 ±0.19 (2) 13.04 ± 0.93 (2) 12.10 (1) 12.83 (1) 2.74 
X 2.39 ±0.35 
lumbers in parentheses are number of observations. 
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that rumen propionate production averaged 12.4 ± 0.68 and 
14.4 ± 0.53 mmol carbon min respectively (Van Maanen et 
al., 1978). The difference they reported in rumen propionate 
production was not statistically significant but addition of 
monensin to their diets significantly increased propionate 
production up to two-fold with little impact on glucose 
irreversible loss. Thus, glucose irreversible loss can be 
maintained relatively constant in spite of varying substrate 
(i.e., propionate) availability for gluconeogenesis. The 
manner in which glucose is metabolized may vary under condi­
tions of constant net glucose utilization. The present 250% 
difference in recycling through pyruvate-lactate is evidence 
of such variation. 
In mature sheep fed a maintenance ration, glucose 
carbon recycling via lactate expressed as precent of glucose 
irreversible loss was 7% (Reilly and Chandrasena, 1978) or 
8% (Annison et al., 1963, calculated from data presented; 
a different value is given in the text). The lactate 
recycling values for these sheep were obtained by direct 
measurement; i.e., specific radioactivities of plasma 
glucose and lactate were determined after intravenous infu­
sions on separate occasions of lU-^^C]-glucose and lU-^^C]-
L-lactate. Lactate recycling values reported herein for 
cattle were 9 and 21% of glucose irreversible loss measured 
with [U-^^C]-glucose for regimes A and B, respectively. 
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The larger values for lactate recycling measured in cattle 
by the indirect method of the present research supports, but 
is not proof, that the 3-position of pyruvate is completely 
detritiated in conversion to phosphoenolpyruvate. If 
detritiation were incomplete, lactate recycling measured by 
3 difference between glucose irreversible loss using [6- H]-
and -glucose tracers would yield falsely low values. 
Calculation of lactate recycling from sheep data by the 
indirect method we used for cattle gives 4% (Brockman et al., 
1975) to 5% (Judson and Leng, 1972) of lU-^^C]-glucose 
irreversible loss. 
Verification of pyruvate-lactate recycling measured by 
3 difference in glucose irreversible losses using [6- H]- and 
[U-^^C]-glucose was attempted by modeling plasma glucose-
RBC glucose interchange. The major product of glucose 
metabolism in RBC is lactate with a small amount of carbon 
dioxide production (Katz, 1961). Thus, recycling of glucose 
from RBC to plasma glucose should not exist for [6-^H]-
glucose tracer data but should approximate RBC lactate 
production times the fraction of plasma lactate entering 
gluconeogenesis for the model using lU-^^C]-glucose as 
tracer. Present attempts to model the glucose interchange 
between plasma and RBC were unsuccessful. RBC glucose 
specific radioactivity had reached a maximum prior to the 
first sampling (two minutes), preventing a reliable estimate 
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of the rate of ascending RBC glucose specific radioactivity. 
Data are presented in the Appendix (Tables 2.6a through 2.16). 
The greater detritiation of the 6-position than of the 
5-position of glucose is unexplainable (Table 2.3b). Thus, 
no estimation of glycerol recycling is possible. The only 
published data found where glucose-glycerol recycling could 
be calcualted were obtained from rats (DeFreitas and 
Depocas, 1970). Glycerol recycling was 11 and 4% of the 
glucose irreversible loss for fed and fasted rats, 
respectively. Bergman et al. (1968) measured the glycerol 
contribution to glucose production to be 5, 23, and 28% for 
fed, fasted, and hypoglycemic sheep, respectively. However, 
the data and model used by Bergman et al. do not allow 
calculation of recycling via glycerol. 
Irreversible loss of glucose measured with [2-^H]-
glucose in vivo is difficult to interpret (Table 2.3b). The 
lack of large differences in glucose irreversible loss 
3 
measured with [2- H]-glucose versus other isotopic glucoses 
indicate that phosphoglucoisomerase activity is not in 
great excess of overall glucose metabolism and that a large 
portion of glucose metabolism may proceed by the HMP 
pathway. 
Differentiation of Physical and Chemical Recycling 
Results of these experiments are presented in Table 
2.4 . Irreversible loss measured with 2-deoxy-glucose is 
Table 2.4. Measurement of tissue uptake, chemical recycling, total recycling, and physical recycling 
of glucose by combined use of isotopic glucose and 2-deoxy-glucose tracers^ 
Irreversible loss 
Estimated 
urinary loss Tissue 
Dietary of 2-deoxy- uptake of Chemical Total Physical 
regime Animal Glucose 2-deoxy-glucose glucose glucose recycling^ recycling recycling 
(mmol glucose carbon (or its measured equivalent) min 
A 181 10.29 28.15 0.50 27.65 17.36 64.14 46.78 
8046 9.43 31.61 0.50 31.11 21.68 61.70 40.02 
C M 24.74 48.53 0.43 48.10 23.36 121.66 98.30 
D 7272 27.80+0.95 (3) 86.03±3.49 (2) 0.69 85.34 58.26 99.62+7.76 (3) 41.36 
lumbers in parentheses are number of observations. 
^Minus pyruvate-lactate and carbon dioxide recycling for dietary regimes C and D. 
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two- to three-fold greater than irreversible loss measured 
with isotopic glucose. The assumed urinary loss of 2-deoxy-
glucose is small relative to total irreversible loss of 
2-deoxy-glucose and suggests that most loss of 2-deoxy-
glucose was by intracellular trapping of 2-deoxy-glucose 
6-phosphate. Thus, chemical recycling was one- to two-fold 
greater than glucose irreversible loss. Carbon dioxide and, 
presumably pyruvate-lactate, recycling have been excluded 
from steers on regime C and D. For regime A, carbon 
dioxide and pyruvate-lactate recycling have been shown to 
be small. 
At present, what comprises the apparent large chemical 
recycling is unknown. Contributions of carbon dioxide, 
pyruvate-lactate, and glycerol to recycling have already 
been discussed. Total amino acid conversion to glucose is 
10 to 35% of glucose production in fed nonpregnant sheep 
(Wolff and Bergman, 1972; and Bergman and Heitmann, 1978). 
Glucose contributions to total amino acid carbon are less 
than 5% (Kleiber et al., 1955). Thus, recycling of carbon 
from glucose to amino acids and back to glucose also is 
small. It is possible that urinary excretion of 2-deoxy-
glucose from cattle is much greater than what was observed 
in human cancer patients given pharmacological doses of 
2-deoxy-glucose. Although less likely, it is possible that 
2-deoxy-glucose is sequestered in a manner unlike glucose. 
132 
Further experiments wherein urinary excretion of 2-deoxy-
glucose is measured directly are needed. 
Using what appears to be overestimates of chemical 
recycling to calculate physical recycling, physical recycling 
comprises a large portion of the total kinetics of glucose 
metabolism. Reasons for existence of a large physical 
recycling component in glucose metabolism, are at best, 
speculative. The interstitial matrix has been shown to 
possess properties similar to a gel filtration column 
(Watson et al., 1980; Bell et al., 1980; and Watson and 
Grodius, 1978), i.e., small molecules, such as glucose, 
entering the interstitium are retained longer and equilibrate 
in a larger volume than do larger molecules. Therefore, I 
have calculated the amount of interstitial glucose that 
might be returning to plasma via lymph. Assuming a lymph 
flow of 4 ml kg ^ hr ^ (Hartman and Lascelles, 1966) and 
equal plasma and lymph glucose concentrations (Guyton, 
1971), recycling of glucose carbon via lymph would account 
for 0,6 mmol carbon min ^ of the physical recycling of 
44.4 mmol carbon min ^ for steers of regime A. 
Direct exchange through capillary pores is more likely 
than recycling via lymph. A volume of water approximately 
equivalent to that of plasma volume exchanges across the 
capillary endothelium each minute (Ganong, 1975). Glucose 
permeability through capillary pores is 60% that of water 
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(Pappenheimer, 1953). These permeability rates are consis­
tent with the observations of Heath et al. (1980), wherein 
3 
the distribution space of [6- H]-glucose injected intra­
venously approximated the expected extracellular space. 
Thus, the diffusion of freely exchangeable glucose between 
plasma and interstitial fluid is too rapid to be resolved 
by in vivo isotope-dilution techniques. 
The possibility of glucose binding to plasma membranes 
as a contributing factor to physical recycling has been 
discussed in the literature review of this dissertation. 
Glucose binding to or incorporation into and turnover of 
the mucopolysaccharide interstitial matrix is a speculative 
possibility for what seems to be physical recycling of 
glucose. The origin and fate of the interstitial matrix is 
unknown to me. 
Hepatic glycogen is a chemical component that may be 
included in estimation of physical recycling calculated by 
difference in irreversible loss of 2-deoxy-glucose corrected 
for urinary loss and irreversible loss of lU-^^C]-glucose. 
No literature was found concerning incorporation of 2-deoxy-
glucose into glycogen. If the hydroxyl group of the 
2-position of glucose is not essential for substrate binding, 
2-deoxy-glucose should be a substrate for phosphoglucomutase 
and glycogen synthetase. However, gluconeogenic precursors 
rather than plasma glucose are the major contributors to 
hepatic glycogen (Radziuk, 1979; and Baker, 1977). 
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Although the data reported herein are inadequate to 
define the mechanism of physical recycling, they indicate 
that physical recycling is the major portion of recycling of 
glucose carbon. Recycling via carbon dioxide and pyruvate-
lactate is small. 
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PROGRESS AND PROSPECTUS 
A dissertation often is a complete record of a stu­
dent's research activities. Such a record, in the present 
case, would result in a dissertation that would be large 
and difficult to organize. This portion of the disserta­
tion, therefore, will be a summary of various aspects of 
gluconeogenesis research with which I have been involved. 
The approach will be to present the status of knowledge 
when I became involved in the gluconeogenesis research at 
Iowa State University, my involvements in contributing to 
this base of knowledge, and a prospectus for future 
research. 
When I arrived at Iowa State, research just completed 
had verified that glucose irreversible loss measured with 
either single-injections or primed continuous-infusions of 
tracer [U-^^CJ glucose was the same. Although the same 
conclusion had been reached mathematically, controversy had 
existed that in application, the two methods of isotope 
administration yielded different answers. The Iowa State 
result was an important milestone in research on kinetics 
of glucose metabolism because it validated the use of iso­
tope dilution techniques. Had a significant difference in 
glucose irreversible loss actually existed between the two 
isotope administration procedures, the applicability of 
isotope dilution methods to measure glucose kinetics would 
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have been questionable. The controversy existed, as was 
pointed out (Young et al., 1974), because other workers 
failed to make sufficient observations, particularly soon 
after isotope administration, to adequately define the 
plasma glucose specific radioactivity disappearance curve 
following a single-injection of tracer. 
The results from comparing methods of isotope adminis­
tration have been emphasized not only because they validate 
the use of isotope dilution techniques, but because they 
also point out the importance of knowledge of glucose 
recycling in understanding glucose kinetics. Ignoring the 
early portion of the plasma glucose specific radioactivity 
curve following a single injection of labeled glucose, or 
essentially ignoring recycling, overestimates "true" glu­
cose irreversible loss that is correctly measured by con­
tinuous infusion of tracer. 
The data from comparing methods of isotope adminis­
tration also have had a subtle but profound influence on 
experimental approaches taken by our reserach group and on 
development of my understanding of kinetic analyses. This 
influence is evidenced by the preference of our group to 
measure glucose kinetics by single injections of isotopic 
tracer. Use of single injections of tracer allows calcula­
tion of glucose pool size and recycling in addition to 
glucose irreversible loss. However, I have become 
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skeptical of the reliability of the additional kinetic 
parameters that can be obtained from single-injection 
experiments. In my experience, the nonlinear least-squares 
fit of a glucose specific radioactivity curve is dependent 
on the initial estimate of the curve parameters used in 
starting the iterations. Calculation of recycling from the 
curve parameters is very sensitive to changes in the 
parameters, whereas irreversible loss, which is calculated 
from the area under the curve, is not influenced signifi­
cantly by small changes in curve parameters. 
I have been gently leading into a discussion of con­
troversy between stochastic, or probabilistic, versus com­
partmental, or deterministic, approaches to kinetic 
analyses. Calculation of irreversible loss from area 
under the specific radioactivity disappearance curve is a 
stochastic calculation that we have found to be robust, 
i.e., does not require precise mathematics for a valid 
answer. Calculation of recycling by isotopic labeling of 
only one pool is a compartmental calculation that we have 
found to be not robust. 
At the outset it may seem that I strongly favor a 
stochastic approach. Such is not the case. Both types of 
approach are necessary. Initially, I was oriented toward 
compartmental analysis. Eventually I realized the diffi­
culties in solving complex metabolic models by compartmental 
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analysis. There are many combinations of equations that 
will fit a given set of data equally well, and a powerful 
computer program exists that will find such equations 
(Herman and Weiss, 1978). The combination of equations 
that meet the convergence criteria of the program, however, 
depend on the initial estimates of the model supplied sub­
jectively by the experimenter. 
On the other hand, a unique set of equations can be 
written for stochastic analysis. The problem with stochas­
tic analyses is that it is sometimes difficult to obtain 
the data necessary to solve the equations and it almost 
always requires a large amount of data to solve the set of 
equations. 
Thus, based upon my current understanding of kinetic 
analyses, I suggest that we proceed in research by first 
defining parameters of a metabolic system by stochastic 
analysis with extensive data obtained from a few animals. 
Subsequently, the stochastically defined parameters will be 
used as initial values in compartmental analysis of less 
extensive data obtained from each of many animals. Mathe­
matical theory exists for direct combination of stochastic 
and compartmental analysis. The theory for such combination 
is beyond my present understanding, but I recognize its 
importance as a link to understanding control theory, which 
I also have not mastered. Although my ability to interpret 
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kinetic data has increased, there is still much I do not 
know. As in problem solving of any kind, being able to 
define the problem is a major step toward the solution. 
Likewise, my understanding of kinetic analyses has developed 
to the point that I can recognize important gaps in my 
knowledge, that can be filled in time. 
Describing how my understanding of a mathematical con­
cept developed is difficult. However, I spent considerable 
time gaining competence in this area and, therefore, some 
attempt at describing this development seems appropriate. 
Upon coming to Iowa State, I became involved in two 
ongoing areas of the gluconeogenesis project. One area was 
the effects of body size on glucose kinetics, and the other 
was the conversion of propionate to glucose. 
The effects of body size on glucose kinetics have 
practical implications toward gluconeogenesis research, 
i.e.,,is it essential to strictly control body size of 
animals on kinetic experiments. It was known that the 
amount of feed intake was closely correlated with parameters 
of glucose kinetics. During experiments on the first set 
of steers, some technical difficulties were encountered 
because of some minor flaws in experimental design. The 
design problems were corrected and the experiments repeated 
with another set of steers. Data from these two sets of 
steers are being organized for journal publication. The 
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results indicate that in steers with identical feed intakes 
body size does not have significant influence on glucose 
irreversible loss. A preliminary report has been presented 
(Moss et al., 1980). 
The conversion of propionate to glucose, was a major 
area where I became involved. The experimental approach 
was altered from continuous infusions of isotopic propionate 
into the mesenteric arterial system to single injections 
into the rumen. The change was made to circumvent the 
problem of failure of portal propionate specific radio­
activity to reach a stable plateau and the problem of 
unrepeatable and, at times, unrealistic blood flow 
measurements. 
Although some problems were circumvented, others were 
exposed by the change in method of administering labeled 
propionate. The usual technique being used for mixing 
isotopic propionate in the rumen was to thoroughly stir the 
entire rumen contents in situ by hand. I have reservations 
as to whether metabolic steady state is maintained after 
such disturbance within the rumen. Therefore, I chose to 
administer labeled propionate by spraying it into the 
liquid layer of the rumen contents. To test the efficacy 
of spraying for mixing the dose with total rumen water, I 
compared dilution of polyethylene glycol (PEG) in rumen 
fluid after administration by spraying or by hand-mixing. 
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The use of PEG as a rumen marker caused additional 
problems. First, procedural difficulties were encountered 
in the PEG assay. These difficulties were defined and 
resolved, resulting in a manuscript now drafted for journal 
publication. 
Second, other peculiar properties of PEG were observed. 
After hand-mixing PEG in the rumen, the PEG concentration 
in aspirated rumen fluid was less than expected and remained 
constant over a four-hour period. PEG concentration in 
rumen fluid decreased in a multi-exponential manner when 
PEG was sprayed into the rumen. Calculation of rumen fluid 
turnover from the terminal slope (data after one hour from 
when dose was administered) yielded estimates comparable to 
literature values derived from hand-mixing of PEG in the 
rumen and one-hour sampling intervals. Thus, it was con­
cluded that spraying is an adequate method for mixing water 
soluble materials with rumen fluid in situ. Probably the 
initial slope of the PEG concentration in rumen fluid after 
spray administration is due to PEG associating with partic­
ulate matter in the rumen. Such an association has been 
observed in vitro by others. Also, PEG association with 
particulate matter could explain the low and constant PEG 
concentration in rumen fluid after hand-mixing if my mixing 
technique was more vigorous than that used by others. 
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Third, concentrated solutions of PEG seem to bind 
some propionate such that the binding is not reversed under 
conditions that occur in the rumen. Mixing of a tracer 
dose of isotopic propionate with a 40% PEG solution prior 
to intraruminal administration increases the calculated 
rumen pool size of propionate up to ten-fold as compared 
to the propionate pool size calculated when labeled pro­
pionate is administered without PEG. Propionate turnover 
rates are comparable with and without the presence of PEG. 
These data suggest that a large portion of the labeled 
propionate was bound to PEG before administration and 
remained associated with PEG in the rumen. The apparent 
ability of PEG to bind short-chain acids was not pursued, 
but if very strong, this property of PEG may be useful in 
balancing amino acid composition reaching the abomasum to 
achieve optimum utilization of protein. 
Other technological advancements made to use in 
studying the conversion of propionate to glucose include an 
assay for carbon dioxide specific radioactivity in blood, 
rumen fluid, and expired air; a high-pressure liquid-
chromatographic (HPLC) technique for isolation and quanti­
tation of short-chain organic acids in rumen fluid and 
blood; and improvement of methodology to determine specific 
radioactivity of glucose. The carbon dioxide assay is 
presented in detail in Section I of this dissertation. A 
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preliminary report of the HPLC technique has been published 
(Bush et al., 1979). Further development of the HPLC 
technique will be required for separation of some acids in 
blood before the quantities necessary for economical in vivo 
tracer studies can be separated. The method for determining 
glucose specific radioactivity has been submitted for 
publication and a preliminary report was given (Mills et 
al., 1980). 
The methods developed have been applied in gathering 
data to solve stochastically a model of propionate metab­
olism. Gathering data and solving the model has been a 
slow process. Approximately three months are required to 
gather necessary samples. Then the samples must be analyzed 
and data evaluated for each steer on experiment. Data have 
been obtained from two steers, but evaluation is incomplete. 
A summary of a portion of the data from one steer has been 
presented (Russell and Young, 1980) . 
I also was involved in a project studying the effects 
of zeranol on glucose kinetics (Heath et al., 1980). 
Although the zeranol project results had little impact on 
our understanding of glucose metabolism, other findings 
that branched from the zeranol project show important dif­
ferences between monogastric and ruminant animals in control 
mechanisms of glucose metabolism. Steers fed at two-hour 
intervals have been shown to have a significant diurnal 
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variation in plasma insulin concentration (Herbein et al., 
1978) , whereas glucose production rate does not show a 
diurnal variation (Armentano et al., 1980). This contrasts 
with what has been observed in monogastrics (Gatewood et 
àl., 1970). 
Another of my involvements was in finding a suitable 
marker for measuring portal and hepatic blood flow. One 
important criterion for a marker is that it should be 
measured easily. A method for determining p-aminohippuric 
acid (PAH) has been submitted for publication (Meerdink et 
al., 1981b). A reliable method for measuring blood flow is 
essential for trans-gut, trans-liver, and trans-mammary 
gland studies in combination with isotope dilution tech­
niques to be used in research planned for the future. 
Research on glucose metabolism in ruminants is cur­
rently in the descriptive stage. I am optimistic that with 
the approach we are taking, a realistic description even­
tually can be obtained. After obtaining a description of 
glucose metabolism, control mechanisms can be elucidated 
and evaluated. 
As increasing world population causes increased demand 
for food, feedstuffs available for animal production are 
likely to change. These changes will occur too rapidly for 
current empirical methods of selecting diets for optimum 
animal performance from available resources. I would like 
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to emphasize optimum performance as opposed to maximum 
performance. We must optimize nutrient output from animal 
and plant products when balanced against limited resource 
inputs. The demand for food will eventually become so great 
that any proposed change in technology will need to be 
evaluated universally for its expected impact on total 
resource utilization before the change can be implemented. 
Our current ability to produce food by a sustainable pro­
duction system is much greater than our current food pro­
duction by an unsustainable production system, as detailed 
in the Introduction. 
Although the current situation for food production 
ability looks optimistic, we must not take solace in past 
research performance. A part of agricultural research 
programs, but not completely the duties of the bench 
scientist, is implementation of positive results into 
agricultural production systems. The goal of agricultural 
research is to provide a sustainable food production 
system capable of providing adequate nutrients for the 
world's human population. In spite of technical capabili­
ties being available to achieve this goal, existence for 
millions of people is a day-to-day struggle against starva­
tion. To overcome starvation, agricultural research pro­
grams must be integrated with programs of other disciplines 
in order to provide incentives for adoption of appropriate 
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technology. Little argument is expected from stating that 
elimination of starvation is a worthy goal. The converse 
statement that to eliminate starvation, no one has the 
right to excessive consumption of resources, however, is 
likely to be met with vehement argument. Thus, positive 
direction of human greed is more likely to be successful, 
but paradoxical, in distribution of resources even though 
an evanglistic approach may be superior ideologically. 
In closing, I would like to present a brief, general 
prospectus of what I would like to pursue in developing a 
research program. First, the utility of ruminants results 
from the microbial ecosystem within the rumen. There is a 
paucity of information regarding the diet-microbe-host 
interaction. Because I expect resources available for the 
dietary component of this interaction to be changing nearly 
continuously, we must establish the basic biological prin­
ciples involved in the interaction for optimum utilization 
of ruminants in the food chain. 
Second, as outlined and discussed in the Literature 
Review, I have an interest in the role of lactose synthetase 
in regulation of milk production. Induction of lactose 
synthetase not only would increase milk nutrient output by 
the mammary gland, but would probably show other points in 
mammary gland metabolism that limit nutrient output. 
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Third, ruminant meat production currently is limited 
severely by high animal maintenance costs. However, with 
adaption of knowledge available from cancer research to 
development of technology to culture and harvest aberrant 
muscle cells in vivo, meat production efficiency should 
approach that of lactation efficiency. 
Fourth, involvement in an international agriculture 
development program is desired. At this point, the problems 
seem so overwhelming, I am not certain of the form in which 
I could make the most effective contribution. 
As this portion of the dissertation evolved, I became 
self-conscious of the use of "I". It should be emphasized 
that I have been but one member of a dynamic team of 
researchers. I make no sole claims to any of the progress 
reported and discussed herein. In addition to intellectual 
support. Dr. J. W. Young, leader of the research team, 
provided funds for technical assistance. 
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Table 2.5a. Specific radioactivity of plasma glucose and 
fclood carbon dioxide following an intravenous 
injectioE of [U-i+Cjglucose in experiment 
7984G. 
Timei Plasma glucose Elood carbon dioxide 
min [dpm/(mmol carbon x dose) ] x 100% 
5 0. 120558 0.000512 
10 0.CS2C76 0.000976 
15 G.G80035 0.001319 
20 0.C72263 0.001517 
25 0.065628 0.001752 
30 C.C59495 0.001836 
40 0.051532 0.002193 
50 0.C457C5 0.002044 
60 0.C40281 0.002513 
70 C.C36357 0.002219 
80 0.031674 0.002363 
90 C.028562 0.002811 
100 C.0260C8 0.002725 
110 C.023688 0.002653 
120 C.02C898 0.002838 
135 C.C16339 0.002632 
150 0.016423 
165 0.014411 0.002272 
180 C.012158 0.002147 
195 C.01C992 0.002098 
210 0.0C9971 0.002159 
225 0.0(6834 0.001930 
240 0.CC7762 0.002090 
260 0.CC685O 0.001732 
230 0.0C6170 0.001575 
300 C.CC54C9 0.001404 
320 0.CC4844 O.OC 1297 
340 0.CC4314 0.001260 
360 0.CC37C8 0.001114 
^Relative to time of injection being zero. 
169 
tôL 
in-
cd: 
ux. 
U_ 
++ 
edi 
32.00 
(xlO* 1 
8.00 
TIME (MINUTES) 16.00 0.00 
Figure 2.2. Specific radioactivity of plasma glucose and 
tlcod carbon dioxide following an intravenous 
injection of [U-i*C]glucose ii; experiment 
79840. 
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Figure 2.3. Residuals of curve fitted to plasma glucose 
specific radioactivity in experiment 7984G. 
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Table 2.5t. Specific radioactivity of plasma glucose and 
tlcoô carbon dioxide follcwiag an intravenous 
injection of NaH^^COj in experiment 7984H. 
Time* Plasma glucose Elcod carbon dioxide 
irin [dpm/(mmol carbon x dose)] x 100% 
5 0.000773 0.030969 
15 C.000983 0.017752 
25 C.CC1049 0.011589 
35 0.CC1101 0.C09362 
45 C.CC1015 0.007655 
55 0.0C104 2 0.005820 
65 C.CC1047 0.005379 
75 C.0C0990 0.004613 
85 C.CC0946 0.003728 
95 0.000924 0.003394 
105 C.CCC8S1 0.003149 
115 O.OC0820 0.002218 
130 0.CC0767 0.002063 
145 0.0C0739 0.001666 
160 C.CC0646 0.001547 
175 C.000628 0.001337 
190 0.0C058 5 0.001193 
205 C.000531 0.001042 
220 0.CCC491 0.000797 
235 0.000464 0.000732 
^Relative to time of injection teirg zero. 
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Figure 2.4. Specific radioactivity of plasma glucose and 
blood carbon dioxide following an intravenous 
injection of NaHi^CCj in experiment 7984H. 
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Table 2.5a. Glucose specific radioactivity (i*C) in blood, 
plasma, and red fclood cells following an intra­
venous injection of [U-i+C, 6-3H]glucose in 
experiment IfilA. 
Time 1 Bleed Plasma SBC 
min [ dfm (i*C)/(mg glucose X dose) X 100%]---
2 0. 4427692-02 0. 447492E-02 0.427813E-02 
4 0. 37C3421-C2 0. 38C807E-C2 0.337203E-02 
5 G. 3404295-C2 C. 354073E-02 0.297223E-02 
10 0. 288226Î-C2 0. 3053475-02 0.234009E-02 
15 0. 262662E-C2 0. 265C83E-02 0.254996E-02 
20 0. 245912Î-02 0. 2434505-02 0.2537C8E-02 
25 0. 2185 10E-C2 0. 2217765-C2 0.207334E-02 
30 0. 2049335-C2 0. 2060615-02 0.201361E-02 
HO 0. 187418E-C2 c. 1815225-C2 0.206089E-02 
50 0. 1688845-C2 0. 1616095-C2 0. 191922E-02 
50 0. 1455615-C2 c. 1494055-02 0.133413E-02 
75 0. 1239655-02 0.  1283015-C2 0.110234E-02 
90 0. 1108235-C2 c. 1141755-C2 0.100208E-02 
105 0. 10C02C5-C2 c. 1014575-C2 0.9546S5E-03 
135 0. 6775C8E-C3 c. 7S73016-C3 0.113150E-02 
150 0. 784223E-C3 0. 7187535-C3 C.991544E-03 
180 c. 574193E-C3 c. 58C028E-03 0.555716E-03 
200 0. 507518E-C3 0, 5063205-C3 0.511312E-03 
220 0. 45C349E-03 c. 4584825-03 0.424595E-03 
240 0. 4025015-C3 0. 3975455-03 0.418196E-03 
250 0. 351Û14E-C3 0.  355956E-C3 0.335365E-03 
280 0. 303 1975-C3 0. 3096045-03 0.282908E-03 
300 0. 272ÛS4E-C3 c. 2870005-C3 0.224892E-03 
330 0, 2374335-03 0. 24C5695-03 0.227502E-03 
360 0. 2020135-C3 0. 1963925-C3 0.219813E-03 
390 0. 167411E-C3 0. 1724465-C3 0. 151467E-03 
U 2 0  0. 151776E-C3 c. 145611E-03 0.171299E-03 
450 0. 1324525-03 0. 1,293625- C3 0.142237E-03 
480 0. 1167345-C3 c. 1C64275-03 0. 143039E-03 
iTime after injection of tracer. 
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Figure 2.5. Specific radioactivity (**C) of blood glucose 
following an intravenous injection of [U-i+C, 
6-3H]giucose in experiment 181A. 
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Table 2.6b. Glucose specific cadioactivity (^H) in blood, 
plasma, and red blood cells following ao intra­
venous injection of [U-i+C, 6-3H]glucose in 
experiment 181 A. 
Time i Bleed Plasma BEC 
min [ dpm (3H)/ (mg 1 glucose x dose) X 100%] 
2 0. 4187C5E-02 0.402880E-02 0.468818E-02 
U 0. 350075Î-C2 0.3513482-02 0.346044E-02 
6 0. 30945iE- 0 2 C.312343E-02 0.300297E-02 
10 0. 271523E-C2 0.277569E-02 0.252377E-02 
15 0. 2360C4E-C2 0.24E113E-02 0.207159E-02 
20 0. 223430E-C2 0.222218E-C2 0.227268E-02 
25 0. 204474E- C2 0.2C5763E-02 0.200392E-02 
JO 0. 190725Î-02 0.1911572-C2 0.189357E-02 
40 0. 171581E-C2 C.1657692-02 0.189986E-02 
50 0. 153506E-02 0.1477342-C2 0. 171784E-02 
60 0. 134477E-C2 0.135364E-02 0.131668E-02 
75 0. 112693E-C2 0.1142782-02 0. 107674E-02 
90 0. 1008G2E-C2 C.1024132-02 C.957005E-03 
105 0. 905322E-C3 0.898703E-C3 0.926282E-03 
135 c. 765042E-C3 C.704152E-C3 C.957861E-03 
150 0. 716778E-C3 0.6538972-03 0.915902E-03 
180 0. 501779E-C3 0.514114E-03 0.462718E-03 
200 0. 445792E-C3 0.4511202-C3 0.4289.20E-03 
220 0. 39 37442-C3 C.3916312-03 0.400436E-03 
240 0. 340170E-CJ 0.3451532-0 3 0.324390E-03 
260 0. 296323E-C3 0.2892672-03 0.318668E-03 
280 0. 2641801-C3 0.2643592-C3 0.263613E-03 
300 0. 2 318562-C3 C.23C2S7E-03 0.2368C1E-03 
330 0. 190934E-C3 0.193934E-03 0. 181434E-03 
360 0. 161641E-C3 C.157283E-03 0. 175441E-03 
390 0. 13t€29E-C3 0.135829E-C3 0. 139162E-03 
420 0. 1155C8Î-C3 C.111672E-03 0. 127655E-03 
450 0. 991231E-04 0.S82809E-C4 0.101790E-03 
480 0. 85É5C7E-C4 C.815867E-04 0.993534E-04 
iTime after injection of tracer. 
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Figure 2.9. Specific radioactivity (^H) of blood glucose 
following an intravenous injection of [U-i+C, 
6-^H]glucose in experiment 181 A. 
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Figure 2.10. Eesiduals of curve fitted to blood glucose 
tritium specific radioactivity in experiment 
181A. 
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Figure 2. 11. Specific radioactivity (^H) of plasma glucose 
following an intravenous injection of 
6-3H]glucose in experiment 181A. 
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Figure 2. 12. Residuals of curve fitted to plasma glucose 
tritium specific radioactivity in experiment 
181A. 
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Table 2.7. Glucose specific radioactivity (i*C) in blood, 
plasma, and red blood cells following an intra­
venous injection of [U-i*C, 6-3H]glucose in 
experiment 181B. 
Timei Blood Plasma BEC 
irin [ dfin (i+C) / (I zg glucose x dose) K 100%]---
2 0. 4067915-02 0. 442492E-02 0, 295966E-02 
U 0. 340530E-02 0. 372457E-C2 0. 233644E-02 
6 0. 318CC8E-Û2 0. 342185E-C2 0. 237068E-02 
10 0. 27C465E-02 0. 2780C8E-C2 0. 245212E-02 
15 0. 2256C5E-C2 0. 247072E-C2 0. 153737E-02 
20 0. 208795E-02 0. 231608E-02 0. 132421E-02 
30 0. 181030E-02 0. 198618E-02 0. 122148E-02 
40 0. 15448CE-C2 0. 171619E-02 0. 971016E-03 
50 0. 143573E-C2 0. 156114E-02 0. 101588E-02 
60 0. 129851E-02 0. 136533E-C2 0. 107481E-02 
75 0. 114618E-C2 0. 1iei89E-C2 0. 102Ô63E-02 
90 c. Ç98669E-C3 0. 106346E-02 0. 781760E-03 
105 0. 849313E-03 0. 921384E-03 0. 608033E-03 
120 0. 756858E-C3 c. 800472E-C3 0. 610846E-03 
135 0. 6 8 4 8 e 3 E - C 3  0. 701582E-C3 0. 628978E-03 
150 0. 5954C7E- C 3  0. 614346E-C3 0. 532003E-03 
165 0, 540890E-C3 0. 55 1061E-03 0. 5068402-03 
180 0. 466361E-C3 0. 494188E-03 0. 373201E-03 
200 0. 416488E-C3 0. 439593E-C3 0. 3391j6E-03 
220 0. 354457E-C3 c. 365517E-03 0. 317430E-03 
240 0. 313614E-C3 0. 330233E-03 0. 257977E-03 
260 0. 269255E-C3 0. 284877E-03 0. 216955E-03 
280 0. 242088E-03 0. 24S770E-C3 0 .  216370E-03 
300 0. 218776E-C3 0. 227016E-03 0. 191 I90E-03 
330 0. 183936E-03 0. 191547E-C3 0. 158456E-03 
360 0. 140760E-C3 0. 156410E-03 0. 883666E-04 
390 0. 113841E-Û3 0. 120619E-C3 c. 911494E-04 
420 0. 894366E-C4 0. 988037E-04 0. 580771E-04 
450 0. 7113C7E-04 0. 825869E-04 0. 327773E-04 
480 c. 6C8361E-C4 0. 672288E-04 0. 394345E-04 
iTime after injection of tracer. 
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Figure 2.13. Specific radioactivity (i+C) of fclcod glucose 
followirg an intravenous injection cf [U-i*C, 
6-3H]giucose in experiment 181B. 
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Figure 2.14. Residuals of curve fitted to blood glucose ^ +0 
specific radioactivity in experiment 181B, 
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Figure 2.15. Specific radioactivity (i+C) cf plasma glucose 
following an intravenous injection of [U-i+C, 
6-3H]giucose in experiment 181B. 
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Figure 2.16. fiesiduals of curve fitted to plasma glucose &*0 
specific radioactivity in experiment 181B. 
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Table 2.8. Glucose specific radioactivity (^H) in blood, 
plasma, and red blood cells following an intra­
venous injection of [D-i+C, S-^Hjglucose in 
experiment 161B. 
Time 1 Blood Plasma BBC 
min 1 1 1 1 
o
 
o
 
M 
2 0. 394138E-02 0. 422748E-02 0.298356E-02 
4 0. 326955E-C2 0. 357565E-02 0.224478E-02 
6 0. 309556E-(2 0. 332640E-02 0.232284E-02 
10 0. 260322E-C2 0. 271219E-02 0.223841E-02 
15 0. 221946E-C2 0. '243931E-02 0. 148344E-02 
20 0. 200592E-02 0. 219871E-C2 0.136049E-02 
30 0. 173519E-C2 0. 18S816E-02 0.118959E-02 
40 0. 149989E-C2 0. 163789E-C2 0.103769E-02 
50 0. 139564E-C2 0. 148586E-02 0.109360E-02 
60 0. 124273E-C2 0. 130329E-C2 0.103999E-02 
75 c. 109123E-C2 c. 115397E-02 0.881188E-03 
90 0. 941156E-03 0. 99C2e3E-C3 0.776754E-03 
105 0. 7fi676lE-C3 c. 871867E-C3 0.501842E-03 
120 0. 706850E-03 0. 761481E-03 C.523956E-03 
135 0. 635066E-C3 0. 656366E-03 0.563766E-03 
150 0. 566079E-C3 0. 570460E-03 0.551413E-03 
165 0. 510379E-C3 c. 506560E-03 0.516469E-03 
180 0. 427813E-03 0. 448453E-C3 0.358714E-03 
200 0. 381460E-C3 0. 393080E-03 0.342559E-03 
220 0. 328714E-C3 0. 331744E-03 0.318570E-03 
240 0. 2804S3E-C3 0. 284890E-03 0.265772E-03 
260 0. 236460E-03 0. 252016E-C3 0.184362E-03 
280 0. 211202E-C3 c. 21 1606E-03 0.209849E-03 
300 0. 178935E-C3 0. 16585 3E-03 0. 155775E-03 
330 0. 147127E-C3 0. 151490E-03 0. 132520E-03 
360 0. 1156C7E-03 0. 123576E-03 0.889282E-04 
390 0. S13946E-C4 0. 966449E-04 0.738175E-04 
420 0. 653672E-C4 0. 717977E-C4 0.438390E-04 
450 0. £16S6€E-C4 0. 535209E-04 0.455545E-04 
480 0. 414270E-04 0. 445018E-04 0.311332E-04 
iTime after injection of tracer. 
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igure 2.17, Specific radioactivity (SH) of blood glucos 
iollcwing an intravenous injection of [U-i* 
6-3H]giucose in experiment 181B. 
190 
o 
03 
O 
13 O 
O Q 
O , 
I 
cc 
jQOO 
en I 
ixJ 
oc 
o fU 
o (O 
* % tt * * * " % * „ * 
•Ht 
* M 
Y  
X 
1 1 1 
0.00 1.00 2.00 3.00 
TIME (MINUTES) 
1— 
M.00 
(XI 0^ ) 
Figure 2.18. Besiduals of curve fitted to blood gluccse 
tritium specific radioactivity in experiment 
181E. 
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i g u r e  2. 19. Specific radioactivity (^H) of plasma glucose 
following an intravenous injection of [U-i+C 
6-3fi]glucose in experiment 181B. 
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Figure 2.20. Residuals of curve fitted to plasma glucose 
tritium specific radioactivity in experiment 
181B. 
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Table 2.9. Glucose specific radioactivity (i*C) in hlood, 
plasma, and red fclood cells following an intra­
venous injection of [U-i+C, 6-3H]glucose in 
experiment 181C. 
lime 1 Blocd Plasma BBC 
min glucose x dose) X  100%] 
2 0. 402409E-C2 0 .  427275E-02 0,314246E-02 
H 0. 337536Ï-C2 0. 359791E-02 0.258632E-02 
6 0. 293675E-02 0. 316537E-C2 0.212619E-02 
10 0. 244126E-C2 0. 259453E-C2 0.189785E-02 
15 0. 224267E-C2 0. 224876E-C2 0.2221C8E-02 
20 C. 207313E-C2 0. 213529E-02 0. 185274E-02 
25 0. 188696E-C2 0. 196544E-02 0.160871E-02 
30 0. 174890E-C2 0. 183774E-C2 0.143392E-02 
40 0. 15Ê744E-C2 0. 1631132-02 0. 143254E-02 
50 0. 140344E-C2 0. 143120E-02 0. 130502E-02 
60 0. 127496E-02 0. 129692E-02 0. 11971ÛE-02 
75 0. 1U331E-C2 c. 113979E-C2 0. 115579E-02 
90 0. 10C045E-02 0. 101653E-C2 C.943439E-03 
105 0. 882191E-C3 c. 891253E-C3 C.850063E-03 
120 0. 779035E-03 0. 787240E-03 C.749945E- 03 
135 0. 665782E-C3 c .  74C180E-03 0.492916E-03 
150 0. 6385e7E-C3 0. 629940E-03 C.669244E-03 
165 0. 56CCe0E-C3 0. 58C046E-03 0.489292E-03 
180 0. 510332E-C3 0. 523229E-03 0.4646C7E-03 
220 0. 386105E-C3 0. 414160E-03 0.286637E-03 
240 0. 346143E-03 0. 35 1235E-03 C.328090E-03 
260 0. 313e44E-C3 0. 3C8313E-03 0.332545E- 0 3  
280 0. 267993E-03 0. 275363E-C3 0,241792E- 0 3  
300 0. 249545E-C3 0. 258499E-03 Û.217799E-0 3  
330 0. 221747E-03 0. 213715E-03 C.250224E-0 3  
360 0. 186768E-C3 0, 184901E-C3 0.19i387E-0 3  
390 0. 156009E-03 0. 160240E-C3 0. 141ÛC8E-03 
420 0. 135573E-C3 c .  140486E-03 0.118 154E-0 3  
450 0. 121964E-03 0. 120702E-03 0. 126438E-03 
480 0. 1065e7E-C3 0. 105624E-03 0.110001E-03 
iTime after injection of tracer. 
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Figure 2.21. Specific radioactivity (i^C) cf bleed glucose 
following an intravenous injection of 
6-3H]glucose in experiment 181C. 
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Figure 2.22. Residuals of curve fitted to klood glucose i^C 
specific radioactivity in experiment 181C. 
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Figure 2,23, Specific radioactivity (i+C) of plasma glucose 
following an intravenous injection of [U-i+C, 
6-3H]glucose in experiment 181C. 
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Figure 2.24. Residuals of curve fitted to j-lasma glucose 
specific radioactivity in experiment 181C. 
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Table 2.10. Glucose specific radioactivity (^H) in blood, 
plasma, and red blood cells following an intra­
venous injection of [U-i+C, 6-'H]glucose in 
experiment 181C. 
l imei Blood Plasma HEC 
din X 100%] 
2 0. 388667E-02 0. 418658E-02 0.282335E-02 
a 0. 339459E-C2 0. 352125E-02 0.294552E-02 
6 0. 292475E-C2 0. 30e067E-C2 0.237194E-02 
10 0. 247E45E-C2 0. 26C920E-02 0,200125E-02 
15 0. 2264571-02 0. 224294E-02 0.234126E-02 
20 0. 203472E-C2 0. 208302E-02 0. 186347E-02 
25 0. 189ei7E-02 0. 190435E-C2 0. 1Ô7626E-02 
30 0. 176777E-C2 0. 173302E-02 0.189097E-02 
40 0. 158890E-02 0. 15E019E-02 0. 172615E-02 
50 0. 1404 16E-C2 0. 138709E-02 0. 146468E-02 
60 0. 127800E-C2 0. 125348E-C2 0. 136493E-02 
75 0. 115063E-C2 0. 112364E-02 0.124632E-02 
90 0. 983515E-03 0. 971322E-03 0.102674E-02 
105 0. 644913E-C3 0. 856703E-03 0.803113E-03 
120 0. 744259E-C3 c. 77E242E-C3 0.634411E-03 
135 C. 66C979E-C3 0. 677789E-03 C.601379E-03 
150 0. 573640E-03 0. 61 1179E-C3 0.440547E-03 
16 5 0. 545749E-C3 0. 554916E-03 0.513249E-03 
180 0. 469862E-03 0. 463638E-03 0.421020E-03 
220 0. 357683E-C3 0. 3741032-03 0.299468E-03 
240 0. 313757E-C3 0. 319297E-03 0.294116E-03 
260 0. 286574E-C3 0. 28C196E-C3 0.309187E-03 
280 0. 236802E-C3 0. 25C8S7E-C3 0. 187193E-03 
300 c. 219777E-C3 0. 217401E-03 0.228201E-03 
330 0. 186573E-03 0. 18S407E-03 0.176525E-03 
360 0. 16C1C6E-C3 0. 162922E-03 0.150122E-03 
390 0. 132897E-03 0. 133474E-C3 0. 130851E-03 
t»20 0. 112431E-C3 c. 118657E-03 0.903570E-04 
450 0. 100259E-C3 0. 984203E-G4 0. 106778E-03 
480 0. 847222E-C4 c .  830402E-C4 0.906857E-OU 
iTime after injection of tracer. 
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Figure 2.25. Specific radioactivity (^H) of bleed glucose 
following an intravenous injection of [U-i+C, 
6-3H]glucose in experiment 181C. 
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figure 2.26, Besiduals of curve fitted to blood glucose 
tritium specific radioactivity in experiment 
181C. 
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Figure 2.27. Specific radioactivity of plasma glucose 
following an intravenous injection of [U-i*C, 
6-3H]glucos€ in experiment 181C. 
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Figure 2.28. Residuals of curve fitted to plasma glucose 
tritium specific radioactivity in experiment 
181C. 
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Table 2.11. Glucose specific radioactivity (i+C) in blood, 
plasma, and red blood cells following an intra­
venous injection of [U-i+C, 6-3H]glucose in 
experiment eOU6F. 
Time* Bleed Plasma B£C 
min [ dpm (i4C)/(mg glucose X dose) X 100%] 
2 0. 450171E-C2 0. 538693E-02 0.198226E-02 
6 0. 343270E-C2 0. 347321E-C2 0.331740E-02 
10 0. 298155E-C2 0. 315528E-02 0.248709E-02 
15 0. 279138E-02 0. 252991E-02 0.353556E- C2 
20 0. 22e3S7E-C2 C. Z37959E-C2 0.193490E-02 
25 0. 208169E-02 0. 214066E-02 0, 191385E-02 
30 0. ig3857E-02 C. 19Ê743E-02 0.179951E-02 
40 0. 175963E-02 0. 178749E-02 0. 168Û34E-02 
50 0. 1E541CE-C2 0. 161546E-02 0.137946E-02 
60 0. 146654E-C2 0. 147711E-02 0. 143646E-02 
75 0. 129956E-C2 0. 129632E-02 0.13Û878E-02 
90 0. 126335E-C2 0. 116958E-C2 0.153023E-02 
105 0. 1Û4724E-C2 0, 104546E-02 0. 105231E-02 
120 0. 955754E-C3 0. 965853E-C3 0.927011E- 03 
135 0. 768681E-C3 c .  83e835E-03 0.569012E-03 
150 0. 76S657E-03 0. 771060E-03 0.766434E-03 
165 0. 6966Ç3E-C3 0. 6S6856E-03 0.703922E-03 
180 0. 631583E-03 0. 635861E-03 0.619407E-03 
200 0. 5fc4457E-CJ 0. 576748E-03 0.529475E-03 
220 0. 4786e6E-C3 0. 510635E-C3 0.387754E-03 
240 0. 4361£3E-C3 0. 446155E-C3 0.407725E-03 
260 0. 391390E-03 0. 386579E-C3 0.405083E-03 
280 0. 348622E-C3 c. 355992Z-03 0.327646E-03 
300 0. 318057E-C3 0. 316065E-03 0.323726E-03 
330 0. 264474E-C3 0. 329796E-03 0.785574E-04 
360 0. 236300E-C3 0. 2 2 e 9 e 7 E - 03 Û.257114E-03 
390 0. 196391E-C3 c .  1837882-C3 0.232261E-03 
420 0. 167205E-03 0. 167095E-03 0. 167518E-03 
450 0. 146C5CE-C3 0. 142145E-03 0. 157164E-03 
480 0. 127877E-C3 0. 121523E-03 0. 1459€2E-03 
ilime after injection of tracer. 
204 
vo_ 
»—• o 
C_1 
LJ \n— 
UJ 
Q_ (n 
0 . 0 0  I .  0 0  2 . 0 0  3.00 
TJM£ IMJNUTES) (%]o? )  
Figure 2.29. Specific radioactivity (i+C) of blood glucose 
follcwing an intravenous injection of [U-i+C, 
6-3Hjglucose in experiment 8046F. 
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Figure 2.30. Besiduals of curve fitted to blood glucose i 
specific radioactivity in experiment 8046F. 
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Figure 2.31. Specific radioactivity (i+C) cf plasma glucose 
fciiowing an intravenous injection of [U-i+C, 
6-3H]glucose in experiment 80U6F. 
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Figure 2.32. Residuals of curve fitted to plasma glucose i*0 
specific radioactivity in experiment 804bF, 
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Table 2.12. Glucose specific radioactivity (^H) in blood, 
plasma, aad red blood cells following an intra­
venous injection of [U-i+C, 6-3H]glucose in 
experiment 8046F. 
Timei Blcod Plasma a EC 
trin X  10054] 
2 0. 419739E-02 0.492126E-02 0.213714E-02 
6 0. 314620E-02 0.329818E-C2 0.27 1364E-02 
10 0. 273896E-02 0.276786E-02 0.259978E-02 
15 0. 267599E-02 0.234691E-02 0.361260E-02 
20 0. 217767E-C2 0.2172E1E-C2 0.219236E-02 
25 0. 193696E-C2 0.205360E-02 0.160498E-02 
30 0. 187Û0CE-C2 C.187058E-C2 0.186835E-02 
40 0. 164260E-02 C.169070E-C2 0. 15C570E-02 
50 0. 147C65E-C2 0.148446E-02 0. 143135E-02 
60 0. 133469Ï-02 0. 138491E-02 0. 119176E-02 
75 0. 120515E-C2 0,116e67E-C2 0. 125149%-02 
90 0. 112938E-02 0. 107461E-02 0.128526E-02 
105 c. 960427E-C3 G.948004E-03 0.995785E-03 
120 0. 864 148E-C3 0 . 8 5 e 7 4 7 E - 0 3  0.879520E-03 
135 0. 698824E-C3 0.764112E-03 0.513005E-03 
150. 0. 680239E-03 C.67C080E-C3 0.709153E-03 
165 0. 602449E-Û3 0.625641E-03 C.53Ô442E-03 
180 0. 56 1496E-03 0.547633E-03 0.600953E-03 
200 0. 51111CE-03 0.486S77E-03 0.579796E-03 
220 0. 414936E-C3 0,436591E-C3 0,347611E-03 
240 0. 392C64E-C3 0.375919E-C3 0.438092E-03 
260 0. 3356685-03 0.326555E-C3 0.3b2374E-03 
280 0. 303578E-C3 C.289763E-03 0.342898E-03 
300 0. 268094E-C3 0.259368E-C3 0.292930E-03 
330 0 .  2186S1E-C3 C.264600E-C3 0.880272E-04 
360 0. 184011E-03 0.185732E-C3 0.179113E-03 
390 0. 15SÇS3E-C3 C.146300E-03 0.198965E-03 
420 0. 13 1628E-03 0. 134792E-03 0. 122623E-03 
450 0. 1117CGE-C3 0.1C8680E-C3 0.120295E-03 
480 0. 936547E-C4 0.910068E-04 0. 101 191E-03 
ilime after injection of tracer. 
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Figure 2.33. Specific radioactivity (^H) of blood glucose 
following an intravenous injection of [U-i+C, 
6-3H]glucose in experimenk 8046F. 
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Figure 2.34. Residuals of curve fitted to blood glucose 
tritium specific radioactivity in experiment 
80a6F. 
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Figure 2.35, Specific radioactivity (^h) of plasma glucose 
following an intravenous injection of 
6-3H]glucose in experiment 0O46F, 
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Figure 2.36. Residuals of curve fitted to glucose 
tritium specific radioactivity in experiment 
8046F. 
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ïable 2.13, Glucose specific radioactivity (**C) in blood, 
plasma, and red blood cells following an intra­
venous injection of [U-i+C, 6-3H]glucose in 
experiment 0OU6G. 
Timei Blood flasma BBC 
min 
2 G.335003E-C2 
6 0.26e665C-C2 
10 0.23402CC-C2 
15 0.207934E-02 
20 0. 19133CC-C2 
25 0. 175923C-C2 
30 C. 17C3£l9C-C2 
40 0.145889[-02 
50 0.134254C-C2 
60 0.123356E-02 
75 0. 108CS6E-02 
90 0,939346E-C3 
105 0.8C6C7CE-C3 
120 0.753 149E-03 
135 0.653130D-C3 
150 0.5893C5E-03 
165 0.51C914E-C3 
180 0.462345E-C3 
200 0.42f356E-C3 
220 0.373700E-03 
240 0.3283€3E-C3 
260 0.297216E-C3 
280 0.2633C6E-C3 
300 0.235219E-C3 
330 C. 1994 16D-C3 
360 0.1686S7E-C3 
390 0.143132E-C3 
420 0.12B862E-03 
450 0. 1066Ê7D-C3 
480 0.9218g5E-04 
iTime after injection of tracer. 
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Figure 2.37, Specific radioactivity (i+C) of blood glucose 
following an intravenous injection of [0-i*C, 
6-3H]glucose in experiment 8046G, 
215 
o 
oo 
a 
o 
J* 
a 
o 
AJ 
CC 
JD 
lOQ 
W 
OC 
O 
f\i 
Q , 
I 
O 
J" 
X 
M 
M MM 
 ^ * * * M 
M M * « _ X M 
-jjjj M jr~jir 
M 
H 
JK 
-* 1 1 1 1— 
0.00 l.OQ 2.00 3.00 4.00 
TIME (MJNU7ES3 (%io? Î  
I I 
Figure 2.38. Residuals of curve fitted tc blood glucose i+C 
specific radioactivity in experiment 8046G. 
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Table 2.14, Glucose specific radioactivity (^H) in blood, 
plasma, and red blood cells following an intra­
venous injection of [U-i+C, 6-3H]glucose in 
experiment 8046G. 
Timei Blood Plasma EEC 
Œin 
2 0.317553E-02 
6 0.255SS6C-02 
10 0.223153E-02 
15 0.1S37€2C-C2 
20 0. 175965C-C2 
25 0.164267C-C2 
30 0.155267E-C2 
40 0.135313C-02 
50 0.124511E-C2 
60 0.118557E-C2 
75 0.101332E-02 
90 C . e f o 4 6 5 2 C - C 3  
105 0.722545E-C3 
120 C.675e57E-C3 
135 0.595311E-03 
150 C.51575€E-C3 
165 0.465699E-03 
180 0.420626E-C3 
200 0.379396E-03 
220 0.3265E5C-C3 
240 0.288Û69E-03 
260 0.254549C-C3 
280 0.222546E-C3 
300 0.2C22fc6E-C3 
330 0.171169E-C3 
360 0.141378D-C3 
390 0.111479E-C3 
020 0.102931E-C3 
450 0.862120E-C4 
480 0.728712E-C4 
iTime after injection of tracer. 
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Figure 2.39. Specific radioactivity (^fl) of blood glucose 
follcwimg an intravenous injection of 
6-3H]glucose in experiment 80460. 
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Figure 2.40, Residuals of curve fitted to blood glucose 
tritium specific radioactivity in experiment 
8046G. 
219 
Table 2.15. Glucose specific cadioactiwity (i+C) in blood, 
plasma, and red blood cells following an intra­
venous injection of [U-i+C, 6-3H]glucose in 
experiment 8046H. 
Timet Bleed Plasma BEC 
Din glucose X dose) X 100%]---
2 0. 369271E-02 0. 415935E-02 0. 229279E-02 
4 0. 322249E-02 C. 350377E-C2 0. 237865E-02 
6 0. 286327E-02 0. 316026E-02 0. 197230E-02 
10 0. 239120E-02 0. 268079E- C2 0. 152243E-02 
15 0. 215449E-C2 0. 237251E-C2 0. 150043E-02 
20 0. 193379E-C2 0, 217957E-C2 0. 119645E-02 
25 0. 172691E-C2 0. 193912E-C2 0. 109028E-02 
30 0. 168189E-02 0. 176517E-C2 0. 1372C5E-02 
40 0. ia6Ê63E-C2 0. 15ee62E-02 0. 110946E-02 
50 0. 132235E-02 0. 143777E-02 c. 9760S0E-03 
60 0. 117678E-02 0. 131541E-02 0. 757891E-03 
75 0. 960190E-03 0, 107527E-02 0. 614951E-03 
90 0. 8670CCE-C3 0. 925661E-03 0. 691017E-03 
105 0. 780629E-03 0. B13922E-C3 c. 680750E-03 
120 0. 666767E-C3 0. 713110E-C3 0. 527818E-03 
135 0. 57C799E-C3 0. 592819E-03 0, 504740E-03 
150 0. 46265 1E-C3 c. 488021E-03 0. 386542E-03 
165 0. 386640E-03 0. 41 1753E-G3 0. 319301E-03 
180 0. 339730E-C3 0. 373113E-03 0. 239581E-03 
220 0. 261181E-03 0. 28E681E-C3 0. 187681E-03 
240 0. 248456E-C3 c. 243971E-C3 0. 261919E-03 
260 0. 2184Û4E-C3 0. 227502E-03 0. 1911lOE-03 
280 0. 191165E-03 0. 2CC523E-C3 0. 163Û91E-03 
300 0. 175025E-03 0. 179565E-03 c. 16iyC5E-03 
330 0. 146416E-C3 0. 155759E-03 0. 118387E-03 
360 0. 122615E-C3 0. 127234E-03 0. 108758E-03 
390 0. 105094E-C3 0. 11 1760E-03 c. 850 960E-04 
420 0. 903721E-04 0. 931572E-04 c. 820168E-04 
450 0. 776268E-C4 0. 866809E-04 0. 504645E-04 
iTime after injection cf tracer. 
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Figure 2.41. Specific radioactivity (&*€) cf blood glucose 
following an intravenous injection of [U-i+C, 
6-3H]glucose in expeciment 8046H. 
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Figure 2.42. Residuals of curve fitted to blood glucose i 
specific radioactivity in experiment 8046H. 
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Figure 2.43 Specific radioactivity (i+C) of plasma glucose 
following an intravenous injection of [U-i+C, 
6-3H]glucose in experiment 8046H. 
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Figure 2.44. Residuals of curve fitted to plasma glucose i*0 
specific radioactivity in experiment 8046H. 
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Table 2.16. Glucose specific radioactivity ('H) in blood, 
plasma, and red blood cells following an intra 
venous injection of [U-i+C, 6-3H]glucose in 
experiment 8046H. 
Time : Blood Plasma BBC 
min [ dpm <3H)/(mg [ glucose x dcse) X 100%] 
2 0. 359969E-C2 0.38E588E-C2 0.274112E-02 
4 0. 304ÉC4E-C2 C.326784:-02 0.238064E-02 
6 0. 26S861E-02 0.300675E-02 0. 177419E-02 
10 0. 229265E-C2 C.253182E-C2 0. 157514E-02 
15 0. 203855E-C2 Û.220502E-02 0, 153914E-02 
20 0. 182880E-C2 0.199612E-02 0. 132b84E-02 
25 0. 169041E-02 0.184773E-C2 0.121845E-02 
30 C. 15fi95CE-C2 0.17C803E-C2 0.123391E-02 
40 0. 141428E-C2 0. 149744E-02 0. 116480E-02 
50 0, 122947E-C2 0.129547E-02 0.103147E-02 
60 0. 106729E-C2 0. 123816E-02 0.5546Ê1E-03 
75 0. 918C39E-C3 0.984186E-03 0.719598E-03 
90 0. 796367E-03 0.848066E-03 0.641270E-03 
105 0. 7090C1E-C3 0.753154E-C3 0.576542E-03 
120 0. 612146E-03 0.6460C7E-03 0.510563E-03 
135 0. 5179S8E-C3 C.536766E-03 0.461694E-03 
150 0. 413617E-03 0.427106E-C3 0.373150E-03 
165 0. 344467E-C3 0.36C073E-C3 0.297649E-03 
180 0. 294703E-C3 0.316563E-03 0.223123E-03 
220 0. 225476E-C3 0.243508E-C3 0.171380E-03 
240 0. 197273E-C3 0.211147E-C3 0. 15565 1E- 03 
260 0. 178811E-C3 0.181470E-C3 0. 170834E-03 
280 0. 157729E-C3 0.162366E-03 0. 143Ê18E-03 
300 0. 138257E-C3 C.145091E-03 0.117755E-03 
330 0. 11II733E-C3 0.1182S6E-C3 0.104044E-03 
360 0. 92020CE-C4 0.943771E-04 0.849487E-04 
390 0. 7872E6E-C4 0.833550E-C4 0.648494E- 04 
1120 0. 667C57E-C4 C.712364E-04 0.531136E-04 
450 0. 574825E-C4 0.601915E-C4 Û.493555E-04 
iTime after injection of tracer. 
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Figure 2.45. Specific radioactivity (^h) of blood glucose 
following an intravenous injection of 
6-JglL'cose in experiment flOlôH. 
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Figure 2.46 Residuals of curve fitted to blood glucose 
tritium specific radioactivity in experiment 
8046H. 
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Figure 2.47, Specific radioactivity (^H) of plasma gluco 
following an intravenous injection of [U-i* 
6-3H]gluco£e in experiment 8046H. 
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Figure 2.48. Besiduals of curve fitted to plasma glucose 
tritium specific radioactivity in experiment 
e046H. 
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Table 2.17, Elcod glucose specific radioactivity following 
an intcavencus injection of £ 6-]glucos€ in 
experiment 114A. 
Time 1 Blood glucose specific radioactivity 
min [dpm/fmg glucose x dose) ] x 100% 
5 0.239042E-02 
10 0. 194795E-C2 
15 0.1558605-02 
20 0. 148080E-02 
25 0. 136318E-02 
30 0. 11 1465E-C2 
40 C.107158E-02 
50 0.934015E-03 
75 0.822550E-C3 
90 0.746519E-C3 
105 C.614331E-C3 
120 0.532642E-03 
135 0.52C265E-03 
166 0.432635E-03 
180 0.381157E-C3 
200 0.353633E-C3 
220 0.319118E-03 
240 0.284745E-03 
260 0.255818E-C3 
30 0 0.2167772-0 3 
330 C.192235E-03 
360 0.145767E-03 
390 0.132754E-03 
420 0. 1 12031E-03 
450 C.99S366E-C4 
480 0.87S839E-04 
iTime after injection. 
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Figure 2.49. Specific radioactivity of blood glucose 
following an intravenous injection of 
glucose in experiment 114A. 
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Figure 2.50, Residuals of curve fitted to blood glucose 
specific radioactivity in experiment 114A. 
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Table 2.18. Blood glucose specific radioactivity following 
an intravenous injection of [6-3HJglucose in 
experinent 114B. 
Timei Elood glucose specific radioactivity 
nin [dpm/(mg glucose x dose) ] x 100% 
5 C.249255E-02 
10 C.2C7121E-02 
15 0.174315E-02 
20 C.176016E-02 
25 0.13E770E-02 
30 C.125U27E-02 
UO 0.115292E-02 
50 C.10C746E-02 
60 0.89S762E-G3 
75 C.813765E-03 
90 C.690428E-03 
105 0.567451E-03 
120 0.564135E-03 
135 0.556494E-03 
150 0.477129E-03 
165 0.423642E-03 
180 0.4100182-03 
200 0.352494E-03 
220 0.3C4126E-03 
240 0.285311E-03 
260 0.25ie64E-03 
280 0.252873E-C3 
300 0.203495E-03 
330 C.165218E-03 
360 0.145323E-03 
390 C.126076E-03 
420 0.10S713E-C3 
450 C.896014E-C4 
480 0.804466E-04 
»Time after injection. 
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gure 2.51. Specific radioactivity of blood glucose 
following an intravenous injectico of [6--'H] 
gluccse in experiment 1148. 
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Figure 2. 52. Residuals of curve fitted to tlood glucose 
specific radioactivity in experiment 1148. 
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Table 2.19. Blood glucose specific radioactivity following 
an intravenous injection of [0-^*CJgluccse 
in experiment 114C. 
Time» Elood glucose specific radioactivity 
min [dpm/(mg glucose x dose) ] x 100% 
5 0.271223E-02 
10 0.22C879E-02 
15 0.19CU77E-02 
20 0.174ie4E-C2 
25 ' 0.16C075E-C2 
30 0.142317E-02 
41 C.130022E-02 
51 0.116Û99E-C2 
60 0.105919E-02 
75 C.954128E-C3 
90 0.701244E-03 
105 0.75ea22E-03 
120 0.671492E-03 
135 0.5S6417E-C3 
150 0.569455E-03 
165 0.526223E-03 
180 0.48C202E-0 3 
200 0.436273E-03 
220 0.3B5603E-C3 
240 C.34Ç576E-03 
260 0.299603E-03 
280 C.281474E-03 
300 0.244517E-C3 
330 0.2C6631E-03 
360 0.183155E-C3 
390 C.167815E-03 
420 0.142248E-C3 
450 0.1210961-03 
480 0.1C8080E-C3 
iTime after injection. 
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Figure 2.53. Specific radioactivity of blood glucose 
fcllowiag an intravenous injection of [U-
glucose in experiment HUC. 
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Figure 2.54, Residuals of curve fitted tc blood glucose 
specific radioactivity in experiment 1140. 
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Table 2.20, Blood glucose specific radioactivity following 
an intravenous injection of [Jglucose in 
experiment 114D. 
Timei Elood glucose specific radioactivity 
min [dgm/trng glucose x dose)] x 100% 
10 C.224895E-02 
15 C.179051E-C2 
20 0.167748E-02 
25 C.154588E-02 
30 0.137880E-C2 
40 C.123812E-C2 
50 0.113286E-02 
60 C.1C2650E-C2 
75 0.762202E-03 
90 C.687839E-C3 
105 0.637562E-03 
135 C.506248E-C3 
150 0.446685E-03 
165 C.426185E-03 
180 0.38C811E-C3 
200 C.350848E-03 
220 0.314718E-03 
240 0.255591E-03 
iTime after injection. 
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Figure 2.55. Specific radioactivity of blood glucose 
fcllcMing an intravenous injection of 
glucose in experiment 114D. 
240 
G 
00 
O 
— O 
I 
QVD 
O 
O 
a 
o 
a" 
cc 
OD 
Q® 
m? 
W 
OC 
O 
ry 
O 
to 
% X 
_ X % X 
* X 
X 
1— 1 1 1 
0.00 s.00 10.00 15.00 20.00 
TJME IMJNU7E5) i>io'  )  
I 
Figure 2.56. Residuals c£ curve fitted to blood glucose 
specific radioactivity in experiment 1140. 
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Table 2,21. Elood glucose specific radioactivity following 
an intravenous injection c£ [5-^HJglucose in 
experiment V14E. 
Time! Elocd glucose specific radioactivity 
ffiin [d].ni/(nig glucose x dose)] x 100% 
5 0.255657E-02 
10 0.212588E-C2 
15 0.182523E-02 
20 0.171C94E-02 
25 C.155444E-02 
30 0.139601E-02 
40 0.123951E-02 
50 0.111557E-C2 
60 0.10C838E-02 
75 0.89C776E-03 
90 C.7S1554E-03 
105 C.675870E-03 
120 Û.589040E-03 
135 0.543433E-03 
150 C. 4e3472E-03 
165 0.450134E-03 
180 0.419266E-03 
200 0.387009E-C3 
220 C.350507E-C3 
240 0.286302E-C3 
260 0.258829E-03 
280 0.222945E-03 
300 0.2ie469E-C3 
330 0,181967E-C3 
360 C.149556E-G3 
390 C.132501E-C3 
U 2 0  0.111974E-03 
450 0.105723E-03 
480 0.934532E-04 
iTime after injection. 
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Figure 2.57. Specific radioactivity of blood glucose 
following an intravenous injection of [5-^H] 
glucose in experiment 114E. 
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Figure 2.58. Residuals of curve fitted to blood glucose 
specific radioactivity in experiment 114E. 
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Table 2.22. Elood glucose specific radioactivity following 
an intravenous irjection of f2-'HJglucose in 
experiment 114F. 
Time* Elood glucose sfecific radioactivity 
min CdEiD/(ag glucose x dose) ] x 100% 
5 0.246637E-02 
10 0.199111E-C2 
15 0.178865E-02 
20 0.159843E-02 
25 0.144255E-02 
33 0.135397E-02 
40 0.114303E-02 
50 0.103732E-C2 
60 0.893103E-03 
75 0.802643E-03 
90 C.684204E-03 
105 0.55e016E-C3 
120 0.467229E-03 
135 0.450915E-03 
150 C.390473E-C3 
165 0.36S509E-03 
180 0.344631E-C3 
200 0.298136E-03 
220 0.262653E-C3 
240 0.239324E-03 
260 C.220319E-C3 
280 0.2G6370E-C3 
300 0.17C235E-03 
330 0.14É172E-C3 
360 0.113789E-C3 
390 0.935601E-C4 
020 C.792854E-04 
450 0.6S6602E-04 
480 0.630531E-04 
ilime after injection. 
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Figure 2.59 Specific radioactivity of blood glucose 
following an intravenous injection of £2-^H] 
glucose in experiment 11UF. 
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Figure 2.60. Residuals of curve fitted to blood glucose 
specific radioactivity in experiment 114F. 
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Table 2.23. Elcod glucose specific cadioactivity following 
an intravenous injection of [U-i+Cjglucose 
in experiment 114G. 
Timei Elood glucose specific radioactivity 
trin [dpm/(mg glucose x dose)] x 1C0% 
5 0.271573E-C2 
10 0.2268242-02 
20 0.175519E-C2 
25 0.15Ç800E-C2 
30 0.148239E-02 
40 0.133319E-02 
50 C.117325E-02 
60 0.103182E-C2 
75 C.942485E-03. 
90 0.836470E-03 
105 0.734339E-C3 
120 0.652314E-03 
135 C.596793E-03 
150 0.5360732-03 
165 C.507228E-03 
180 0.446224E-C3 
200 0.413551E-03 
220 0.358716E-03 
240 0.318960E-C3 
260 0.28E373E-03 
280 0.264810E-03 
300 0.231451E-03 
330 C.196265E-03 
390 0.14Se84E-0 3 
420 0.126122E-03 
450 0.112870E-03 
480 0.10Û989E-03 
iTime after in jection 
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Figure 2.61. Specific radioactivity of blood glucose 
following an intravenous injection of 
glucose in experiment 114G. 
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Figure 2.62. Residuals of curve fitted to blood glucose 
specific radioactivity in experiment 114G. 
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Table 2.24. Blcod glucose specific radioactivity following 
an intravenous injection of [6-3H]glucose in 
experiment 1424A. 
Timei Blood glucose specific radioactivity 
min [dpm/(mg glucose x dose) ] x 100% 
5 0.26C956E-02 
10 0.218902E-C2 • 
15 0.187273E-G2 
20 0.17C616E-02 
25 0.154642E-02 
30 0.146250E-02 
40 0.1377C6E-C2 
50 0.125722E-02 
60 0.1C6535E-02 
75 0.94C997E-C3 
90 C.886333E-G3 
105 0.759943E-03 
120 C.663844E-C3 
135 0.605002E-03 
150 0.5Uaai8E-03 
165 0.489962E-03 
180 0.465937E-03 
200 0.415660E-03 
220 0.3777C8E-03 
240 0.327222E-C3 
260 C.2e5C92E-03 
280 0.267822E-03 
300 0.242613E-03 
330 0.204940E-03 
350 0.172838E-C3 
390 0.163C88E-C3 
£)20 0.144267E-C3 
450 0.125276E-03 
480 0.S88141E-04 
^Time after injection. 
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Figure 2.63. Specific radioactivity of blood glucose 
following an intravenous injection of [G-^H] 
glucose in experiment 7424A. 
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Figure 2.64, Residuals of curve fitted to blood glucose 
specific cadioactivity in experiment 7424A, 
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Table 2.25. Elood glucose specific radioactivity following 
an intravenous injection of [ô-'HJglucose in 
experiment 7424E. 
Time* Blood glucose specific radioactivity 
min [dfffl/(n!g glucose x dose) ] x 100% 
5 C.2E2835E-02 
10 0.204654Ï-02 
15 0. 182443E-02 
20 G.176774E-C2 
25 C. 1491691-02 
30 0. 148119E-C2 
40 0.125253E-C2 
50 0.1C7425E-02 
60 0.991236E-03 
75 0.79C813E-03 
90 Û.743104E-03 
105 0.693492E-03 
120 0.598531E-C3 
135 0.503037E-C3 
165 C.422761E-03 
180 0.400618E-0 3 
200 C.364932E-C3 
220 0.306038E-C3 
240 0.274003E-03 
260 0.246306E-C3 
280 0.207652E-C3 
300 0.182162E-03 
330 C.155682E-03 
360 0. 1404Ê4E-03 
390 0.118245E-G3 
420 0.98ei38E-C4 
450 C.918417E-04 
480 0.837000E-04 
ilime after injection. 
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Figure 2.65. Specific radioactivity of blood glucose 
following an intravenous injection of [ô-^h] 
glucose in experiment 7424B. 
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Figure 2.66. Residuals of curve fitted to blood glucose 
specific radioactivity in experiment 7424B. 
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Table 2.26. Blood glucose specific radioactivity following 
an intravenous injection of [0-i*C]glucose 
in experiment 7M24C. 
Timei Elood glucose specific radioactivity 
Bin [dfm/(mg glucose x dose) ] x 1C0% 
5 0.266967Ï-02 
1 0  C.22C152E-02 
15 0.19309aE-C2 
20 0. 1 7 e 6 3 l E-C2 
25 0.161860E-02 
30 C.152320E-02 
40 0.13q428E-C2 
50 0.126078E-02 
60 0.115791E-C2 
75 C.1C1795E-02 
90 C.95E204E-03 
105 0.845338E-03 
120 0.787723E-03 
135 C.725909E-03 
150 0.671559E-C3 
165 C.626073E-C3 
180 0.5714902-03 
200 0.529969E-03 
220 C.485650E-C3 
240 C.420103E-03 
260 0.38Ç779E-C3 
280 C.3722e5E-C3 
300 0.325E66E-0 3 
330 0.291576E-C3 
360 0. 271749E-C3 
390 0.2222S8E-03 
420 0.195006E-03 
450 C.180078E-03 
480 0.164916E-03 
iTime after injection. 
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Figure 2.67. Specific radioactivity of blood glucose 
fcilcwing an intravenous injection of [U-i* 
glucose in experiment 7424C. 
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Figure 2.68. Besidaals o£ curve fitted to fclood glucose 
specific radioactivity in experiment 7424C, 
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Table 2.27. Elcod glucose specific radioactivity following 
an intravenous injection of £Ô-^H ]glucose in 
experiner.t 7424D. 
Time : Elood glucose specific radioactivity 
min [dfm/{jng glucose x dose) ] x ICOK 
10 0.176735E-02 
15 0.173857E-C2 
20 C. 140879E-02 
25 C.lail10E-02 
30 0.131822E-C2 
40 Û.117065E-C2 
50 0.101475E-02 
60 0.925168E-03 
75 0.773476E-C3 
90 C.693051E-C3 
105 C.656489E-03 
120 0.5q2843E-03 
135 0.5041572-03 
150 C.447077E-C3 
165 0.U0517UZ-03 
180 0.395440E-03 
200 0.340422E-03 
220 0.304210E-03 
240 0.276660E-03 
iTime after injection 
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Figure 2.69, Specific radioactivity of blood glucose 
following an intravenous injection of [6-^H] 
glucose in experiment 7424D. 
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Figure 2.70. Residuals of curve fitted tc fclood glucose 
specific radioactivity in experiment 7424D. 
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Table 2.28. Blood glucose specific radioactivity following 
an intravenous injection of [5-'H ]glucos€ in 
experiment 7424E. 
limei Elood glucose specific radioactivity 
min [d;m/(mg glucose x dose) ] x 1C0% 
5 C.242380E-02 
10 0.2CS132E-02 
15 0. 18613aE-02 
20 C. 171868E-C2 
25 0. 152268E-02 
30 0. 147872E-02 
40 0.136871E-a2 
50 C.1175C7E-02 
60 0. 10E657E-02 
75 C.959852E-03 
90 0.835065E-03 
105 C.7327S8E-03 
120 0.671050E-C3 
135 0.6iy824E-03 
150 0.531060E-C3 
166 0.51786UE-03 
200 0.47 5838E-C3 
220 0.357793E-03 
240 0.328533E-03 
260 0.2b79aiE-C3 
280 0.265350E-C3 
300 0.24Ê059E-C3 
330 0.236162E-C3 
360 0.18S403E-03 
390 0.163944E-C3 
420 0.143361E-03 
450 0.11S623E-C3 
(180 0. 101622E-03 
iTime after injection. 
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Figure 2.71, Specific radioactivity of blood glucose 
following an intravenous injection of [S-^h] 
glucose in experiment 7U24E. 
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Figure 2.72. flesiduals of curve fitted tc blood glucose 
specific radioactivity in experiment 742WE. 
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Table 2.29. Elood glucose specific radioactivity following 
an intravenous injection of [2-3H]glucose in 
experiment 7424F. 
Timei Blood glucose specific radioactivity 
min [dgm/(mg glucose x dose) ] x 100% 
5 C.271C28E-02 
10 0.2512242-02 
15 C.1B3153E-C2 
20 0.17C931E-02 
25 0.16CC98Î-02 
31 0.145225E-C2 
40 C.13C656E-02 
50 0.117087E-02 
60 C.1C4820E-C2 
75 C.912312E-03 
91 0.824775E-C3 
105 C.77C946E-C3 
120 0.674024E-C3 
135 0.58C555E-03 
150 C.5Û5631E-03 
165 0.4B1982E-03 
180 0.444444E-03 
200 C.4C0150E-C3 
220 0.340015E-C3 
240 0.301952E-C3 
260 C.276Û51E-C3 
280 0.237763E-C3 
300 C.218093E-C3 
330 0.181607E-Û3 
360 C.155330E-03 
390 C.138213E-C3 
420 0.1CS760E-03 
450 C.886637E-04 
480 0.811562E-C4 
iTime after injection. 
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Figure 2.73. Specific radioactivity of blood glucose 
following an intravenous injection of [2-
glucose in experiment 7424F. 
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Figure 2.74, Residuals of curve fitted 
specific radioactivity in 
to tlood glucose 
experiment 7424F. 
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Table 2.30. Eicod glucose specific radioactivity following 
an intravenous injection of [U-i+Cjglucose 
in experiment 7^240. 
Timei Blood glucose specific radioactivity 
icin [dpm/(mg glucose x dose)] x 1C0X 
5 0.2638C1E-02 
10 0.22C464E-02 
15 C.197936E-02 
20 C.18C180E-C2 
25 C.160479E-02 
40 0.1JÇ467E-C2 
50 0.124674E-02 
60 0.11C696E-02 
75 C.1C2485E-02 
90 0.939353E-C3 
105 C.83C331E-C3 
120 0.775820E-03 
135 C.6e5345E-03 
165 0.607763E-03 
180 C.542169E-03 
200 0.481551E-C3 
220 C.439254E-03 
240 C.407588E-03 
260 C.383160E-03 
300 0.306483E-C3 
330 0.281602E-03 
360 0.237722E-C3 
390 C.2C9901E-C3 
420 0.194294E-G3 
U50 C . 1 5 e 7 8 3 E - C 3  
480 0. 1357121-03 
iTime after injection. 
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Figure 2.75, Specific radioactivity of blood glucose 
fcllcwing an intravenous injection of [U-i+C] 
glucose in experiment 7424G. 
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Figure 2.76. Residuals of curve fitted tc blood glucose 
specific radioactivity in experiment 742WG. 
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Table 2.31. Blood glucose specific radioactivity (i+C) and 
tritium radioactivity in freeze-dried blcod 
fcllouiag a simultaneous intravenous injectioîi 
of [0-i*C]glucose and [1-3H]-2-deoxyglucose in 
experiment 181E. 
ïimei Glucose 2-decxyglucose 
min radioactivity^ radioactivity^ 
2 C.430E43D-C2 0.2236410-02 
4 C.363É24D-C2 0.1864320-02 
6 0.334103D-02 0. 1698370-02 
10 C.276725D-C2 0. 1330960-02 
15 0.238S46D-02 0. 1022100-02 
20 0.236098D-02 0,8291980-03 
25 0. 1994900-02 0.6349650-03 
30 0. 189693D-02 0.6822410-03 
40 0.166460D-02 0.6531860-03 
50 0. 1625 38D-02 0.4943340-03 
60 0. 1385690-02 0.4582660-03 
75 0. 122418D-C2 0.3672820-03 
90 0. 103045D-02 0.:- 163040-03 
105 0.Ç25664D-03 0.2630960-03 
120 0.8219730-03 0.2277060-03 
135 C.714047D-C3 0.1770580-03 
150 0.6393950-03 0. 1683340-03 
165 C.57CC93D-03 0.1453020-03 
180 0.498686D-03 0. 1503660-03 
200 C.4889800-C3 0.1099830-03 
220 0.4205260-03 0. 1024030-03 
240 C.3776670-03 0.8734500-04 
260 0.3351560-03 0.7865450-04 
280 C.2822830-C3 0.704577D-Û4 
300 0.2525230-03 0.7437390-04 
330 0.205S35D-C3 0.6292750-04 
360 0. 1808150-03 0.4684910-04 
390 0. 147722D-C3 0.5067760-04 
420 0. 1294640-03 0.463iafcO-04 
450 C. 107459D-C3 0.4154380-04 
480 0.9520260-04 0.3545460-04 
iTime after injection of tracer. 
2[ dpm ( 1 *C) / (ng glucose x dose) ] x 100%. 
3[dpm(3H)/(ml blcod x dose)] x 100%. 
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Figure 2.77. Specific radioactivity (i*C) of blood glucose 
following a simultaneous intravenous injection 
of [U-:4C]glucose and [ 1-]-2-deoxyglucose 
in exferioent 181E. 
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Figure 2.78. Residuals of curve fitted tc blood glucose 
specific radioactivity in experiment 181E. 
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Figure 2.79. Tritium radioactivity in freeze-dried blood 
foilcwing a simultaneous intravenous injection 
of [0-i*C]glucose and []-2-dGoxyglucose in 
experiment 181E. 
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Figure 2.80. Besiduals of curve fitted to tritium 
radioactivity in freeze-dried blood in 
experiment 181E. 
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Table 2.32. Blood glucose specific radioactivity (i+C) and 
tritium radioactivity in freeze-dried blood 
following a simultaneous intravenous injection 
o f  [ D - ] g l u c o s e  and  [ 1  -3H]-2-deoxyglucose in 
experiment 60461. 
Time 1 Glucose 2-deoxyglucose 
nin radioactivity2 radioactivity3 
2 0.409078D-02 0.2375260-02 
4 0.361241D-02 0. 1839680-02 
6 C.321922D-02 0.1574500-02 
10 0.274735D-C2 0. 125798D-02 
15 C.2^57120-02 0. 1106840-02 
20 0.5 768100-03 
25 0.206334D-C2 0.8169110-03 
30 0.196028D-02 0.7106900-03 
40 0. 175147D-C2 0.5732000-03 
50 0.158694D-C2 0.4880840-03 
60 0.3965340-03 
75 0.125599D-02 0.2652820-03 
90 0.111S65D-Û2 0.3012190-03 
105 C.990U43D-03 0.: 111270-03 
120 C.S172C1D-C3 0.1898800-03 
135 0.7929450-03 C. 177C29D-03 
150 C.7104410-03 0.1458840-03 
165 0.6536780-03 0.1448340-03 
180 0.603913D-C3 0.1129250-03 
200 C.E42361D-03 0. 1131450-03 
220 C.470960D-03 0.9031860-04 
240 0.266198D-03 0. 1142530-03 
260 0.362814D-C3 0.€492840-04 
280 0.5340680-03 0.5301470-04 
300 0.292583D-C3 0.5456000-04 
330 0.252420D-03 0.4805550-04 
360 0.222526D-C3 0.4860650-04 
390 0.179233D-03 0.4512380-04 
£|20 0.158408D-C3 0.3350680-04 
450 0. 138141D-03 0.2902070-04 
480 0. 1162800-03 0.2174770-04 
iTime after injection of tracer, 
2[dpm(i4C)/(mg glucose x dose)] x 100% 
3[dpm(3H)/{mi blcod x dose)] x 100*. 
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Figure 2.81. Specific radioactivity (i*C) of blood glucose 
following a simultaneous intravenous injection 
of [U-i4C]gluco5€ and [ 1-3H ]-2-d€oxyglucose 
in experiment 80461. 
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Figure 2.82. Besiduals of curve fitted tc tlood glucose 
specific radioactivity in experiment 80461. 
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Figure 2.03. Tritium radioactivity in freeze-dried blood 
following a simultaneous intravenous injection 
o f  [ U - i 4 C ] g l u c o s e  a n d  [ ] - 2 - d e o x y g l u c o s e  in  
experiment 80461. 
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Figure 2.84. Besiduals of curve fitted to tritium-
radioactivity ij3 freeze-dried blood in 
experiment 80461. 
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Table 2.33. Blood glucose specific radioactivity following 
an intravenous injection of [6-'H]glucos€ in 
experiment M1GA. 
Time* Elood glucose specific radioactivity 
min [dEm/(mg glucose x dcse) ] x 100* 
2 C.257019E-02 
3 C.221868E-02 
4 0. 202586E-C2 
5 0.19684UE-02 
7 0. 182058E-02 
10 0.172246E-02 
15 0.14H070E-C2 
20 C.1179C9E-02 
25 0. 103424E-C2 
30 C.954347E-03 
50 C.77C713E-03 
60 0.639292E-Û3 
75 0.573924E-C3 
90 0.45W014E-03 
105 0.a02U87E-C3 
120 C.32Ç561E-03 
135 0.272299E-C3 
150 . C.258183E-C3 
167 0.198845E-C3 
180 0.185963E-03 
200 0.15e281E- C 3  
220 C.132107E-03 
240 0.1C5658E-03 
^Time after injection. 
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figure 2.85. Specific radioactivity of blood glucose 
following an intravenous injection of [6-'H] 
glucose in experiment MiGA. 
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Figure 2.86, Residuals of curve fitted tc blood glucose 
specific radioactivity in experiment M1GA. 
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Table 2.34. Tritium radioactivity in freeze-dried blood 
following an intravenous injection of 
2-deoxyglucose in experiment M2EA, 
Time» Blood 2-deoxyglucose 
min [dpm/(ml bleed x dose) ] x 100% 
2 0.166675E-02 
3 0.12571CE-02 
4 0.1l3€45E-02 
5 Û.1C7867E-02 
7 0.824401E-03 
10 0.747635E-03 
15 0.647595E-03 
20 0.493251E-03 
25 0.436516E-03 
30 C.375380E-03 
40 0.325245E-03 
50 0.2E6688E-03 
60 Û.244657E-03 
75 0.163753E-03 
90 0.151217E-03 
105 0.135586E-03 
120 0.126902E-03 
135 0.102355E-03 
150 0.100387E-05 
165 C.8684C0E-04 
180 0.927451E-C4 
200 C.627875E-04 
220 0.7e2718E-04 
240 C.64G300E-04 
270 0.679668E-04 
300 0.518724E-04 
330 0.523356E-04 
360 C.527S87E-04 
420 0.555776E-C4 
480 0.4S2C93E-04 
iTime after injection of tracer. 
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Figuce 2.87. Tritium radioactivity in freeze-dried blood 
following an intravenous injection of 
[1-3H]-2-deoxyglucose in experiment M2DA. 
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Figure 2.88. Residuals o£ curve fitted to tritium 
radioactivity in freeze-dried blood in 
experiment M2DA. 
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lable 2.35. Elood glucose specific radioactivity following 
an intravenous injection of [6-'H]glucos€ in 
experiment 7272A. * 
Timei Blood glucose specific radioactivity 
Bin [dfni/(Hig glucose x dose)] x 100% 
5 0.170758E-02 
10 0.135408E-C2 
15 C.I 185342-02 
20 0.103716E-02 
25 0.943151E-03 
30 C.872273E-C3 
40 0.747027E-03 
50 0.64q419E-03 
60 C.598947E-C3 
75 0.45ei81E-03 
91 0.3S6793E-03 
105 . 0.334220E-03 
120 0.277577E-03 
135 0.245846E-03 
150 C.2C5811E-03 
165 0.191774E-C3 
180 0.171212E-03 
200 0.1371C8E-03 
220 0.123467E-03 
240 0.114768E-03 
iTime after injection. 
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Figure 2.89 Specific radioactivity of blood glucose 
follcwing an intravenous injection of 
glucose in experiment 7272A. 
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Figure 2.90. Residuals of curve fitted to jblood glucose 
specific radioactivity in experiment 7272A, 
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Table 2.36. Blood glucose specific radioactivity following 
an intravenous injection of [6-3H]glucos€ in 
experiaent 7272B. 
Timei Elood glucose specific radioactivity 
min [dpm/(mg glucose x dose) J x 100X 
5 C.175177E-02 
10 0.141651E-02 
15 0.1243741-02 
20 0.1C6593E-02 
25 0.952C97E-03 
30 0.872009E-03 
40 0.734800E-03 
50 0.622475E-C3 
60 0.5451C6E-C3 
75 0.42e75lE-03 
90 0.37ei79E-C3 
105 0.323679E-C3 
120 0.282174E-C3 
135 C.228076E-C3 
150 0.216995E-03 
165 C.16S546E-03 
180 0.162091E-03 
200 0.136805E-03 
220 0.118168E-03 
240 0.982219E-04 
iTime after injection 
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Figure 2.91. Specific radioactivity of blood glucose 
following an intravenous injection of [6-3H] 
glucose in experiment 7272B. 
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Figure 2.92. Eesiduals of curve fitted to fclood glucose 
specific radioactivity in experiment 7272B. 
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Table 2.37, Elood glucose specific radioactivity following 
an intravenous injection of £6-'H]glucose in 
exDGriœent 7272C. 
Timei Blood glucose specific radioactivity 
min [dfin/(ing glucose x dose)] x 100% 
5 0.19C845E-02 
10 0.159094E-02 
15 C.128997E-02 
20 0.riU559E-C2 
25 C.109455E-C2 
30 0.927785E-C3 
40 C.7885a0E-03 
50 0.652787E-03 
50 C.572998E-03 
75 0.505635E-C3 
90 C.43C159E-03 
105 0.3€2796E-03 
135 0.293687E-C3 
150 0.23E133E-03 
165 0.19S728E-03 
180 0.164711E-03 
200 0,154340E-Û3 
220 0.126819E-03 
240 0.115421E-03 
iTime after injection. 
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Figure 2.93. Specific radioactivity of blood glucose 
following an intravenous injection of 
glucose in experiment 7272C. 
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Figure 2.94, Residuals of curve fitted to blood glucose 
specific radioactivity in experiment 7272C. 
Table 2.38. Iritium radioactivity in freeze-dried blood 
following an intravenous injection of [1-3H] 
2-deoxyglucose in experiment 7272D. 
Time» Blocd 2-deoxyglucose 
min [dpn/(ml blocd x dose) 
5 0.934326E-03 
10 0.676730E-03 
15 0.5C6959E-03 
20 0 . 4 2 t i e i 8 E - 0 3  
25 C . 3 8 C 9 0 5 E - 0 3  
30 0 .  3  1 6 9 9 6 E - 0 3  
40 0.221133E-03 
50 0. 1944721-03 
6 0  0. 15938CE-03 
75 0. 119192E-03 
9 0  0.1C2725E-03 
105 0.835130E-04 
120 C . 7 5 0 8 3 3 E - 0 4  
135 0.515585E-04 
150 0.511664E-04 
165 0.49402 1E-04 
180 C . 4 4 3 0 5 0 E - 0 4  
200 0.36e555E-04 
220 0.2S7981E-04 
240 0.311703E-04 
iTime after injection of tracer. 
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Figure 2.95. Tritium radioactivity in freeze-dried blood 
following an intravenous injection of 
[1-3H ]-2-deoxyglucose in experiment 7272D. 
298 
§ 
t\î 
m (O 
O-*" 
O (D 
a 
o 
Œ 
ZDO 
D«D 
^d. 
en I 
LU 
OC 
Q (o 
§ 
"y-
X 
* 
X 
n 
X 
1 1 1 1 1 
0.00 5.00 10.00 15.00 20.00 
TIME (MINUTES) (%io' ) 
Figure 2.96. Residuals of curve fitted to tritium 
radioactivity in freeze-dried blood in 
experiment 7272D. 
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Table 2.39, Iritium radioactivity in freeze-dried blood 
following an intravenous injection of 
2-deoxyglucose in experiment 7272E. 
Time! Blocd 2-deoxyglucose 
sin [dpm/(ml bleed x dose) ] x 100% 
5 0.8699542-03 
10 0.626222E-03 
15 0.4S7771E-03 
20 0.3819175-03 
25 0.338C19E-03 
30 0.330384E-03 
UO 0.226173E-03 
50 0.160516E-03 
60 0.136849E-03 
75 0.115281E-03 
90 0.1C8410E-03 
105 0.69C925E-Oy 
120 0.54396GE-04 
135 0.511512E-04 
150 0.471U32E-0U 
165 0.395087E-04 
180 0.383635E-04 
200 0.2S3929E-C4 
221 0.3C9198E-04 
240 -- 0.244305E-04 
iTime after injection of tracer. 
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Figure 2.97, Tcitiam radioactivity in fceeze-dcied blood 
following an intravenous injection of 
[1-3H]-2-deoxyglucose in exfeciment 7272E. 
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Figure 2.98. Residuals of curve fitted to tritium 
radioactivity in freeze-dried blood in 
experiment 1272E. 
Table 2.40. Curve parameters of 
exponential curved. 
Exptz Tracers Sample* A1 
181 A 0 blood .00227638 
181A 6 blood .00238451 
181A 0 plasma .00186714 
181A 6 plasma .00165444 
181B 0 blood .00210492 
181B 6. blood .00196035 
181B D plasma .00241776 
181 B 6 plasma .00205892 
181C 0 blood .00248029 
181C 6 blood .00216268 
181C 0 plasma .00200233 
181C 6 plasma .00232887 
181D 0 blood .00186988 
181D 2 blood .00300672 
181D U plasma .00186387 
181D 2 plasma .00148196 
181E U blood .00230896 
181E D blood .00159712 
181E U plasma .00225884 
181E D plasma .00270326 
8046F 0 blood .00220057 
8046E 6 blood .00163438 
8046F U plasma .00633072 
8046F 6 plasma .00346593 
8046G 0 blood .00150762 
8046G 6 blood .00141850 
8046H 0 blood .00204304 
8046H 6 blood .00204293 
8046H 0 plasma .00224685 
a least-squares fit of data to a three-component 
K1 A2 K2 A3 K3 
31366402 
32981232 
22714640 
28873509 
18526104 
18633980 
22873597 
22139764 
27863528 
21673671 
30100687 
25350587 
20158830 
77165295 
33505712 
32963335 
20281340 
13760139 
35639409 
15071420 
15514801 
24278202 
94750724 
24992818 
18079394 
16180610 
20101324 
23414736 
20815761 
.00136203 
.00120891 
.00150795 
.00144924 
.00099888 
.00086913 
.00134596 
.00114477 
.00117635 
.00135049 
.00170C77 
.00119326 
.00128251 
.00177978 
.00119672 
.00139644 
.00147708 
.00091837 
.00151811 
.00190307 
.00104306 
.00146602 
,00240793 
.00125892 
.00125818 
.00108616 
.00165357 
.00182495 
.00190332 
.03588350 
.03115822 
.03479798 
.03810985 
.02740286 
.02967378 
.02505163 
.03281285 
.02640248 
.01906386 
.03692664 
.03794073 
.02122967 
.05761217 
.03405661 
.04014179 
.02055165 
.01625007 
.04638615 
.01950564 
.03314383 
.04487137 
.07783027 
.04301188 
.01809675 
.02096270 
.01564418 
.01445183 
.01630046 
.00193451 
.00178127 
.001E7358 
.00177828 
.00166536 
.00175082 
.00162129 
.00184489 
.00149126 
.00121142 
.00148317 
.00169721 
.00133836 
.00207215 
.00180303 
.00177222 
.00134276 
.00012718 
.00188585 
.00030903 
.00189290 
.00167298 
.00211170 
.00186104 
.00109407 
.00111738 
.00072232 
.00050228 
.00081851 
.00642711 
.00673538 
.00636355 
.00681611 
.00693530 
.00768764 
.00665206 
.00773840 
.00594783 
.00570422 
.00584841 
.00677892 
.00590420 
.00757302 
.00700955 
.00742503 
.00557546 
.00252870 
.00685957 
.00350260 
.00601516 
.00664884 
.00646853 
.00657732 
.00520035 
.00556860 
.00534094 
.00526353 
.00547976 
8046H 6 plasma .00208424 .21070290 .00147888 .01881376 .00108206 .00705744 
80461 0 blood .00895880 .67452065 .00137398 .01938150 .00139220 .00517217 
80461 D blood .00162000 .13960000 .00085285 .01840000 .00018400 .00387400 
80461 U plasma .00223939 . 18984866 .00116722 .02648805 .00160773 .00581325 
80461 D plasma .00251446 .18828435 .00222733 .02803101 .00064226 .00594451 
7948G 0 plasma .09282116 .2214 3740 .05380653 .02571540 .04398789 .00712237 
114A 6 blood .00159055 .10309876 .00070307 .01670860 .00082417 .00465963 
114B 6 blood .00083859 .11850842 .00118447 .03672469 .00106428 .00547547 
114C U blood .00139453 .17265571 .00115685 .02999926 .00115759 .00504325 
114E 5 blood .00120880 .12966392 .00106763 .02217799 .00099106 .00512782 
114F 2 blood .00138856 .23284281 .00139908 .02492640 .00082072 .00529137 
114G D blood .00142340 .09949913 .00092825 .01931893 .00103678 .00498189 
7424A 6 blood .00143780 .15246787 .00097451 .02011119 .00108523 .00499030 
7424B 6 blood .00172873 .54395803 .00149552 .03821141 .00117927 .00600836 
7424C U blood .00136114 .13130553 .00083563 .02424127 .00124581 .00437335 
7424E 5 blood .00091946 .12755597 .00105477 .01987378 .00101053 .00469628 
7424F 2 blood .00161150 .11826989 .00085410 .01853494 .00108722 .00543382 
7424G a blood .00124730 .10706221 .00085405 .01994372 .00115262 .00437687 
7272A 6 blood .00081524 .19719921 .00101829 .03008532 .00054529 .00648915 
7272B 6 blood .00072168 . 14606478 .00091245 .03222990 .00065059 .00780761 
7272C 6 blood .00119377 .15415676 .00087166 .02665336 .00066742 .00731916 
7272D D blood .00098998 .37619500 .00075126 .05540704 .00022573 .00932896 
7272E D blood .00099346 . 38837357 .00071084 .05162285 .00018764 .00897450 
M1GA 6 blood .00142009 . 22595640 .00083265 .03025893 .00085888 .00850905 
H2DA D blood .00201494 .57168855 .00085115 .04892529 .00022785 .00476968 
iY(t)=A1*exp(-Kl*t) + A2*exp (-K2*t) + A3»exp (-K3*t) ; where t=tim€ (minutes) 
after injection of tracer and Y=concentration of tracer at time=t. 
^Experiment identification. 
3D=[ 1-3H ]-2-deoxyglucose; U=[ 0-*^ *C ]glucose; 2=[2-3H]glucose; 5=[5-3H]glucose; 
and 6=[6-3H]glucose. 
•Tracer concentration measured in blood or plasma. 
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C  X H A T = P R E D I C T E D  X - V A L U E  F R O M  A  G I V E N  Y - V A L U E  
C  P E R R = X I N T / X H A T  
C  P X I N T = A B S O L U T E  V A L U E  O F  X I N T  ( N E C E S S A R Y  F O R  C U R V E S  W I T H  
C  N E G A T I V E  S L O P E S )  
C  X B A 8 = A V E R A G E  O F  T H E  X - V A L U E S  
C  N = N U M B E B  O F  P O I N T S  I N  T H E  S T A N D A R D  C U R V E  
C  T = T - V A L U E  F O R  N - 2  D E G R E E S  O F  F R E E D O M  
C  S I G X ^ C O R E E C T E D  S U M  O F  S Q U A R E S  O F  T E E  X - V A L U E S  
C  M = N U M B E R  O F  I N D E P E N D E N T  M E A S U R E M E N T S  T O  B E  M A D E  
C  O N  Y  I N  A P P L I C A T I C N  O F  T H E  A S S A Y  
C  G L A B = C H A R A C T E B  V A R I A B L E  U S E D  1 0  L A B E L  P L O T S  
C  
c*********************************************************** 
c 
c  
I M P L I C I T  R E A L * 8  ( A - H ,  C - Z )  
C H A H A C T E R * 2 0  G L A B ( 1 8 )  
D I M E N S I O N  B ( 1 8 ) ,  Y E A R ( 1 8 ) ,  S B ( 1 8 ) ,  S Y X ( 1 8 ) ,  Y M A X ( 1 8 )  
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Table 4, Continued. 
D I M E N S I O N  Y  ( 5 0 ) ,  S X H A T  ( 5 0 ) ,  X I  ( 5 0 ) ,  X 2  ( 5 0 ) ,  X L  ( 5 0 ) ,  
1  X I N T  ( 5 0 ) ,  X H A T ( 5 0 ) ,  P E R B ( 5 0 ) ,  P X I N T ( 5 0 ) ,  E M S  ( 1 8 ) ,  
2  X U ( 5 0 )  
C  
E f A D ,  X B A R ,  T ,  S I G X ,  N ,  M  
P R I N T ,  • « = • ,  M  
C  
1 = 1 
1 0 0  R E A D  ( 5 ,  1 )  G L A f l  ( I )  
1  F O R M A T  ( A 2 0 )  
I F  ( G L A B ( I )  . E Q .  ' S T O P  • )  G O  T O  5 0 0 0  
C  
R E A D , B  ( I ) ,  Y E A R  ( I ) ,  S B  ( I ) ,  E M S ( I ) ,  Y M A X ( I )  
S Y X  ( I )  = D S Q E T  ( E M S  ( I )  )  
C S Q = ( T * * 2 * S B  ( I ) * * 2 ) / B ( I ) * * 2  
F A C 1  =  ( T * S Y X  ( I )  )  / B  ( I )  
F A C 2 =  (  ( N +  ( 1 / M )  )  / N )  f  ( 1 - C S Q )  
F A C 3 = 1 - C S Q  
R I N C = . 0 2 * Y M A X ( I )  
C  
W R I T E  ( 6 , 2 )  G I A B ( I )  
2  F O R M A T ( ' 1 ' ,  A 2 0 / '  ' ,  1 2 X ,  ' Y ' ,  1 3 X ,  ' X L ' ,  1 3 X ,  ' X U ' ,  
1  1 1 X ,  ' X I N T ' ,  1 1 X ,  ' X H A T ' ,  1 1 X ,  ' P E E R ' )  
C  
D O  1 5 0  K = 1 , 5 0  
Y  ( K ) = K * R I N C  
S X H A T  ( K )  =  ( Y  ( K )  - Y B A E  ( I )  )  / B  ( I )  
X I  ( K )  =  ( S X H A T ( K ) + F A C l * D S Q f i T ( F A C 2 + ( S X H A T ( K ) » * 2 / S I G X ) ) ) /  
1  F A C 3  
X 2  ( K )  =  ( S X H A T  ( K )  - F A C 1 * D S Q R T  ( P A C 2 +  ( S X H A T  ( K )  * * 2 / S I G X )  )  ) /  
1  F A C 3  
X U ( K ) = X B A R + X 1 ( K )  
X L ( K ) = X E A R  +  X 2  ( K )  
X I N T  ( K )  = X U  ( K ) - X I  ( K )  
X H A T  ( K ) = X B A S  +  S X H A T  ( K )  
P E B R  ( K )  = X I N T  ( K )  / X H A T ( K )  
P X I N T  ( K )  = C A B S  ( X I N T  ( K )  )  
C  
W R I T E  ( 6 , 3 )  Y  ( K )  ,  X L ( K ) ,  X U ( K ) ,  X I N T ( K ) ,  X H A T ( K ) ,  
1  P E R R ( K )  
3  F O R M A T ( '  ' ,  6 ( 0 1 3 . 6 ,  2 X ) )  
W R I T E  ( 7 , 4 )  Y ( K ) ,  X I N T ( K ) ,  G L A B ( I )  
4  F O R M A T ( 2 ( 0 1 3 . 6 ,  2 X )  ,  A 2 0 )  
1 5 0  C O N T I N U E  
C 
C A L L  G R A P H ( - 5 0 ,  Y ,  P X I N T ,  0 ,  4 ,  5 . 0 , 7 . 0 ,  0 . 0 ,  0 . 0 ,  
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Table U. Continued. 
1  0 . 0 ,  0 . 0 ,  
2  ' Y - V A L U E ; ' ,  • X - I N T E R V A L  ; • ,  G L A E ( I ) ,  
3  ' L I N E A R  C A L I B R A T I O N ; ' )  
C  
C  
C A L L  G R A P H ( - 5 0 ,  Y ,  X U ,  0 ,  1 0 4 ,  5 . ,  7 . ,  0 . 0 ,  0 . 0 ,  
1  0 . 0 ,  0 . 0 ,  
2  ' Y - V A L U E ; ' ,  • X - I N T E R V A L ; • ,  G L A E ( I ) ,  
3  ' L I N E A R  C A L I E B A T I C N ; ' )  
C A L L  G R A P H S ( - 5 0 ,  Y ,  X L ,  0 ,  1 0 4 ,  ' ; ' )  
C A L L  G R A P H S ( - 5 0 ,  Y ,  X H A T ,  1 1 ,  7 ,  ' ; ' )  
C  
1 = 1 + 1 
G O  T O  1 0 0  
C  
5 0 0 0  S T O P  
E N D  
S E N T R Y  
6 3 . 2 2 3  2 . 2 6 2  1 7 5 8 7 . 3 9 9 4 3  1 1  1  
C 0 2  S T A N D A R C  C U R V E  
- 2 . 0 0 9 7 0 0 2 3  1 6 9 . 1 1 8 1 9 1 9 2  . 0 1 8 8 7 2 4 5  6 . 2 6 4 0 8 9 8 1  3 0 0  
S T O P  
$ S T O P  
/ / G O . F T 1 4 F 0 0 1  D D  D S N A M E = 5 S M , U N I l = S C R T C H , D I S P = ( N E W , P A S S ) ,  
/ /  S F A C E =  ( 8 0 0 ,  ( 1 2 0 ,  1 5 ) ) ,  
/ /  C C B = ( R E C F M = V B S , L R E C L = 7 9 6 , B L K S I Z E = 8 0 0 )  
/ / S M E L T T R  E X E C  E L O T , P L C T T E B = P R I N T E B  
/ / S M F L T T R  E X E C  P L O T , P L C T T E R = I N C R M N T L , F O R M = W  
( 0 9 ) a V S N T  M 0 9 ) D N O D  '  ( 0 9 )  W d Q  ' ( 0 9 )10Hn M 0 9 ) W d 3  I  
M09)H '(09) UNO M09)dVS '(09)VS ' (09) SWU N0ISN3Wia 
dVSNl 'HHOM 8*lV3a 
( 2 - 0  ' H - ¥ )  8 * T V a 8  I I D I l d W I  
( v i v a  ' M  ' N  ' 3 s o a  ' i d x a )  Z Q D i a  3 N i & n o a g n s  
***********************************************************3 
3 
Z 0 0 1 Q  3 N n n o a g n s  3  
3 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 3  
QN3 
a o i s  Z 0 5  
0 0 5  0 1  0 5  
1 + 1 = 1  L O S  
((I) viva 'N 'idxa) 
No i i v i i N i v n S  vJAi ' 3 a '  (i)viva) a i  
( ( I ) v i v a  ' I  ' N  ' a s o a  ' l e x a )  
( VA A T1V3 
J08d3 TIV3 ( 
30198 nV3 ( 
Z 0 3 X a  T1V3 ( 
2038 T1V3 ( 
20310 11V3 ( 
ZOS 01 09 ( 
aivNoiaoad NawnHi 
( (I) viva 'I 
3203319 VWSVldi 
((I)viva *i 
203 asaidxai 
((I) VIVO 'I 
203 Nawna• 
((I) VIVO 'I 
203 00019• 
dOlS , 
N  
' 0 3 '  ( I )  v i v a )  3 1  
' N  ' a s o a  ' i d x a )  
' 0 3 '  ( I ) V I V 3 )  3 1  
'N 'asoa 'idxa) 
*0a' (i)viva) 31 
'N 'asoa 'idxa) 
'Oa' (i)viva) £i 
'N 'asoG 'idxa) 
•03 '  ( l )V IVa)  31 
'Oa' (i)viva) 31 
(ri'02v)ivwaoa 
'(I) viva (L's)av3ff 
1=1 
i 
o o s  
( 0'213 ' 0 2 V ) l V W a 0 3  2  
a s o a  ' 1 3 X 3  ( 2 ' s ) a v 3 a  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 3  
3 
(asoa 30 iN33aad sv aassaaaxa d loww/wda) 3 
'3S03ni9 VWSVld ONV '3IVNDId083. N3MfiS '203 OaaidXa 3 
'203 Nawna '203 aooie 30 AIIAIIOV 3i3iDaas aivin3iv3 01 wvasoad 3 
3 
***********************************************************3 
l a x a  ' ( 6 ) V 1 V ]  0 2 * a 3 I 3 V 3 V H 3  
(z-o'H-v) g*ivaa ii3ndWT 
5 = 3 w i i ' g i = s a D V d ' a H 8  a o p î  
*  a a  N i s x s ' 0 9 / /  
• a i e n o a I = a ' A i £ i v H  3 a x a  l a a i s / /  
"msTToqegam 50 
soT^euTx ÉUTxspoQi j o j  Aiessaosu sazsTAt^oeoTpea 
OTjTOsds o:^ luçjèojd 3e:>ndai03 ' g ayqei 
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Table 5. Continued. 
C H A E A C T E B * 2 0  E X E T ,  D A T A  
R E A C  ,  N O R M ,  B I K ,  B K G  
W R I T E ( 6 , 1 )  E X P T ,  B I K ,  N O B M ,  B K G  
1  F O f l M A T ( • 1 * , A 2 Û / ' B L 0 0 D  C 0 2  C A T A ' ,  5 X ,  
1 ' T I T R A T I O N  E 1 A & K = ' ,  F 4 . 0 ,  
2  »  U N I T S  H C L » ,  5 X ,  ' N O R M A L I T Y  H C L = ' ,  F 7 . 5 ,  5 X ,  
3  ' B A C K G R O U N D : ' ,  F 4 . 0 ,  '  D P M ' / )  
W R I T E  ( 6 , 2 )  
2  F O R M A T ( ' 0 ' ,  ' T I M E  U N I T S  U K O L  H #  C P M '  
1  9 X ,  ' D f M / M M C I '  6 X ,  ' 1 5 5  D P M / M M O L  L N  %  D P M / M M O L '  
2  ,  2 X ,  ' U M O L / M L ' / )  
C 
C O  1 0 0  1 = 1 , N  
R E A D ,  I I M E ( I ) ,  U N I T  ( I )  ,  H ( I ) ,  C P M ( I )  
U M O L  ( 1 )  =  ( (  ( B L K - U N I T  ( I )  )  / 1 6 0 C )  * N G R M )  * 1 0 0 0  
D P M  ( I )  =  ( C P M  ( I )  /  ( 1 - 0 . 0 5 3 7 1 4 3  9 8 + 0  . 0 0 0 0 1 6 1 6 1 * H  ( I )  -
1  0 .  0 0 0 0 0 5 0 3 * H  ( I ) * * 2 )  ) - B K G  
S A  ( I )  =  ( D P M  ( I )  / U M C L  ( I )  )  * 1 0 0 0  
S A P  ( I ) =  ( S A  ( I )  / D G S E )  * 1 0 0  
L N S A P  ( I )  = D L O G  ( S A P ( I )  )  
C O N C ( I )  = U M C L ( I ) / 3  
W R I T E  ( 6 , 3 )  T I M E ( I ) ,  U N I T  ( I )  ,  U M O L  ( I )  ,  H ( I ) ,  C P M  ( I )  ,  
1  S A ( I ) ,  S A P ( I ) ,  L N S A P  ( I ) ,  C C N C ( I )  
3  F O R M A T ( '  ' ,  F 4 . 0 ,  2 X ,  F 4 . 0 ,  2 X ,  F 5 . 1 ,  2 X ,  F 4 . 0 ,  2 X ,  
1  F 9 . 2 ,  2 X ,  3 ( E 1 3 . 6 ,  2 X )  ,  F 7 . 3 )  
W R I T E  ( 7 , 1 6 )  E X P T ,  D A T A ,  T I M E ( I ) ,  S A P ( I )  
1 6  F O R M A T ( 2 A 2 0 ,  E 5 . 1 ,  2 X ,  D 1 3 . 6 )  
1 0 0  C O N T I N U E  
C  
C A L L  A P I O T  ( N ,  K ,  T I M E ,  L N S A P ,  E X P T ,  D A T A )  
R E T U R N  
E N D  
C * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
C  
C  S U B R O U T I N E  R C C 2  
C  
C * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
S U B R O U T I N E  R C 0 2  ( E X P T ,  D O S E ,  N ,  K ,  C A T A )  
I M P L I C I T  B E A L * e  ( A - H ,  O - Z )  
R E A L * 8  N O R M ,  I N S A P  
D I M E N S I O N  T I M E  ( 6 0 ) ,  S A  ( 6 0 )  ,  S A P  ( 6 0 )  ,  U N I T  ( 6 0 )  ,  H  ( 6 0 ) ,  
1  C P M  ( 6 0 ) ,  U M C L  ( 6 0 ) ,  D P M  ( 6 0 ) ,  L O N G  ( 6 0 ) ,  L N S A P  ( 6 0 )  
C H A R A C T E R * 2 0  E X P T ,  D A T A  
C 
R E A C ,  N O R M ,  E L K ,  B K G  
W R I T E ( 6 , 1 )  E X P T ,  B I K ,  N O B M ,  B K G  
(09) 3V8a ' (09) 9SVS5 t? 
M09)VSVDJ '(09)svoa M09)wnDNl '(09) TOWNS M09)SVD E 
' ( 0 9 ) w n D  M 0 9 ) a i V H  M 0 9 ) d V S N T  '  (0 9 )  D N D D  ' ( 0 9 ) W d a  Z  
'(09)Wd3 '(09)e3HIl M09)V3WII '(09)9SV0 '(09)VSV5 I 
M09)H '(09)lINn '{09)dVS ' (09) ¥S M09)3HI1 NOISNIWIQ 
Vi?a 'idXi 03*a3IDVa¥HD 
WnONl 'dVSNl 'W80N 8*lV3a 
(z-0 'H-v) 8»ivaa 
(ViV3 'N 'îsoa 'idXïï) 203X3 3^11008805 
******************** ******************** ************* ******3 
3 
z o D x a  3 N r i n o a g n s  o  
3  
***********************************************************3 
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Table 5. Continued, 
C  
C 
c  
C  N O R M = N O £ M A 1 I T Y  C Î  A C I D  U S E D  I N  T I T B A I I O N  
C  B L K = U N I Ï S  O F  A C I D  B E Q U I B E D  T O  T I T R A T E  B L A N K S  
C  B K G = E A C K G E C U t i D  C E M  
C  G A S A = A L I Q U O T I N G  G A S  M E T E R  H E A D I N G  A T  S T A H T  O F  C O L L E C T I N G  
C  I N T E R V A L  
C  G A S B = A L I Q U O T I N G  G A S  M E T E R  R E A D I N G  A T  E N D  O F  C O L L E C T I N G  
C  I N T E R V A L  
C  G A S = V O L U M E  O F  G A S  E X P I R E D  T H R U  A L I Q U C T I N G  M E T E R  
C  F G A S A = T E A P  G A S  M E T E R  R E A D I N G  A T  S T A R T  C F  C O L L E C T I N G  
C  I N T E R V A L  
C  F G A S B = T R A P  G A S  M E T E R  R E A D I N G  A T  E N D  O F  C O L L E C T I N G  
C  I N T E R V A L  
C  F G A S = V C L U M E  O F  C C 2 - F R E E  G A S  L E A V I N G  T H E  T R A P  
C  C A L G A S = f A C T O R  T O  P O T  B O T H  G A S  M E T E R S  C N  T H E  S A M E  S C A L E  
C  V C I = V O L U M E  O F  E A ( C H ) 2  I N  C C 2  T B A P  
C  T I M E A = T I M E  A T  S T A R T  O F  C O L L E C T I N G  I N T E R V A L  
C  T I M E B = T I M E  A T  E N D  C F  C O L L E C T I N G  I N T E R V A L  
C  T I M E = T I M E  A T  M I D P O I N T  O F  C O L L E C T I N G  I N T E R V A L  
C  U N I T = U N I T S  O F  A C I D  B E C O I R E D  T O  T I T R A T E  S A M P L E  
C  R M M O L = M M O L  O F  C O 2  E X P I R E D  D U R I N G  C O L L E C T I O N  I N T E R V A L  
C  C O N C = C O N C E N T R A T I C N  O F  C 0 2  I N  E X P I R E D  A I R  
C  R A T E = A V E R A G E  R A T E  O F  C 0 2  E X P I R A T I O N  D U R I N G  I N T E R V A L  
C  D E M = C P M  C O 2  E X P I R E D  D U R I N G  I N T E R V A L  
C  S A P = E P M / M M C L  C A R B O N  E X P R E S S E D  A S  P E R C E N T  O F  D O S E  
C  C U M = R A T E  O F  1 4 C C 2  E X P I R E D  A S  P E R C E N T  O F  E O S E  
C  •  
C  
C  
R E A D ,  N O R M ,  E L K ,  B K G ,  G A S A ( 1 ) ,  F G A S A ( I ) ,  C A L G A S ,  V O L  
W R I T E ( 6 , 1 )  E X P T ,  B L K ,  N O R M ,  B K G  
1  F 0 R M A T ( ' 1 ' ,  A 2 0 / ' E X F I R E E  C 0 2  D A T A " ,  5 X ,  
1  ' T I T R A T I O N  E L A & K = ' ,  F 4 . 0 ,  
2  •  U N I T S  H C L ' ,  5 X ,  ' N O R M A L I T Y  H C I = ' ,  F 7 . 5 ,  5 X ,  
3  ' B A C K G B O U N D = ' ,  F 4 . 0 ,  '  D P M ' / )  
C  
W R I T E  ( 6  , 2 )  
2  F O R M A T ( ' 0 ' ,  2 X ,  ' T I M E ' ,  5 X ,  ' E X P I R E D  A I R  ( L ) ' ,  3 X ,  
1  ' H # ' ,  5 X ,  ' C E M ' ,  3 X ,  ' U N I T S ' ,  2 X ,  ' M M O L  C 0 2 / L  A I R ' ,  
2  2 X ,  ' M M O L  C C 2 / M I N ' ,  2 X ,  ' 1 4 C 0 2  E X P I R E D / M I N • ,  2 X ,  
3  ' G A S  A L I Q U O T  ( F T 3 )  •  ,  2 X ,  ' F R A C T I O N ' / )  
C 
î 
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Table 5. Continued. 
D O  1 0 0  1 = 1 , N  .  
R E A D ,  T I M E A ( I ) ,  T I M E B ( I ) ,  G A S B ( I ) ,  U N I T  ( I ) ,  H  ( I ) ,  
1  C P M  ( I )  ,  F G A S B  ( I )  
T I M E  ( I )  =  ( T I M E S  ( I )  t l l M E A  ( I )  ) / 2  
I F  ( I  . E Q .  1 )  G O  T O  1 0 1  
G A S A ( I )  = G A S B ( I - 1 )  
F G A S A  ( I ) ^ F G A S B  ( 1 - 1 )  
1 0 1  G A S  ( I )  = G A S B  ( I )  - G A S A  ( I )  
E H M O L ( I ) =  (  ( B I K - U N t T  ( I )  )  / 1 6 0 C )  * N O B M  
F G A S  ( I )  =  (  ( F G A S B  ( I )  - F G A S A  ( I )  )  » C A L G A S * 2 8 .  3  1 7 )  +  
1  ( R M M O l  ( I )  * 0 . 0 2 4 4 5 )  
F B A C  ( I )  = F G A S  ( I )  / G A S  ( I )  
B M H O L  ( I )  =  ( B M M O L  ( I )  / F B A C  ( I )  )  • V O L  
D E M  ( ! ) = ( (  ( C E  M  ( I ) / ( 1 - 0 .  0  5 3 7  1 4  3 9 8  +  0 .  0 0 0 0 1 6 1 6 1 » H  ( I ) -
1  0 .  0 0 0 0 0 5 0 3 « H  ( I ) * * 2 ) ) - B K G ) / F R A C  ( I )  )  
H A T E  ( I )  = B M M C I  ( I ) / ( T I M E B ( I )  -  T I M E A  ( I )  )  
S A  ( I )  = D E H  ( I ) / a H M C l  ( I )  
S A P ( I ) = ( S A ( I ) / D O S E ) * 1 0 0  
L N S A P ( I )  = D L O G  ( S A P ( I )  )  
C O N C ( I ) = R M M C I  ( I ) / G A S ( I )  
C U M  ( I )  = B A T E  ( I )  * S A P  ( I )  
L N C U M  ( I )  = D L O G  ( C U M ( I )  )  
W R I T E ( 6 , 3 )  T I M E A ( I ) ,  T I M E B ( I ) ,  G A S A  ( I ) ,  G A S B ( I ) ,  H  ( I ) ,  
1  C P M  ( I ) ,  U N I T  ( I ) ,  C C N C ( I ) ,  B A T E  ( I ) ,  C U M  ( I ) ,  
2  F G A S ( I ) ,  F B A C  ( I )  
3  F O R M A T  ( '  %  F 4 . 0 ,  I X ,  F 4 . 0 ,  2 X ,  F 7 . 0 ,  1 X ,  F 7 . 0 ,  2 X ,  
1  F 4 . 0 ,  2 X ,  F 7 . 0 ,  2 X ,  F 4 . 0 ,  3 ( 2 X ,  E 1 3 . 6 ) , 2 X ,  F 6 . 3 ,  
2  1 3 X ,  F 5 . 4 )  
W R I T E ( 7 , 1 6 )  E X P T ,  D A T A ,  T I M E  ( I ) ,  S A P  ( I ) ,  C U M  ( I )  
1 6  F O R M A T < 2 A 2 0 ,  F 5 . 1 ,  2 X ,  D 1 3 . 6 ,  2 X ,  D 1 3 . 6 )  
1 0 0  C O N T I N U E  
C  
W B I T E  ( 6 , 4 )  
4  F 0 B M A T ( ' 1 ' ,  ' T I M E  E P M / M M O L  %  D P M / M M O L '  
1  ,  4 X ,  ' L N  %  D J E M / M M C L V )  
C  
C O  2 0 0  1 = 1 , N  
W B I T E  ( 6 , 5 )  T I M E  ( I ) ,  S A  ( I ) ,  S A P ( I ) ,  L N S A P ( I )  
5  F O B M A T C  » ,  F 4 . 0 ,  3  ( 2 X ,  E 1 3 . 6 ) )  
2 0 0  C O N T I N U E  
C  
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Table 5. Continued. 
C*********************************************************** 
C  
C  S U B R O U T I N E  V F A  
C  
C*********************************************************** 
C  
S U B R O U T I N E  V F A  ( E X P T ,  N ,  D A T A )  
I M P L I C I T  E E A E + 8  ( A - H ,  0 - Z )  
C H A R A C T E R * 2 0  E X E T ,  D A T A  
D I M E N S I O N  T I M E  ( 6 0 ) ,  H  ( 6 0 ) ,  C H 1  ( 6 0 )  ,  C H 2 ( 6 0 ) ,  A H T ( 6 0 ) ,  
1  E H T  ( 6 0 )  , B H T  ( 6 0 )  ,  H D P W ( 6 0 ) ,  C D P M ( 6 0 ) ,  F R A C  ( 6 0 )  ,  A  ( 6 0 )  ,  
2  P ( 6 0 ) ,  B ( 6 0 ) ,  T O T  ( 6 0 ) ,  A M  ( 6 0 )  ,  F M  ( 6 0 ) ,  B M  ( 6 0 )  
C  
C  
c 
c  S D O S E = D E M  C F  T R I T A T E D  A C E T A T E  A D D E D  T O  T H E  S A M P L E  
C  V C 1 = V O L U M E  O F  R U M E N  F L U I D  S A M P L E  A N A L Ï Z E E  
C  B K G 1 = E A C K G E C U N D  C E M  I N  C H A N N E L  1  
C  B K G 2 = B A C K G E 0 U N C  C E «  I N  C H A N N E L  2  
C  H = H #  F R O M  C O U N T I N G  P R O G R A M  
C  C H 1 = C P M  I N  C H A N N E L  1  F R O M  A C E T A T E  P E A K  
C  C H 2 = C P M  I N  C H A N N E L  2  F R O M  A C E T A T E  P E A K  
C  A C S ^ S L O P E  C F  A C E T A T E  S T A N D A R D  C U R V E  
C  A C I = I N T E R C E P T  O F  A C E T A T E  S T A N D A R D  C U R V E  
C  P S G P I = P % O P I C N A T E  S T A N D  C U R V E  
C  B S S B I - B U T Y R A T E  S T A N D A R D  C U R V E  
C  A H T = A C E T A T E  P E A K  H T  
C  P H T = P R O P I C N A T E  P E A K  H T  
C  B H I = B O T Y R A T E  P E A K  H T .  
C  
c 
c 
c 
R E A D ,  S E O S E ,  A C S ,  A C I ,  P S ,  P I ,  E S ,  B I ,  V O L ,  B K G l ,  b K G 2  
W R I T E ( 6 , 1 )  E X P T  
1  F O R M A T ( ' 1 ' ,  A 2 0 ,  ' R U M E N  V F A  D A T A ' / ' O ' ,  2 3 X ,  ' A C E T A T E ' ,  
1  2 6 X ,  ' P B O P I C N A T E ' ,  1 U X ,  ' B D T Y R A T E » / '  » ,  7 X , '  •  
2 ,  «  ' ,  4 X , '  '  
3 ,  '  ' , 4 X ,  '  '  )  
W R I T E  ( 6 , 3 )  
3  F O R M A T ( '  ' , * T I M E ,  4 X , ' H #  
1 ' ,  4 X ,  ' C H I ' ,  4 X ,  • C H 2 ' ,  4 X ,  ' H T ' ,  3 X ,  ' M M C L A B ' ,  2 X ,  
2 ' M 0 L A R % ' , 5 X , ' H T ' , 3 X , ' M O L A R ' , 2 X , ' M O L A R * ' , 5 X ,  ' H T ' ,  3 X ,  
3  ' M M O L A E ' ,  2 X ,  ' M O L A R % ' ,  5 X ,  ' H T ' ,  2 X ,  ' K M C L A R ' ,  
4  • 4 X ,  ' R E C O V E R Y ' / )  
C 
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Table 5. Continued. 
D O  1 0 0  1 = 1 , N  
R E A D ,  T I M E  ( I ) ,  H  ( I ) ,  C H I  ( I ) ,  C H 2  ( I )  ,  A H T ( I ) ,  P H T ( I ) ,  
1  B H T ( I )  
C H I  ( I ) = C H 1  ( I ) - E K G I  
C H 2  ( I )  = C H 2  ( I )  - E K G 2  
C 
CALL CULCNI(H(I), CHl (I) , CH2(I), HDPM(I), CDPM(I)) 
C 
F R A C  ( I )  = H D P M ( I ) / S D C S E  
A  ( I )  =  (  (  ( A H T  ( I ) - A C I )  / A C S )  / F R A C  ( I )  )  /  V O L  
P  ( I )  =  (  (  ( P H I  ( I ) - P I ) / P S ) / F R A C  ( I )  )  /  V C L  
B  ( ! )  =  ( (  ( B H T  ( I ) - B I ) / B S / F E A C ( I )  )  /  V O L  
T O T  ( I )  = A  ( I )  * P  ( I )  f B  ( I )  
A H  ( I )  = A  ( I ) / T C T  ( I )  
P M  ( I )  = P  ( I )  / I C T  ( I )  
E M  ( I )  = B  ( I ) / T C T  ( I )  
W R I T E  ( 6 , 2 )  T I M E  ( I ) ,  H  ( I ) ,  C H I  ( I ) ,  C H 2  ( I )  ,  A H T ( I ) ,  
1 A ( I ) ,  A M  ( I ) ,  P H T ( I ) ,  P ( I ) ,  E M  ( I ) ,  B H T  ( I ) ,  B  ( I )  ,  B M  ( I )  ,  
2  F R A C  ( I )  ,  C D P M  ( I )  
2  F O R M A T ( '  • ,  F 4 . 0 ,  3 X ,  F 4 . 0 ,  2 X ,  F 5 . 0 ,  I X ,  F 5 . 0 ,  2 X ,  
1  F 5 . 1 , 2 X , F 5 . 1 ,  2 X ,  F 5 . 2 ,  5 X ,  F 5 . 1 ,  2 X ,  F 5 . 1 ,  2 X ,  F 5 . 2 ,  
2  5 X ,  F 5 . 1 ,  2 X ,  F 5 . 1 ,  z X ,  F 5 . 2 ,  6 X ,  F 6 . 3 ,  a x ,  F 5 . 0 )  
1 0 0  C O N T I N U E  
C  
R E T U R N  
E N D  
C 
c 
c 
S U B R O U T I N E  C U L C N T  ( H ,  C H I ,  C H 2 ,  H D P M ,  C D P M )  
C 
C*********************************************************** 
C  
C  P R O G R A M  T O  C A L C U L A T E  3 H  6  1 4 C  I N  A  M I X T U R E  U S I N G  
C  B E C K M A N  L I Q U I D  S C I N T I L L A T I O N  C O U N T E R  W I T H  A U T O M A T I C  
C  Q U E N C H  C O E H E C T I C N .  E N D P O I N T S  A R E  0 - 3 9 7  &  4 4 0 - 6 5 5 .  
C  E F F I C I E N C Y  C C E F F I C I E N T S  W E R E  D E T E R M I N E D  U S I N G  
C  A  S E R I E S  O F  Q U E N C H E D  S T A N D A R D S .  
C 
c 
I M P L I C I T  R E A L*e ( A - H ,  O - Z )  
Table 5. Continued. 
E H 1 = 0 . 6  2 0 5 3 S 9 2 - C . 0  0 3 6 3 C 8 9 « H + 0 . 0 0 0 0 0 4 9  
E H 2 = 0 . 0 0 0 1 3  3 0 8 + 0 , 0 0 0 0 0 1 0 9 * H + 0 . 0 0 0 0 0  0 0  7 * H * * 2  
E C 1 = 0 . 1 6 2 3 6 6 C 6 + 0 . 0 0 0 8 6 9 7 2 * H - 0 . 0  0 0 0 0 7 7 5 * H » * 2 +  
1  C . 0 0 0 0 0 0 0 1 * H * » 3  
E C 2 = 0 . 6 6 4 1 3 3 6 2 - 0 . 0 0 0 1 2 0 3 2 * H - 0 . 0 0 0 0 0 2 2 3 * H * * 2  
C D P M =  ( C H 2 * E H 1 - E H 2 * C H 1 ) / ( E C 2 * E H 1 - E H 2 * E C 1 )  
H D P M = ( C H 1 - E C 1 * C C P M ) / E H 1  
E E I L E N  
E N D  
C*********************************************************** 
C  
c  S U E B O U T I N E  A E L C T  
C  
C * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
S U B B O U T I N E  A f L C T  ( N ,  I ,  T I M E ,  L N S A P ,  E X P T ,  D A T A )  
I M P L I C I T  EEA1*6 (A-H, 0 - Z )  
R E A I * 8  I N S A E  
C H A 8 A C T E R + 2 0  E X P T ,  D A T A  
D I M E N S I O N  T I M E ( N ) ,  L N S A P  ( N )  
C  
L  =  - N  
I E  ( I  . G I .  1 )  G C  T O  1 0  
C A L L  G R A P H ( I ,  T I M E ,  L N S A P ,  I ,  1 0 7 ,  5 . 0 ,  - 7 . 0 ,  0 . 0 ,  
1  0 . 0 ,  - 0 . 5 ,  C . C ,  
2  ' T I M E  ( M I N U T E S ) ; ' ,  ' S P E C I F I C  A C T I V I T Y ; ' ,  E X P T ,  D A T A )  
G O  T O  1 1  
1 0  C A L L  G R A P H S  ( I ,  T I M E ,  L N S A P ,  I ,  1 0 7 ,  D A T A )  
1 1  R E T U R N  
E N D  
C  
C  S U B R O U T I N E  C P I C T  
C  
c*********************************************************** 
S U B B O U T I N E  C E L O T  ( N ,  X ,  Y ,  G L A B ,  E L A B ,  I )  
IMPLICIT aEAL* 8  (A- H ,  0 - Z )  
D I M E N S I O N  X ( N ) ,  Y ( N )  
C H A B A C T E B * 2 0  G L A B ,  D L A B  
C 
IF (I . GI. 1 )  GO T C  1 0  
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Table 5. Continued. 
L = - N  
C A L L  G R A P H ( 1 ,  X ,  Y ,  I ,  1 0 7 ,  5 . ,  7 . , 0 . 0 ,  0 . 0 ,  0 . 0 ,  0 . 0 ,  
1  ' T I M E  ( M I N U T E S ) ; ' ,  ' C C 2  C C N C  ( U M O L / M L ) ; ' ,  G L A B ,  D L A B )  
G O  T O  1 1  
1 0  C A L L  G R A P H S  ( I ,  X ,  Y ,  I ,  1 0 7 ,  L L A B )  
1 1  R E T U R N  
E N D  
Î Î N T R Y  
$ £ T O F  
/ / G O . F T 1 4 F 0 0 1  D D  C S N A M E = 5 S H , U N I 1 = S C R I C H , D I S P = ( N E W , P A S S ) ,  
/ /  S P A C E =  ( 8 0 0 ,  ( 1 2 0 ,  1 5 ) ) ,  
/ /  C C B =  ( R E C F M  =  V B S , L R E C L  =  7 9 6 , B L K S I Z E  =  8 0 0 )  
/ / S M E L T T B  E X E C  E L O T , P L C T T E E = P H I N T E R  
/ / S M P L T T R  E X E C  E L O T , P L C T T E B = I N C R M N T I  
318 
T a b l e  6 ,  C o m p u t e r  p r o g r a m  t o  c a l c u l a t e  l e a s t - s g u a r e s  f i t  o f  
s p e c i f i c  r a d i o a c t i v i t y  d a t a  f r o m  s i n g l e - i n j e c t i o n  
e x p e r i m e n t s  t o  a  t h r e e - c o m p o n e n t  e x p o n e n t i a l  
c u r v e .  
/ /  J O B  
/ • J O E P A E M  L I N E S = 1 0  
/ / S T E P 1  E X E C  S A S , T I M E = ( 0 , 5 9 ) , R E G I C N = 1 9 2 K  
/ / D S 1  D D  O N I T = D I S K ^ V C L = S E P=LIBOCr , D S N = R . 1 4 0 1 8 . T E S T ,  
/ /  D I S P = ( N E W , C A I L G , C A T 1 G )  ,  
/ /  D C B =  ( S E C F H  =  f  D , L a E C L = 8 0 ,  B L K S I Z E = 6 i * 0 0 )  ,  
/ /  S P A C E =  ( T E K ,  ( 1 ,  1 )  , R L S E )  
/ / S Y S I N  D D  *  
[ A T A  R E C Y C L E ;  
I N P I I  
E X P T  $  1 - 8  
T  
S A ;  
* S A = S P E C I F I C  R A D I O A C T I V I T Y  A S  P E R C E N T  O F  D O S E ;  
C A R E S  ;  
P B G C  S O R T ;  B Y  E X P T ;  
P E O C  N L I N  M E T H O D = M A E Q U A B D T ;  B Y  E X P T ;  
P A R  M S  
A 1 = . 0 0 1 3 4  
K1=. 128 
A 2 = . 0 C C G 2 4  
K 2 = . 0 2 4 U  
A 3 = . 0 0 1 2 5  
K 3 = . 0 0 4 4 1 ;  
B C U N D S  
A 1 > 0  
A 2 > 0  
A 3 > 0  
K 1 > 0  
K 2 > 0  
K 3 > 0 ;  
M O D E L  S A  =  A 1 * E X P < - K 1 * T ) + A 2 * E X P ( - K 2 * T ) + A 3 * E X P ( - K 3 * T )  ;  
O U T P U T  0 U 1 = N E W 3  P R E D I C I E D = P 3  R E S I D U A L = R 3 ;  
T I T L E  T H R E E - E X E C N E N T I A l  F I T ;  
P B O C  P R I N T ;  
T I T L E  O U T P U T ;  
Table 6. Continued. 
[ A T A  _ N U L L  ;  
S E T  N E W 3 ;  
F I L E  E S I ;  
P U T  E X P T  $  1-e 
/ 1 0  T  6 . 2  
/ 1 8  S A  1 5 . 1 3 ;  
E U T  P 3  B 3 ;  
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T a b l e  7 .  C o m p u t e r  p r o g r a m  t o  p l o t  t h e  o b s e r v e d ,  p r e d i c t e d ,  
a n d  r e s i d u a l  v a l u e s  o f  t h e  l e a s t - s q u a r e s  f i t  o f  
s p e c i f i c  r a d i o a c t i v i t y  d a t a .  
/ /  J O B  
/ • J O E E A B M  L I N E S = 3 0  
/ / S T . E P 1  E X E C  W A I F I V  
/ / G O . S Y S I N  D C  *  
$ J O B  S W R , T I H E = 5 9 , P A G E S = 2 0 0  
C  
c 
C  P B O G E A M  T O  P L O T  O B S E R V E D  6  P R E D I C T E D  V A L U E S  O F  S P E C I F I C  
C  R A D I O A C T I V I T Y  R E S I D U A L S  V S .  T I M E  F O R  L A T A  S E T  C R E A T E D  
C  E Y  R E C Y C L E # # F I T 3 G L 0  ( S A S  N L I N  P R O G R A M  T O  F I T  3 -
C  C O M P C N E N T  E X P C N E K T I A L ) .  
C  
C  L A S T  T H R E E  [ A T A  C A R D S  M U S T  B E  O F  T H E  F O L L O W I N G  F O R M :  
C  . . . . V .  ,  1 . . . . V . . , . 2 . . . . V . . . . 3  C A R D  C O L U M N S  
C  S T C P  1 . 1  1 . 1  
C  1 1 1 1  
C  1  1  
C  
C  
R E A L  I S A  ( 4 0 ) ,  L P  1 ( 4 0 ) ,  I P 2 ( 1 0 ) ,  L P 3 ( 4 0 )  
D I M E N S I O N  T ( 4 0 ) ,  S A  ( 4 0 ) ,  P 3  ( 4 0 )  ,  
1  R 3 ( 4 0 )  ,  X ( 2 )  ,  Y  ( 2 )  
C  
C H A R A C T E R * 2 0  G L A i i  
C H A R A C T E R * 8  E X P T  ( 4 0 )  
C  
1 = 0 
10 1=1+1 
R E A D  ( 5 , 1 )  E X P T  ( I ) ,  T ( I ) ,  S A  ( I )  
1  F O R M A T ( A 6 ,  I X ,  F 6 . 2 ,  I X ,  F 1 5 . 1 3 )  
R E A D ,  F 3  ( I )  ,  H 3  ( I )  
C  
L S A  ( I )  = A L O G  ( S A  ( I )  )  
L P 3  ( I )  = A L O G  ( P 3  ( I )  )  
C  
I F  ( I  . E Q .  1 )  G O  T O  1 0  
I F  ( E X P T  ( I )  . N E .  E X P T  ( 1 - 1 ) )  G O  T O  2 0  
G O  1 0  1 0  
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Table 7. Continued, 
2 0  J = I - 1  
X  ( 1 ) = 0  
X  ( 2 )  = 1  ( J )  
Y n)=o 
Y  ( 2 )  = 0  
G L A B  =  E X P T  ( 1 )  
C  
C A L L  G R A P H  ( J ,  1 ( 1 ) ,  L S A ( 1 ) ,  1 1 ,  1 0 7 ,  5 . ,  - 7 . ,  0 . 0 ,  
1  0 , 0 ,  - . 5 ,  0 . 0 ,  
2  ' T I M E  ( M I N U T E S ) ; ' ,  ' S P E C I F I C  A C T I V I T Y ; ' ,  G L A B ,  • ; • )  
C A L L  G R A P H S  ( J ,  T ( 1 ) ,  L P 3 ( 1 ) ,  0 ,  1 0 4 ,  
1  ' T H R E E - E X E C N E N T I A L ; ' )  
C  
C A L L  G R A P H ( 2 ,  X ,  Y ,  0 ,  1 0 4 ,  5 . 0 ,  7 . ,  0 . 0 ,  0 . 0 ,  0 . 0 ,  
1  0 . 0 ,  ' T I M E  ( M I N U T E S ) ; ' ,  ' R E S I D U A L ; * ,  G L A B ,  ' ; ' )  
C A L L  G R A P H S  ( J ,  T ( 1 ) ,  R 3 ( 1 ) ,  1 1 ,  1 0 7 ,  
1 ' I H R E E - E X E C N E N T I A I ;  • )  
C  
I F  ( E X P T ( I )  . E Q .  ' S T O P  '  )  G O  T O  3 0  
C  
E X P T  ( 1 )  = E X P T  ( I )  
T ( 1 ) = T  ( I )  
S A ( 1 ) = S A < I )  
P 3 ( 1 ) = P 3 ( I )  
R 3 ( 1 ) = R 3 ( I )  
L S A  ( 1 )  = I S A  ( I )  
L F 3  ( 1 )  = L P 3  ( I )  
1 = 1  
G O  T O  1 0  
C  
3 0  S I O P  
E N D  
S E N T R Y  
S T O P  1 . 1  1 . 1  
1 1 1 1  
11 
$ S T O P  
/ / G O . f T U F C O l  C D  D S N A M E = 5 S M , U N I 1  =  S C R T C H , D I S P =  ( N E W , P A S S )  ,  
/ /  S E A C E =  ( 8 0 0 ,  ( 1 2 0 ,  1 5 ) ) ,  
/ /  r C B =  ( R E C F M = V B S , L R E C L - 7 S 6 , B I K S I Z E = 8 0 0 )  
/ / S M E L T T B  E X E C  E L O T , E L C T T E E = P R I N T E R  
/ / S M P L T T R  E X E C  E L C T , P L O T T E f i = I N C R M N T l  
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Table 8. Continued. 
D C  5 0  1 = 1 , I C  
R E A [ ( 5 , 4 0 )  D E £ C ( I )  
4 0  F C R M A T ( A 2 0 )  
5 0  C O N T I N U E  
C  
C  
C  I N P U T  M A T R I X  A  < A N  I C  X  I C  M A T E I X )  C O N T A I N I N G  A R E A  O R  
C  P L A T E A U  S P E C I F I C  R A D I O A C T I V I T Y  V A L U E S ;  W H E R E  A ( I , J )  I S  
C  T H E  A R E A  O F  E L A T E A U  F O B  P C C L  I  A F T E R  I S O T O P E  A D M I N I S -
C  T R A T I C N  I N T O  E C C L  J .  U N I T S  A R E  ( M I N  P E R  M M O L  C A R B O N ) X  
C  1 0 0 % .  
C  
D C  1 0 0  1 = 1 , I C  
D O  1 0 0  J = 1 , I C  
R E A D ,  A  ( I ,  J )  
1 0 0  C O N T I N U E  
C  
C  W R I T E  M A T R I X  A  
C  
V i F I T E ( 6 , 1 0 1 )  
1 0 1  F O R M A T  ( ' 1 ' ,  ' I N P U T  E C H O  O F  M A T R I X  A ' / )  
C  
D O  1 2 4  3 = 1 , I C  
W H I T E  ( 6 , 1 2 5 )  ( A  ( I ,  J )  ,  J = 1 , I C )  
1 2 5  F O R M A T  ( •  » ,  9  ( F 9 . 5 , 1 X ) )  
1 2 4  C O N T I N U E  
C  
I E = I C + 1  
I S I Z E = I C * I B  
C  
C  S E T  U S E D  P O R T I C N  O F  V E C T O R  B  ( I S I Z E  L E N G T H ) ,  T H E  B I G H T -
C  H A N D  S I D E  O F  T H E  S C I U T I C N  M A T R I X  T C  Z E R O .  
C  
D O  1 5 0  1 = 1 , I S I Z E  
B  ( I )  = 0  
1 5 0  C O N T I N U E  
C  
C  S E T  U S E D  P O R T I O N  O F  M A T R I X  S ,  T H E  L E F T - H A N D  S I D E ,  T O  Z E R O  
C  
D O  2 0 0  1 = 1 , I S I Z E  
D O  2 0 0  J =  1 , I S I Z E  
S ( I , J ) = 0  
2 C 0  C O N T I N U E  
c
 
c
 n n 
c
 
c
 n 
* 
ISJ » 
U1 i-i * O tz * 
c. M n 'V « 
n O • o g c * 
o o o f-3 * 
z CD fo o •tt 
HI to c cz <S « 
H M en g Ln l-î a> * 
Z o M o fo M # 
c il i-q o c c * 
M 1 M t/3 «— k4 M * 
II II en * O M 33 ca « O m s 2 •D * 
n R, n O * 
M ÏO r> ta 
M td z « 
t f )  •-9 c * 
W a» (Tri a» tn * 
N M M M n * 
W DO Cj g (-3 * 
O II W n » g hq KJ * 
M f *-3 * 
m fo O tn CO * 
w E M « * 
w * 
O 05 » 
3 •n O * 
M M * 
sa o Ci * 
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to H * 
CO O * 
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z * 
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o * 
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o rt * 
o ko * 
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Table 8. Continued. 
C  
C  
C  
C  
C  
C  I N E U T  K A T B I X  S  
C  
C  
C  
C  
c I N F D T  F I R S T  I C  F C 6 S  O F  P O S I T I V E  C O E F F I C I E N T S  A N D  
C  N E G A T I V E  C O E F F I C I E N T S  I N  F I E S T  I C  B O N S  A N D  C O L U M N S .  
C  
I A = I C - 1  
C  
B C  1 2 0  I P = 1 , I C  
S  ( I P , I P ) = - 1  
C ( I P , I P ) = - 1  
K = I P * I C + 1  
K I C = K + I A  
E C  1 2 0  J = K , K I C  
S  4 I P , J )  =  1  
C ( I P , J )  =  1  
1 2 0  C O N T I N U E  
C  
C  
C  I N P U T  F I R S T  I C  F C k S  O F  N E G A T I V E  C O E F F I C I E N T S  I N  C O L U M N S  
C  G R E A T E R  T H A N  I C .  
C  
I3RIP=0 
C  
D O  1 3 0  J = 1 , I C  
K  =  I C -  ( J -  1 )  
I F  ( J  . E G .  1 )  K  =  I C - 1  
D O  1 3 0  1 = 1 , K  
M = ( J + 1 ) * I C  +  J + 1 + ( I - 1 ) * I C  
I F  ( K  . L E .  I S I Z E )  G O  T O  1 3 1  
I T R I P = I T E I P + 1  
D C  1 3 5  N N = 1 , I T B I P  
M = N N * I C + J  
C ( J , K ) = - 1  
1 3 5  S ( J , H ) = - 1  
G C  T O  1 3 0  
1 3 1  S ( J , M ) = - 1  
C ( 0 , M ) = - 1  
1 3 0  C O N T I N U E  
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Table 8, Continued. 
C  
c 
c  I N P U T  O F  F C S I T I V E  C O E F F I C I E N T S  I N  E O N S  G R E A T E R  T H A N  I C  
C  A N £  N E G A T I V E  C O E F F I C I E N T S  I N  R O W S  G R E A T E R  T H A N  I C  A N D  
C  C O L U M N S  L E S S  T H A N  C E  E Q U A L  T O  I C .  
C  
D C  1 0 0 0  1 = 1 , I C  
D O  1 0 0 0  I P = 1 , I C  
N = I P + I C * I  
S  ( N , I P )  = - 1 * A  ( I P , I )  
C ( N , I P ) = - 1 * ( ( 1 0 * I P )  + 1 )  
K = I F * I C + 2  
K I C = K + I C - 2  
J J  =  0  
C O  1 0 C C  J = K , K I C  
J J = J o + 1  
I H O W A = J J  
I F  ( J J  . G E .  I P )  I E C W A = J J  +  1  
S  ( N , J )  = A  ( I R O W A , I )  
C  ( N , 0 ) = 1 0 * I E O » A  +  I  
1 0 C 0  C O N T I N U E  
C  
c  
c  I N P U T  R E M A I N I N G  C O E F F I C I E N T S  
C  
D O  1 1 0 0  1 1 = 1 , I C  
I T S 1 P = 0  
D C  1 1 0 0  J = 1 , I C  
K  =  I C -  ( J - 1 )  
I F  ( J  . E C .  1 )  K = I C - 1  
E C  1 1 0 0  1 = 1 , K  
N = J + I 1 * I C  
M =  ( J  +  1 )  * I C  +  J + 1  +  ( I - 1 ) * I C  
I F  ( M  . I E .  I S I Z E )  G O  T O  1 1 3 1  
I T R I E = I T f i I E + 1  
D C  1 1 3 5  N N = 1 , I I f i I F  
K = N K * I C + J  
C ( K , M ) = - 1 * ( ( 1 0 * J ) + I I )  
1 1 3 5  S  ( K , M )  = - 1 * A  ( J , I I )  
G O  T O  1 1 0 0  
1 1 3 1  S ( N , M ) = - 1 * A ( J , I I )  
C  ( N , M ) = - 1 *  (  ( 1 0 * J )  + 1 1 )  
1 1 0 0  C O N T I N U E  
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Table 8, Continued. 
C  
C  
C  
c  « R I T E  S I M O I T A N E O U S  E Q U A T I O N S  
C 
C - - '  
c  
WRITE (6,351) 
3 5 1  F O R M A T  ( ' 1 * ,  ' I N P U T  E C H O  O F  T H E  S E T  O F  S I M U L T A N E O U S ' ,  
1  I X ,  ' E C U A T I C N S ' / '  ( I N T E G E R  F O R M A T  C O D E  O F ' ,  
2  I X ,  ' V A R I A B L E S  I N  M A T R I X  A ) ' / )  
C  
C O  3 5 0  I = 1 , I S I Z E  
L = I S I Z E / 3 1  + 1  .  
D O  3 5 0  1 1 = 1 , 1  
I J = I L * 3 1  
J I = I J - 3 0  
I F  ( J I  . G î .  I S I Z E )  G C  T O  3 5 0  
I f  ( I J  . G ] .  I S I Z E )  I J = I S I Z E  
I F  ( I L  , G 1 .  1 )  G C  T C  4 0 5  
W R I T E  ( 6 , 2 )  B ( I ) ,  ( C ( I , J ) ,  J = J I , I J )  
l  F C F M A T  (  •  «  ,  F 6 . 1 ,  3 1  ( I X ,  1 3 ) )  
G O  T C  3 5 0  
4 0 5  W R I T E  ( 6 ,  4 0 6 )  ( C ( I , J ) ,  J  =  J I , I J )  
4 0 5  F C R M A T  ( '  '  ,  6 X ,  3 1  ( I X ,  1 3 ) )  
3 5 0  C O N T I N U E  
W R I T E  ( 6 , 3 5 2 )  
3 5 2  F O R M A T ( ' 1 ' ,  ' I N P U T  E C H O  O F  T H E  S E T  C F  S I M U L T A N E O U S ' ,  
1  I X ,  ' E C U A T I C N S ' / '  ' ,  ' ( R E A L  N U M B E R S  C O N T A I N E D  I N ' ,  
2  I X ,  ' M A T R I X  S ) ' / )  
C  
C O  5 0 0 0  1 = 1 , I S I Z E  
L = I S I Z E / 1 4  + 1  
E O  5 0 0 C  L L = 1 , I  
I J = L I * 1 4  
J I = I J -  1 3  
I F  ( J I  . G T .  I S I Z E )  G C  T O  5 0 0 0  
I F  ( I J  . G T .  I S I Z E )  I J = I S I Z E  
I F  ( L L  . G T .  1 )  G O  T O  5 0 0 5  
W R I T E ( 6 , 5 C C 2 )  B  ( I )  ,  ( S ( I , J ) ,  J = J I , I J )  
5 0 0 2  F O R M A T  ( '  » ,  1 5 ( F 7 . 3 , 1 X ) )  
G O  T O  5 C 0 0  
5 0 0 5  W R I T E  ( 6 , 5 0 0 6 )  ( S ( I , J ) ,  J = J I , I J )  
5 0 0 6  F C R M A T  ( '  '  ,  7 X ,  1 4  ( I X ,  F 7 . 3 ) )  
5 0 0 0  C O N T I N U E  
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C  
c 
c 
c 
c 
1 0  H = 1  
N = I S I Z E  
I A  =  9 0  
C  
C A L L  L E Q T 1 F ( S ,  H ,  N ,  l A ,  B ,  I D G T ,  W K A E E A ,  1 E R )  
C  
C  
c 
c 
C  W B I I E  S C L C J T I C N  T C  H A T E I X  S  
C  
C  
C  
W R I T E  ( 6 , 1 % )  
1 4  F O R M A T  ( ' 1 ' ,  « S O L U T I O N  T O  M A T R I X  E ' / '  • C A E B C N  F L O W » ,  
1  I X ,  ' I K  K f î C I  E E S  M I N ' / )  
W T I T E  ( 6 , 4 7 4 )  
4 7 4  F O R M A T  ( •  ' ,  " K E Y  T O  P O O L  l E E N T I T Y '  / )  
C  
L O  4 7 5  1 = 1 , I C  
W H I T E  ( 6 , 4 7 6 )  I ,  [ E S C  ( I )  
4 7 6  F O R M A T  ( '  ' ,  ' F O O L  ' ,  I I ,  A 2 0 )  
4 7 5  C C N T I N U E  
C  
P R I N T ,  '  •  
P R I N T ,  • I C G I = « ,  I D G T  
F E I N T ,  '  '  
C  
K = 0 
D C  5 0 0  1 = 1 ,  I B  
I T 0 = I - 1  
D O  5 0 0  J = 1 , I C  
K  =  K + 1  
I F B C = J  
I F  ( J  , I E .  I T C )  I F E 0 = J - 1  
W R I T E  ( 6 , 1 )  I T O ,  I F B C ,  B  ( K )  
1  F O E H A T C  ' F ' , I 1 , I 1 , '  =  ' , D 1 3 . 6 )  
5 0 0  C O N T I N U E  
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asvaois nna - Noiioios NoiivnDa evaNii - asoaana 3 
NoisiAaa 
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AI0NO3/WAI - a3in3WDD 
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Table 8. Continued. 
C  W K A R E A  -  W O B K  A E E A  O F  D I M E N S I O N  G B E A T E H  T H A N  O B  E Q U A L  
C  T C  N  .  
C  1 E R  -  E E E C B  î A f i A H E T E E .  ( O U T P D T )  
C  l E S M I N A L  E B R 0 8  
C  l E B  =  1 2 9  I N D I C A T E S  T H A T  M A T R I X  A  I S  
C  A L G O R I T H M I C A L L Y  S I N G U L A R .  ( S E E  T H E  
C  C H A E T E E  L  P R E L U D E ) .  
C  W A R N I N G  E R R O R  
C  1 E R  =  3 4  I N D I C A T E S  T H A T  T H E  A C C D f i A C Y  T E S T  
C  F A I L E D .  T H E  C O M P U T E D  S O L U T I O N  M A Y  B E  I N  
C  E E f O R  B Y  M C E E  T H A N  C A N  B E  A C C O U N T E D  F O B  
C  E Y  T H E  U N C E R T A I N T Y  O F  T H E  D A T A ,  T H I S  
C  W A E N I N G  C A N  B E  P R O D U C E D  O N L Y  I F  I D G T  I S  
C  G R E A T E R  T H A N  0  O N  I N P U T .  ( S E E  C H A P T E R  L  
C  P E E L U D E  F O B  F U F T H E B  D I S C U S S I O N ) .  
C  
C  P R E C I S I O N -  S I N G L E  A N D  D C U B L E / H 3 2  
C  / H A R D W A R E -  S I N t L E / H 3 6 , H 4 8 , H 6 0  
C  
C  R E Q D  I M S L -  L U C A T F , L U E L M F , D E B T  S T , U G E T 1 0  
C  F C U I I N E S  
C  
C  N O T A T I O N  -  I N F C E K A T I C N  C N  S P E C I A L  N O T A T I O N  A N D  
C  C O N V E N T I O N S  I S  A V A I L A B L E  I N  T H E  M A N U A L  
C  I N T B C D U C T I C N  O B  T H R O U G H  I M S L  R O U T I N E  U H E L P  
C  
C  C O P Y R I G H T -  1 9 7 8  E Y  I M S L ,  I N C .  A L L  E I G H T S  R E S E R V E D .  
C  
C  W A R R A N T Y  -  I M S L  W A B E A N T S  O N L Y  T H A T  I M S L  T E S T I N G  H A S  B E E N  
C  A P P L I E D  T O  T H I S  C O D E .  N O  O T H E R  W A R R A N T Y ,  
C  E X P R E S S E D  O R  I M P L I E D ,  I S  A P P L I C A B L E .  
C  
c 
C  
c 
S T O P  
E N D  
S E N T R Y  
